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THESIS ABSTRACT 
 
Measurements of muscle activity derived from surface EMG electrodes are variable 
due to both intrinsic and extrinsic factors. The intrinsic factors are endogenous in 
nature (features within the body) and include muscle fiber type, muscle fiber 
diameter and length, the amount of tissue between muscle and electrode, and 
depth and location of muscle with respect to the placement of electrodes (24). These 
biological factors vary between subjects and cannot be controlled. The extrinsic 
factors are experimental variables which are influenced by the researcher and can 
be controlled to some extent. Examples of extrinsic factors include the location, 
area, orientation, shape of electrodes and the distance between electrodes (inter-
electrode distance). In order to measure biological variation in the EMG signal, 
which is important in studies where surface EMG is used to gain understanding of 
physiological regulation, it is important to minimise the variation caused by these 
factors. This is in part achieved through the appropriate method of normalisation. 
 
The isometric maximal voluntary contraction (MVC) has been used as a standard 
method of normalisation for both static and dynamic exercises. However, 
researchers have recently improved the methods of normalisation by developing 
alternative techniques for the measurement of EMG during dynamic activities. By 
using the same type of movement for normalisation as during the trial, experimental 
errors can be reduced. The appropriate method of normalisation is defined as a 
method that is capabl  of showing repeatability, reliability (low intra-subject 
variation) and sensit vity to changes in EMG amplitude that is due to biological 
change and not the contribution of experimental factors. 
 
The aim of this thesis was to critically analyse alternative methods of EMG 
normalisation during dynamic exercise. The data should provide possible guidelines 
to researchers who are planning studies involving measurement of EMG activity 
during cycling, running and in clinical populations. Furthermore, the thesis aimed to 
illustrate that decisions regarding the most appropriate method of normalisation 
should be based on the study design, research question (absolute muscle activity or 
changes in muscle pattern) and the muscles being investigated. 
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Study One 
 
The aim of this study was to evaluate possible methods of normalisation for EMG 
measured during cycling. The ideal method of normalisation is required to show 
repeatability, intra-subject reliability and sensitivity to changes in exercise. Four 
methods for normalising EMG during cycling were evaluated and their repeatability, 
reliability and sensitivity to change in workload were compared. The methods of 
normalisation investigated in this study were; 1) MVC method, 2) Active Period MVC 
method (AP MVC), 3) Sprint method and 4) 70 % Peak Power Output Method. 
 
Thirteen well trained cyclists performed the same experimental protocol on three 
separate occasions separated by 5 - 7 days of normal training. EMG activity was 
measured on 6 muscles on the right leg namely; Vastus medialis (VM); Vastus 
lateralis (VL), Rectus femoris (RF), Biceps femoris (BF) and Medial and Lateral 
gastrocnemius (MG and LG respectively). Subjects firstly performed maximum 
voluntary contractions (MVC) using the Biodex Dynamometer 3, followed by a 10 s 
maximal sprint on an electronically braked cycle ergometer starting at 200W. 
Following this they performed an incremental test to exhaustion in order to obtain the 
Peak Power Output (PPO), where work rates began at 3.33 W.kg-1 body mass. After 
a resting period they performed a submaximal cycle at 70 % of PPO for 5 minutes at 
90 rpm. The study showed the 70 % PPO method to be the most repeatable method 
as it demonstrated ‘good’ repeatability for all muscles, ICC values ranged between 
R= 0.82-0.92. The 70 % PPO method also demonstrated the least intra-subject 
variability for 5 out of 6 muscles. The MVC method showed the highest percentage of 
intra-subject variation for most muscles except VM. The AP MVC and Sprint methods 
were found to be the most sensitive in detecting changes in muscle activity with 
increasing workloads. However, when the data were presented as power 
output/EMG ratio (the method with a slope close to zero suggests that the method is 
more sensitive in tracking changes in power output), the 70 % PPO method was the 
most sensitive method for tracking changes in power output for all muscles except 
VM. 
 
In conclusion, based on the results of the present study, these data suggest that 
normalising EMG to dynamic methods is the most appropriate method of 
normalisation for examining muscle activity during cycling over different days and for 
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once-off measurements. The method of normalisation most appropriate for EMG 
measurement during cycling was the 70 % PPO method. The 70 % PPO method is 
recommended for measurement of trials to exhaustion and in repeated trial study 
designs. The Sprint method is recommended for the measurement of maximal 
muscle activity.    
 
Study Two 
 
This study aimed to find the most appropriate method of normalisation for muscle 
activity during running. These methods should be in accordance to the requirements 
of an ideal method of normalisation. The study investigated three methods for 
normalising EMG during running, the methods were; 1) MVC method, 2) Sprint 
method and 3) 70 % Peak Running Speed Method 
 
Twelve well trained runners performed the same experimental protocol on three 
separate occasions separated by 5 - 7 days of normal training. EMG activity was 
measured on 6 muscles on the right leg namely; Vastus medialis (VM); Vastus 
lateralis (VL), Rectus femoris (RF), Biceps femoris (BF) and Medial and Lateral 
gastrocnemius (MG and LG respectively). Subjects firstly performed maximum 
voluntary contractions (MVC) using the Biodex Dynamometer 3, followed by two 20 
m maximal sprints on an indoor running track. Following this, they performed the 
Peak Running Speed test (PRS) until exhaustion, where running speed started at 10 
km.h-1 and increased by 0.5 km.h-1 every 30 s. After a resting period they performed a 
submaximal run at 70 % of PRS for 5 minutes. The MVC and Sprint methods were 
the most repeatable for normalising EMG activity during running.  The MVC method 
showed ‘good’ ICC values for VM, BF and MG (“good” repeatability where ICC R > 
0.80). The Sprint method showed ‘good’ repeatability for RF, VL and LG. The 70 % 
PRS method demonstrated the least intra-subject variability between trials. 
Furthermore, the 70 % PRS method had the greatest ability to detect changes in 
EMG with increasing running speed for most muscles except RF. Presenting the data 
as running speed/EMG ratio, the 70 % PRS method also had the greatest ability to 
track changes in running speed. However, the Sprint and MVC methods also showed 
low slope values for the running speed/EMG relationship and thus could also be 
considered as good methods for tracking EMG to exercise intensity. 
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In conclusion, based on the results of the present study, the methods of 
normalisation most appropriate for the measurement of EMG during running were the 
Sprint and 70 % PRS methods. These two methods of normalisation are 
recommended for trials to exhaustion and in repeated trial study designs, while the 
Sprint and MVC methods are recommended when measuring maximal muscle 
activity during a trial. 
 
Study Three 
 
This study aimed to apply the previously determined appropriate methods of 
normalisation for cycling trials and in particular to measure maximal muscle activity 
during incremental cycling to exhaustion. The study utilised the MVC and Sprint 
methods of normalisation, as these methods are associated with a maximal effort 
during a static isometric contraction and dynamic cycling sprint respectively.  
 
A similar research design was used as in the first study. Considering the advantages 
and disadvantages of each method, the Sprint method of normalisation was 
considered to be the most reliable and repeatable method, as well as being 
representative of the muscle movement used in cycling. The Sprint method was 
therefore chosen as the appropriate method of normalisation to evaluate muscle 
activity at exhaustion during cycling. The main finding of the study was that muscle 
activity at exhaustion, in all the major muscles during cycling, was submaximal as 
compared to EMG activity during a maximal cycling sprint. All six muscles measured 
in the study achieved peak activation of between 44 % - 65 % of that achieved during 
a 10 second all-out sprint. The intra-subject variability showed that only a few 
muscles had CV values which were less than 12 % at exhaustion. This is an 
indication that muscle activity at exhaustion varies from day-to-day. 
 
In conclusion, by using the most appropriate method of EMG normalisation, this 
study found that muscle activity was submaximal at exhaustion during PPO cycling. 
The findings support the central regulation of exercise and confirm that only a 
certain percentage of the limb muscle mass is active during maximal exercise. 
These findings are not compatible with the peripheral model of fatigue, as this model 
assumes that the total muscle mass is active at exhaustion. 
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Study Four 
 
This study attempted to answer the same question that was addressed in the 
previous study but used running as the mode of exercise. The study utilised the 
MVC and Sprint methods as methods of normalisation as these methods measure 
muscle activity during static isometric contraction and dynamic running sprints 
respectively.  
 
The same protocols were used as in the Study Two. After tabulating the advantages 
and disadvantages of each method of normalisation, the Sprint method was 
considered to be the most appropriate method. The Sprint method demonstrated 
greater intra-subject reliability and sensitivity to increasing running speed. By 
applying the Sprint method for normalisation, the main finding of this study showed 
that muscle activity at exhaustion was submaximal during running in all the measured 
muscles. This finding supports the results of Study Three. All six muscles measured 
in the study achieved peak activation of between 42 % - 66 % of that achieved during 
a 20 m maximal sprint. The intra-subject reliability showed only a few muscles had 
CV values which were less than 12 % at exhaustion. This indicates that muscle 
activity is never totally fixed at exhaustion. 
 
In conclusion, the findings from this study concur with Study Three, that muscle 
activity is submaximal at exhaustion during ‘maximal’ exercise. These findings 
support the central regulation of exercise and confirm that only a certain percentage 
of the limb muscle mass is active during maximal exercises. 
 
Study Five 
 
Measuring EMG activity in patients with Peripheral Vascular Disease (PVD) requires 
an appropriate method of normalisation to assess muscle activity and exercise 
intolerance in clinical populations. The MVC and Mean Dynamic methods of 
normalisation are the most recommended methods in the literature. The aims of the 
study were to apply an appropriate method of normalisation to measure and 
evaluate muscle activity in patients with PVD. This study describes the detailed 
findings in a case series of patients with PVD and functional incapacity, who 
undergo an angioplasty intervention. 
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Two patients (AA and AB) were recruited with diagnosed PVD. After partaking in the 
familiarisation trial, the patients arrived at the laboratory prior to their angioplasty 
procedure. They were prepared for the placement of the electrodes on four muscles 
(VM, VL, MG and LG) on both the right and left leg. They then performed maximal 
voluntary contractions on the Biodex Dynamometer 3. Following this, the patients 
were instructed to walk on the treadmill until exhaustion using the Graded Treadmill 
exercise test (GTET) protocol, which involved walking at a constant speed of 3.2 
km.h-1 starting at a 2 % gradient which was increased by 2 % every 2 minutes until 
exhaustion. Heart rate and brachial blood pressure were monitored every two 
minutes during exercise. Patients were asked to report their perceived pain using a 
perception of pain scale and rate their perceived exertion by indicating a value on 
the Borg scale. During exercise, oxygen uptake (VO2) was measured using the 
Oxycon Alpha Analyzer (Oxycon, Viasis, Hoechberg, Germany). Prior to the 
initiation of exercise, a resting venous blood sample (two millilitres) was directly 
drawn from a subcutaneous forearm vein in patient AB.  An additional two millilitre 
blood sample was collected at three, four and five minutes post exercise. The blood 
was then analysed to determine peak blood lactate concentrations. Three days after 
the Pre-Angioplasty trial, the patients underwent angioplasty of the popliteal artery 
(patient AA) and of the femoral artery (patient AB). Once the blood flow was 
restored, the same radiographer measured the blood flow velocity using a duplex 
Doppler, to measure change in blood velocity. Following a three day recovery period 
from the angioplasty, subject  returned to the laboratory where they repeated the 
exercise trial (Post-Angioplasty trial).  
 
EMG data analysis using both methods of normalisation (i.e. MVC and Mean 
Dynamic methods) resulted in contrasting findings. When normalising muscle 
activity using the MVC method, both patients had a decrease in muscle activity in 
the diseased leg after angioplasty, for most muscles. In contrast when normalised 
using the Mean Dynamic method, muscle activity in the diseased leg, increased 
after angioplasty in both patients. The Mean Dynamic method was chosen as the 
more appropriate method, as the MVC method could have produced abnormally low 
EMG activity during the MVC (due to possible muscle inhibition). In addition, the 
MVC method of normalisation is considered less sensitive than the Mean Dynamic 
method in tracking changes in muscle activity with increasing exercise intensity. By 
using the Mean Dynamic method of normalisation, the study was able to 
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demonstrate a reduction in muscle activity during the state of peripheral vascular 
disease. Muscle activity in the diseased leg then increased to greater activity than 
the non-symptomatic (healthy) leg after angioplasty. The physiological variables of 
both patients improved after angioplasty. For example peak blood lactate 
concentration (which has been assumed to be the reason for claudication pain) was 
less than that of healthy controls and patients with other chronic diseases.  
 
The alteration in muscle activity after angioplasty is a novel finding. It can be 
assumed that these changes in the muscle activity could be seen as a readjustment 
of the central drive to the lower limbs and a possible regulatory mechanism to 
protect the body from being harmed, especially in this diseased state. 
 
The findings of this thesis have established that different methods of normalisation 
should be used for different studies. It is important that researchers use a method of 
normalisation that is suitable to their study design and research question.  Choosing 
the most appropriate method of normalisation reduces experimental error and 
increases the chance of detecting biological variation and hence improves the 
interpretation of the data. 
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LIST OF ABBREVIATIONS 
 
Ankle Brachial Index               ABI 
American College of Sports Medicine ACSM 
Analysis of Variance ANOVA 
Active Period Maximum Voluntary Contraction AP MVC 
Biceps femoris BF 
Body Mass Index BMI 
Coronary Artery Bypass Grafting  CABG 
Central Nervous System CNS 
Coefficient of Variation CV 
Electrocardiogram ECG 
Electromyography EMG 
Graded Treadmill Exercise Test GTET 
Heart Rate HR 
Intra-Class Correlation  ICC 
Intergrated Electromyography iEMG 
Lateral gastrocnemius LG 
Maximal Voluntary Contraction MVC 
Median Frequency MDF 
Medial gastrocnemius MG 
Physical Activity Readiness Questionnaire PAR-Q 
Peak Power Output  PPO 
Peak Running Speed PRS 
Percutaneous Transluminal Angioplasty PTA 
Peak Treadmill Running Speed PTRS 
Peripheral Vascular Disease PVD 
Rectus femoris RF 
Root Mean Square RMS 
  
Measurements  
Beats per minute bpm 
Centimeters per second cm.s-1
Degrees Celsius °C 
EMG per unit force µv.Nm 
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Force Nm 
Hertz Hz 
Hour h 
kg Kilogram 
Kilometer km 
Kilometer per hour km.h-1
Meters per second m.s-1
Micro-volt per second µv.s-1
Micro-volt second per second (µv.s)s-1 
Milligrams per day mg.day-1 
Millimeter mm 
Milliliter per kilogram per minute ml.kg-1.min-1 
Millimole per liter mmol.l-1 
Minute min 
Revolutions per minute rpm 
Oxygen uptake VO2 
Watts  W 
Watts per kilogram W.kg-1
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CHAPTER 1 
 
ELECTROMYOGRAPHY: DEVELOPMENT AND FACTORS INFLUENCING 
MEASUREMENT IN LABORATORIES 
 
 
REVIEW OF THE LITERATURE 
 
Electromyography is defined as the study of muscle function by examination of the 
electrical signals that emanate from skeletal muscle (13). 
  
1.1 HISTORICAL DEVELOPMENT OF ELECTROMYOGRAPHY 
 
The detection of electrical signals within muscles originates from research 
performed as early as 1658.  Swammerdam introduced the mechanics of muscular 
contractions by performing experiments on muscle and nerve irritation (cited in (28)). 
He discovered that stroking the innervating nerve of a frog’s Medial gastrocnemius 
muscle generated a contraction. Thereafter, Galvani published research on 
muscular irritation in 1792, where he discovered frog muscle could be excited by an 
electrical current (100). However, due to limited instrumentation, his work was not fully 
accepted until almost 40 years later. Electric current was only shown to be linked to 
muscular contraction in 1838. This was demonstrated by Matteucci using a 
galvanometer (machine which is able to detect and measure small electric current) 
(38; 100). 
 
However, the most important development in electromyography (EMG) was 
accomplished by Duchenne de Boulogne in 1850. de Boulogne studied the 
dynamics and functions of intact skeletal muscles and electrical stimulations. He 
developed techniques for registration and stimulation of both muscle and nerve, and 
applied electrodes for recording the path electric current in contracting muscle 
fibers(cited in (30)).  Piper was, however considered to be the first researcher to study 
the EMG signal (133). In 1907 he developed the metal surface electrode and in 1912 
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recorded human voluntary muscle activity by utilising the Einthoven's string 
galvanometer (154). Thereafter, Proebster in 1928, was able to describe spontaneous 
irregular action potentials in the denervated muscle of a human subject (154). He was 
thus seen as a key contributor to the field of clinical electromyography.  
 
In 1929, Adrian and Bronk, developed the concentric needle electrode and which 
enabled them to conduct studies on motor unit action potential (5). These researchers 
amplified muscle action potential activities and used this amplified signal to produce 
an output from a loudspeaker. The information carried by the resulting sound aided 
in interpreting the EMG signal (5). By using this technique, the researchers 
determined that there was no spontaneous electrical activity in completely relaxed 
normal muscle. This approach, for the first time enabled the measurement and 
observation of electrical activity associated with individual or small groups of muscle 
fibers (13).  
 
The first visual format of EMG was introduced by Gasser and Erlanger in 1922. 
They used a cathode ray oscilloscope in place of the galvanometer, to show 
electrical signals from muscles (13). The cathode ray oscilloscope helped 
neurophysiologists to study the undistorted shape of muscle activity (154). 
Subsequently, the development of sensitive electronic equipment and the invention 
of new techniques to study muscle, contributed significantly to the analysis of EMG 
(154). However, kinesiological study (which is the analysis of function and 
coordination of muscles in different movements and posture in a variety of human 
conditions) only advanced after the development of electrically stable silver-chloride 
electrode and the non-obtrusive wire electrode in 1960  (13). With the introduction of 
the above mentioned advancements, the accuracy of the EMG signal interpretation 
was improved and its application has branched from traditional diagnosis of muscle 
disorders to exercise physiology, movement analysis, rehabilitation, biofeedback 
and myoelectric control of prostheses. 
 
EMG has contributed significantly to research in the aetiology of fatigue, and has 
become a fundamental research tool in exercise physiology and clinical studies. 
Earlier investigations of fatigue have measured EMG data during sustained 
muscular contractions (42; 76; 92; 102; 116; 188). The sustained isometric contraction 
allowed fatigue to be localised to the muscle or group of synergistic muscles 
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performing the contraction (13). From as early as 1954, researchers considered 
localised fatigue to be influenced peripherally (within muscle tissue) and centrally (in 
brain and spinal cord). Important theories were derived to explain the increase in 
amplitude and frequency shift of EMG signal observed during sustained, constant 
force isometric contractions. Due to these studies and the development of new 
technology, research has extended into studying fatigue during dynamic movement. 
This has been achieved by applying the interpretation of fatigue developed from 
static isometric contraction, to understand data obtained during dynamic activity. 
However, EMG becomes complicated during dynamic activity due to changes in 
muscle morphology and other biological and extrinsic factors which influences the 
EMG signal (which is discussed in further detail from Section 1.2.3.1). The thesis 
thus focuses on the measurement of muscle activity during dynamic activity and 
attempts to clarify the difficulty in measuring EMG in dynamic exercise performed in 
athletic and clinical populations.  
 
1.2 ELECTROMYOGRAPHY 
 
1.2.1 Muscle Physiology 
 
Skeletal muscle fibers are innervated in groups called motor units which are 
activated by the central nervous system (CNS) via α- motorneurons. α- 
Motorneurons are neural structures whose cell bodies are located in the anterior 
horn of the spinal cord and through the large diameter axon and terminal branches, 
innervates a group of muscle fibers (13). The motor units are continuously activated 
by the CNS for as long as the muscle is required to generate force. To produce 
greater forces, the CNS increases excitation to the motor units, which results in a 
greater number of motor units being activated and an increase in the firing rates of 
all active motor units (38). The electrical signal that originates from the activation of 
muscle fibers, and which is within the detectable range of an electrode, is called a 
motor unit action potential (38; 141). The motor unit action potential propagates from 
the innervation zone in both directions along each muscle fiber. 
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1.2.2 EMG signal 
 
The EMG signal is comprised of a time and frequency domain (47). Amplitude 
analysis (area under the curve) is derived from the time domain and requires 
rectification of the raw EMG signal, either linearly, by forming the absolute values of 
the raw signal, or quadratically, by calculating the squares of the raw signal. This 
rectified data must then undergo a ‘moving’ or ‘weighted’ averaging over a suitable 
time window. With linear rectification, the outcome is referred to as average rectified 
value. In quadratic rectification, the root is taken of every average reading and is 
referred to as the root mean square (RMS) and is the preferred recommendation for 
smoothing (77).  The size of the amplitude reflects both the number of active motor 
units and their firing rates. During a sustained contraction, the resultant increase in 
amplitude has been suggested to be due to both the recruitment of new motor units 
and the synchronisation of motor unit firing rates (37).  
The frequency domain of the EMG signal can be expressed by the frequency 
spectrum of the EMG signal.  The most common method used for estimating the 
spectrum (frequency content) of the EMG signal is the Fast Fourier Transformation 
algorithm which can be described as a decomposition of the EMG signal to its 
underlying sinus contents (199). For example, if the most dominant sine wave is 
recognised at 100 Hz, the EMG has the most power at this frequency. If this power 
distribution analysis is done continuously over a certain Hertz range, a frequency 
distribution graph or total power spectrum is created. The total power spectrum can 
be calculated again by the following frequency parameters, namely the median and 
mean frequency. The median frequency divides the area of the spectrum into two 
equal halves and the mean frequency is the mathematical mean value of the 
spectrum curve (132).  
Frequency analysis is used to estimate contractile fatigue, fiber type compositions 
and identify pathologies (13). The mean or median frequency of the spectrum is 
influenced by muscle fatigue. During fatigue states there is an increase in the 
amplitude of the low frequency band and a relative decrease in the amplitude of 
higher frequency band. This results in a frequency shift to the left. The frequency 
shift has been attributed to changes in conduction velocity, changes in intra-
muscular pH, altered recruitment and synchronisation of the motor units and the 
fiber type (13; 160). The frequency aspect of the EMG signal is beyond the scope of 
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this thesis and thus the following chapters will focus on the amplitude characteristic 
of the EMG signal. 
Two main types of electrodes are used to measure or detect EMG signals; 
needle/fine-wire electrodes (which are inserted into the muscle) and surface 
electrodes (placed on the skin surface overlying the muscle). 
 
1.2.3 Needle/Fine-wire EMG 
 
Needle or fine-wire EMG recording involves the insertion of an electrode into the 
muscle tissue. The needle electrode contains either one (monopolar) or two (bipolar) 
insulated wires in the cannula. The tip of the wire is exposed and acts as a detection 
surface (13). Motor unit action potentials are detected in a small number near the 
needle tip (13; 133).  Fine - wire electrodes are extremely fine and cause relatively little 
pain during insertion. They are manufactured from mainly highly oxidised, stiff wire 
with insulation (13). The action potentials of the muscle fibers closest to the active 
surface of the needle or wire are recorded with higher amplitudes than the more 
distant fibers (13). Needle EMG is useful in detecting changes in motor unit size and 
is able to detect abnormal muscle function. Therefore this method of EMG recording 
is useful in studying clinical conditions including the effects of loss of nerve supply to 
the muscle, regeneration of nerves and the skeletal muscle myopathies. In addition, 
needle EMG techniques allow the study of motor unit recruitment and firing patterns, 
which provides information about CNS motor control (181). By using needle EMG, 
researchers are able to measure the effects of fatigue on muscle by measuring 
conduction velocity, mean and median frequency.  
 
The disadvantages of utilising needle EMG are; 1) it is an invasive measurement 
and is therefore difficult to use when measuring EMG on more that one occasion 
(due to the re-insertion of the needle in the same place and possible damage 
caused to the muscle fibers); 2) the use of needle EMG may cause minor damage to 
the muscle fibers from where the signal is detected, consequently influencing the 
shape of the motor unit action potential and 3) once the electrode is inserted the 
subject is required to remain steady as slight movement could result in changes in 
motor unit action potential. 
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1.2.4 Surface EMG  
 
Surface electromyography (EMG) is obtained from the summation of electrical 
activity of the active motor units, detected by the electrodes placed on the skin 
overlying the muscle. Bipolar electrodes, which consist of two electrodes placed 
next to each other, are commonly used in modern day research. The EMG signal is 
thus an electric potential difference between the two electrodes. The information 
received from EMG is considered a global measure of motor unit activity since the 
surface electrodes are unable to detect specific activity levels of a single motor unit. 
Therefore the surface EMG signal is viewed as a more complex signal to that of the 
more invasive methods (needle/fine-wire).  
 
Surface EMG signal is dependant on the membrane properties of the muscle fiber, 
the timing of motor unit action potentials and motor unit firing rates. It is therefore 
considered to reflect both central (central nervous system and spinal cord) and 
peripheral properties (for example, muscle fiber, metabolites, ion concentrations) of 
the neuromuscular system  (60).  
 
During trials involving static or isometric exercise, techniques including fine-wire, 
intramuscular EMG and transcranial magnetic stimulation have been used as a 
direct measure of the motor unit activation.  However, during dynamic exercise, 
these techniques are not yet practical, and so the use of surface EMG remains the 
only feasible alternative method of measuring muscle activity. Surface EMG 
measurement of muscle activity is technically easier than the above methods and 
allows for the simultaneous and frequent measurement of multiple muscle groups. 
Therefore surface EMG is seen as the more appropriate measurement and should 
thus be improved upon, by simplifying the signal. Until researchers are able to 
produce a less complex signal, the interpretation of data derived from surface EMG 
should be made with caution. 
 
Measurements of muscle activity derived from surface EMG electrodes are however 
variable due to both intrinsic and extrinsic factors. The intrinsic factors are biological 
in nature (features within the body) and include characteristics of the muscle fiber 
such as, muscle fiber type, muscle fiber diameter and length, the amount of tissue 
between muscle and electrode, and depth and location of muscle with respect to the 
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placement of electrodes (24). These biological factors vary between subjects and 
cannot be controlled.  
 
The extrinsic factors are experimental variables which are influenced by the 
researcher and can be controlled to some extent. Examples of extrinsic factors 
include the location, area, orientation and shape of electrodes and the distance 
between electrodes (inter-electrode distance) (24). Recording factors including 
processing of the EMG signal, amplification filters, various noise contributions 
(ambient and transducer) and motion artefacts are also classified as extrinsic 
factors but are beyond the scope of the thesis. 
 
It is important to note that due to the influence of the above mentioned intrinsic and 
extrinsic factors on the EMG signal, surface EMG should interpreted with caution. 
Indeed interpretation of surface EMG in dynamic tasks is complicated further by 
additional factors including the signal non-stationarity, shift of electrodes relative to 
muscle fiber during contraction and the change in conductivity properties of tissues 
separating the electrodes and muscle fibers (58). These factors will be described in 
more detail in subsequent sections. 
 
The biological and experimental factors, which are common to both static and 
dynamic contractions, have been investigated extensively and are summarised in 
Figure 1.1. 
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Intrinsic/ 
Biological Factors
Muscle Fibre Characteristics
-Biladeau et al (19)
- Moritani et al (140)
Muscle Length
-Kamen & Caldwell (93)
-Enoka (49)
-Moritani et al (139)
-Morimoto (138)
-Elantora & Komi (48)
Electrode Placement
-Falck et al (56)
-Roy et al (164)
-Zipp et al (200)
-Vigreux et al (186)
-Zuniga et al (201)
Inter-Electrode Distance
-Hermans et al (82)
-Kamen & Caldwell(93)
-Fuglevand et al (67)
-Vigreux et al (186)
-Zuniga et al (201)
-Kamen et al (93)
-Winter (195)
-Deluca & Merletti (39)
Amplitude Cancellation
-Keenan et al (97)
-Day & Hullinger (36)
Conductivity of Tissue
-Mesin (137)
Electrode Shift
-Farina et al (58)
-Farina et al (61)
Extrinsic/
Experimental Factors
Tissue Filtering
-Nordander et al (147)
-Farina, 2004 (60)
-Andreassen & Rosenfalck (4)
Muscle Crosstalk
Surface EMG Signal
Electrode Orientation
-Vigreux et al (186)
-Mathiassen & Hägg (123)
Normalisation Methods
- Dubo et al (44)
-Yang & Winter (197, 198)
-Shiavi et al (168, 169)
-Burden et al (24, 25)
Electrode size
-Hermans et al (82)
-Merletti & Hermans (131)
 
Figure 1.1: Summary of important intrinsic biological and extrinsic experimental factors that 
are common to both static and dynamic contractions. 
 
 
 
1.2.4.1          Intrinsic/Biological factors 
 
As mentioned previously, intrinsic or biological factors include muscle fiber type, 
muscle fiber diameter and length, the amount of tissue between muscle and 
electrode, and depth and location of muscle with respect to placement of electrodes 
(24). 
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1.2.4.1.1 Muscle fiber characteristics 
 
Action potentials have greater amplitude in Type II muscle fibers than in Type I 
muscle fibers, due to higher conduction velocities. Furthermore, action potentials 
derived from Type II muscle fibers have an intrinsically higher frequency content 
than those action potentials transmitted from Type I muscle fibers. Therefore EMG 
measurement from a muscle with higher proportion of Type II muscle fibers should 
have higher frequency than EMG from a muscle with a higher proportion of Type I 
muscle fibers (19; 140). This has implications for comparisons between individuals, 
since the proportion of Type I and II muscle fibers are different between individuals 
and therefore the EMG signal will be influenced.  
 
1.2.4.1.2 Muscle length 
 
Muscle length changes with movement. As the muscle length increases, the muscle 
fiber diameter decreases resulting in an alteration of action potentials, and a 
decrease in EMG amplitude (81; 93; 138). Furthermore, the conduction velocity 
decreases due to smaller fiber diameter (138).  
 
Studies have also shown that the rate of change of muscle length alters the EMG 
amplitude (81). For example, EMG amplitudes are greater during dynamic muscle 
activity (involving lengthening and shortening actions, and referred to as eccentric 
and concentric respectively) than in static (isometric, no change in muscle length) 
actions. In isometric actions, muscle fibers experience difficulty in producing force in 
this shortened state. In addition, eccentric muscle actions generate less EMG 
amplitude than concentric actions at the same workload (48; 193).This can be 
explained by the less favourable length-tension relationship of the actin-myosin 
crossbridges (139). As the muscle fiber lengthens, as occurs during eccentric actions, 
the actin and myosin filaments overlap declines until the two can no longer overlap, 
and no force is generated (23). Furthermore, during eccentric actions the lengthening 
of muscle fibers requires lower levels of voluntary activation by the nervous system 
to achieve a given muscle force. Thus resulting in a decrease in EMG amplitude (49; 
153). Therefore the changes in the muscle length-tension relationship accounts for 
the greater EMG amplitude measured during dynamic contraction (21). For this 
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reason the interpretation of activity can be complicated during dynamic exercise 
where the muscle lengthens and shortens during the bout.  
 
1.2.4.1.3 Tissue filtering (i.e. tissue between electrode and muscle, 
depth of muscle) 
 
The tissue between the electrode and muscle fibers consists of skin, fat and 
connective tissue. These tissues cause attenuation in the signal strength, resulting 
in decreased signal amplitude and frequency as the depth of the tissue increases. 
This is known as the low pass filtering effect (62; 93). The largest motor units are 
detectable at depths of approximately 35 mm (67). Nordander et al (147) found EMG 
amplitude to decrease with increasing muscle-electrode distance, furthermore they 
demonstrated that not only the distance, but also the electrical properties of 
subcutaneous tissue, are of importance for the attenuation of the EMG signal. The 
electrical properties are affected by fatigue, temperature and ionic concentrations 
including sodium and potassium (93). Ionic fluctuations alter the excitability of the 
muscle fiber membrane (7), thereby influencing the amplitude and frequency 
domains of the EMG (54). Furthermore, metabolic  
 
1.2.4.2           Extrinsic/Experimental factors 
 
1.2.4.2.1 Electrode orientation 
 
Two factors are important with regards to the surface electrode position. Firstly, the 
electrode orientation, defined as the direction of the sensor in relation to the 
orientation of the muscle fibers, is of importance. Secondly, the positioning of the 
electrode, defined as the location of the centre of the sensor on the muscle, is 
perhaps equally as important. 
 
Electrodes should be orientated and placed parallel to the muscle fibers as less 
than 50 % of the amplitude is captured when the electrodes are placed 
perpendicular, rather than parallel, to the orientation of the muscle fibers (186).  
However, De Luca (40) recommends that the electrode placement should be 
perpendicular to the length of the muscle fibers, since there is less variability in the 
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EMG signal using this orientation. Hermans et al. (82), examined 144 peer reviewed 
papers on the applied surface EMG sensor properties and sensor placement 
procedures, and found that there was a general concensus about orienting the 
surface electrode parallel to the muscle fibers. The orientation of the surface 
electrodes impacts on experiments where EMG data are measured on different 
days, as it is important that the researcher re-aligns the electrodes to similar 
orientation and position to the muscle belly as used in the previous testing sessions. 
 
1.2.4.2.2 Inter-electrode distance 
 
Inter-electrode distance is defined as the centre-to-centre distance between the 
conductive areas of two electrodes (82). There is high variability in EMG amplitude 
for inter-electrode distances (82). For most muscles a certain distance range between 
electrodes were found to provide optimum EMG signals eg. Biceps femoris: 20-50 
mm, Rectus femoris: 1-50 mm, gastrocnemius: 10-50 mm  (82). Thus, the preferred 
inter-electrode distance used by researchers is approximately 20 mm (82). A further 
consideration is that inter-electrode distance should be determined such that the 
two electrodes do not approach the area of motor neuron innervation or tendon 
zones (29; 82) as this may cause large variation in EMG amplitude.  
 
1.2.4.2.3 Electrode placement 
 
Electrode placement is perhaps the most significant variable determining the 
fluctuation in EMG amplitude and frequency over different testing sessions. In 
addition to the above mentioned factors, the placement of electrodes over the motor 
neuron innervation zone could also result in a cancellation of the signals from both 
surface electrodes given that motor unit action potentials propagate bi-directionally 
from the innervation zone, resulting in highly variable recordings from EMG (93). The 
EMG signal is less stable and reproducible if placed on or near the innervation 
zone, since a slight shift of the electrode sensor could move it to a place near or 
over the innervation zone (82). The most reliable EMG signals are obtained from the 
muscle belly area between the innervation zone and the most distal tendon (29). 
During complex movements in sport and physical activity, the muscle belly shortens 
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in the proximal direction during concentric contractions and the electrode on the 
skin may shift to a position over the distal tendon.  
 
The location of the innervation zone of the muscle can be determined by using 
100 ms segments of raw surface EMG signals from adjacent channels (electrode 
array). The data are then plotted to observe the location where the reversal of the 
signal direction occurs. The location of the innervation zone under the electrode 
array is then estimated by evaluating which electrodes show the reversal in signal 
direction. Rainoldi et al. (161) studied the locations of the innervation zones using 
linear electrode array. The study examined 13 muscles and found that 8 out of the 
13 muscles studied, provided information on the ability to provide electrode 
locations based on innervation zone location and bony landmarks. They suggest 
that for Medial gastrocnemius, Soleus, Gluteus medius, Peroneus longus and 
Rectus femoris muscles, it is necessary to determine each individual’s innervation 
zone location before the placement of the electrodes. However, the study does not 
make mention of the effect of innervation zone shifts on EMG amplitude.  
 
The study thus recommends that researchers use the electrode array in identifying 
innervation zones before electrode placement. Although it is possible to use the 
electrode array method to determine electrode placement, electrode arrays are 
costly, and the availability in physiology laboratories is thus limited. It is thus 
proposed that if EMG needs to be measured during repetitive contractions, and the 
electrode array is unavailable, that the electrodes are placed over the visual 
midpoint or muscle belly of the contracted muscle by using anatomical landmarks 
and standardised measurements in the placement of the electrodes  (27; 31). 
 
1.2.4.2.4 Electrode size 
 
Hermans et al.(82) reported that the majority of the research has used circular 
electrodes with a diameter ranging between 8 mm to 10 mm. Small electrodes are 
preferred since larger electrodes introduce excessive low-pass filtering effects which 
attenuates the EMG signal.  Therefore, when two electrodes are placed next to 
each other, the inter-electrode distance should be reduced to the range of 20 mm 
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as previously discussed. The recommended size of electrodes should therefore not 
exceed 10 mm (131).  
 
1.2.4.2.5 Muscle crosstalk  
 
Muscle crosstalk refers to the phenomenon where a signal recorded over a 
particular muscle is in fact generated by a nearby muscle  (60). Thus the measured 
EMG signal is not discernable from the signals originating from deep underlying or 
adjacent muscles. The effect of crosstalk can be minimised through careful use of 
appropriate procedures (195). Placing pairs of electrodes at least 20 mm apart 
minimises crosstalk of the signal. Winter et al. (195) suggested a technique to identify 
and measure the presence of EMG crosstalk. This technique involves the subject 
performing a resistance test to isolate specific muscle groups. EMG activity is then 
examined in the non-active muscles. If the non-active muscle displays a resultant 
EMG signal, then one can assume the presence of crosstalk. 
 
1.2.4.2.6 Electrode shift during muscle contraction 
 
During muscle contraction and subsequent movement, the electrode on the skin 
overlying the muscle may shift with respect to the muscle fibers originally being 
recorded (61). This results in the electrode having a different position throughout the 
range of movement relative to the muscle fibers. This causes an unwanted signal 
component which is difficult to predict or remove  (58). Farina et al.(195) investigated 
the effect of leg movement on the shift of the innervation zone relative to the 
electrodes. The study demonstrated during knee and ankle movement that the 
innervation zone shifted approximately 10 mm for Vastus lateralis and Vastus 
medialis, while for Rectus femoris the innervation zone shifted 5 mm, Biceps 
femoris  30 mm and Medial gastrocnemius 10 mm. Lateral gastrocnemius however, 
did not show any shift in innervation zone over the range of movement. 
 
It is possible that the use of electrode arrays (to maximise recording area) and 
spatial filtering (63) might minimise this technical problem; yet, these techniques are 
expensive and time consuming. Thus the potential problem of electrode shift over 
muscles during dynamic exercise is still not adequately answered. 
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1.2.4.2.7 Conductivity of tissues  
 
The movement of a joint results in changes of muscle fiber diameter, length and 
orientation thus altering conductivity of muscle tissue. At each point along a muscle, 
relative fiber direction changes with movement (137), thus conductivity of tissues 
surrounding the fibers are changed resulting in an alteration in the measured action 
potentials at skin surface.  In addition, the increasing sweat rate during dynamic 
activity alters electrode-skin resistance. The electrode contact stability is therefore 
reduced by sweating excessively. Thus the changing conductivity of tissues during 
dynamic activity is an important contributor to EMG variation. 
 
1.2.4.2.8 Amplitude cancellation 
 
Amplitude cancellation occurs when the positive and negative phases of the motor 
unit action potentials cancel one another. This occurrence reduces the amplitude of 
the EMG signal therefore underestimating the true measurement of motor unit 
activity (36; 97). This limits the interpretation of recruitment patterns and muscle 
activity. The magnitude of the signal lost due to amplitude cancellation can be 
calculated by comparing the signal amplitude obtained by summing motor unit 
action potentials before and after rectification (through filtering and RMS) of each 
potential (36; 60).  
 
A possible technique to minimise amplitude cancellation is to normalise EMG 
activity to maximal levels of muscle excitation which can be obtained from maximal 
voluntary contractions. Day & Hulliger (36) demonstrated this technique by using a 
computational model which simulated surface EMG. They demonstrated a minimal 
amplitude cancellation of less than 5 % when normalising to maximal values. The 
amplitude cancellation increased up to 17 % when normalised to intermediate levels 
of muscle excitation. 
 
1.2.4.2.9 Normalisation of the EMG signal 
  
Most factors which introduce experimental error (discussed above) are common to 
both static and dynamic conditions. These factors are often negligible in static 
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conditions but can significantly complicate the interpretation of the EMG signal 
during movement (58). 
 
By reducing variability caused by these experimental factors during dynamic 
movement, one is able to measure more accurately the true biological variation in 
the EMG signal. A method that could possibly assist in reducing the variation in 
EMG signal during dynamic exercise trials is the use of an appropriate method of 
normalisation. Normalising the EMG recording to a reference value obtained during 
standardised and reproducible conditions, allows for the comparison of muscle 
activity between different muscles over time and between individuals. The method of 
obtaining the reference value used in a normalisation equation has, however varied 
across studies (103).  
 
The most common method of normalisation is based on isometric maximum 
voluntary contractions (MVC). This method has proved popular amongst researchers 
(9; 44; 53; 120; 158; 162) but has certain limitations. For example, it is assumed that subjects 
provide maximum effort during testing and that the maximal contraction achieved 
represents 100 % of muscle activity (24). Although researchers can encourage the 
subject to generate a MVC, the force generated ultimately depends on the level of 
motivation of the subject.  
 
This method also assumes a linear EMG/force relationship, since both force and 
EMG is modulated by a combination of motor unit recruitment (17). The amplitude of 
the EMG signal is also affected by the size of the individual muscle fiber potentials. 
However, the amplitude of the EMG signals cannot be assumed to be homogeneous 
for different fiber types and under different experimental conditions. Bigland-Ritchie 
(17) found that all muscles producing non-linear EMG/force responses were of mixed 
fiber composition, whereas linear responses were found during contraction of 
muscles with uniform fiber composition. 
 
Despite these limitations few studies have addressed the appropriateness of the 
MVC method or proposed alternative methods of normalisation during exercise 
trials. To address this challenge, the first requirement is to determine an appropriate 
method of normalisation that fulfils certain criteria namely; 
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a) Repeatability 
 
An appropriate method of normalisation would need to be highly repeatable. 
Repeatability should consider two different and complementary aspects; 1) 
reliability, which addresses between-day variations of measured variables; 
and 2) constancy, which addresses within-day variations of measured 
variables. Repeatability would ensure precision during the measurement and 
lowest variation in repeated trials with altered electrode positioning (25; 159).  
 
Determination of the Intra-class correlation (ICC) is the most commonly used 
statistical method to identify repeatability of the EMG signal (21; 113; 124; 142; 159). 
A high ICC (closest to 1) is associated with a small within-subject variance 
relative to the between-subjects variance (84). This statistical method 
describes how closely the values of one trial track the values of another trial 
from individual to individual. Furthermore, the ICC statistic represents how 
well the rank order of subjects in one trial is replicated in the second and 
additional trials. The closer the correlation gets to 1, the better the replication 
(84). 
  
b) Reliability 
 
Reliability refers to the extent to which measurements are consistent, 
dependable, and free from error (157). Reliability also refers to the stability 
and consistency of measures with respect to time so that changes between 
the measurements can be attributed to the intervention (99). Improved 
reliability means improved precision of single measurements and improved 
tracking of changes in measurements during experimental trials with 
longitudinal design (84). A reliable measurement should also show 
reproducibility. According to this definition other researchers should obtain 
similar measures with testing using the same method (103).  
 
One of the main contributors to reliability is the within-subject variation which 
affects the precision of estimates of change in the variable of an 
experimental trial (84).  Thus the smaller the within-subject variation, the 
easier it is to measure the change in the variable being investigated (84). The 
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coefficient of variation (CV) is the statistical method often used to evaluate 
intra-subject variability.  
 
c) Sensitivity  
 
Sensitivity is defined as the ability to detect true biological variations. In the 
context of the thesis, the ability of the method to assist in the measurement 
of actual change in muscle activity rather than the measurement of the 
combination of the biological and experimental factors that affect the signal, 
is a requirement of a good method of normalisation. It is reasonable to 
expect muscle force output and EMG amplitude to have a linear relationship, 
as they both depend on the number of motor units recruited (60). For this 
reason, EMG amplitude has been shown to increase with increasing power 
output/workload (18; 51; 52; 119). However, EMG and force relationship are not 
always linear, particularly in high force activity and fatigue states (93). Thus 
an ideal method of normalisation should to some extent, be able to identify 
changes in muscle activity due to the change in workload or exercise 
intensity, if fatigue is not present. Furthermore, a method of normalisation 
should not only be sensitive to a changing workload, but should also be 
sensitive to changes in a clinical condition. 
 
1.3 METHODS OF NORMALISATION  
 
1.3.1 During static exercise tasks 
 
Various techniques of normalisation have been developed to reduce variability and 
standardise the EMG signal. The most commonly used method for EMG 
normalisation remains an isometric maximal voluntary contraction (MVC). The 
isometric MVC is used to obtain the highest force from a voluntary contraction. The 
use of the isometric MVC as a method of normalisation is standard for static tasks 
(128). The EMG activity at maximum effort or the highest EMG amplitude obtained 
during the MVC is selected as value used for the denominator in the normalisation 
equation; 
 
 Normalised EMG =  Trial EMG__                      X 100 %  
                                  Reference EMG (MVC) 
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EMG recordings during static maximal contractions are generally considered to be 
reproducible  (2; 20; 103; 142; 187). However, few studies have actually demonstrated this 
reproducibility (86). Howitson et al.(86) investigated intra-subject reliability and group 
repeatability of EMG amplitude during isometric MVCs repeated over 5 days. They 
studied the EMG signal produced by the biceps brachii of 15 subjects who were 
unfamiliar with performing isometric MVCs. During evaluation of the group data, 
they found that EMG displayed good reproducibility (CV = 4 % and ICC R = 0.92). 
However, the intra-subject reproducibility was more variable (CV = 18 %). Therefore 
individuals can show large variation in EMG during MVCs, however the variation is 
less when the data are expressed as a group. 
 
Kollmitzer et al. (105) investigated the reliability of EMG signal of the vastii muscles 
over short (3 min), intermediate (90 min) and long term (6 weeks) measurements. 
During this study 18 subjects performed isometric MVC’s at 100 % and 50 % MVC 
over the various time intervals. 50 % MVC had greater reliability over the 3 min (for 
all muscles), the 90 min and the 6 week measurement for RF, VM and by combining 
the vastii data (RF + VM + VL). This study demonstrated that EMG measured during 
50 % MVC had greater reliability than EMG measured during 100 % MVC. 
 
The alternative to using maximal voluntary contractions for EMG normalisation is 
the use of submaximal voluntary contractions. Submaximal MVC’s appear more 
reliable than maximal MVC’s (105; 124; 197). Mathur (124) showed EMG amplitudes of RF 
and VM to be more repeatable at 20 % MVC (ICC R = 0.91 and 0.88 respectively) 
than at 80 % MVC (ICC R= 0.66 and 0.83 respectively). Kollmitzer et al. (105) also 
found RF activity to have greater repeatability during submaximal sustained 
contractions of 50 % MVC (ICC R = 0.74) than at 100 % MVC (ICC R = 0.45). Yang 
& Winter (197) demonstrated the repeatability of measuring EMG of the triceps brachii 
muscle during 30 %, 50 % and 100 % MVC during elbow extensions within and 
between 3 days of testing. The EMG showed high repeatability at the submaximal 
contractions of 30 % and 50 % MVC (ICC ranged R = 0.80 - 0.95 and 0.78 - 0.93 
respectively), whereas the repeatability of triceps activity at 100 % MVC ranged 
between R = 0.52 - 0.81. 
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1.3.2 During dynamic exercise tasks 
 
More contentious are studies that have utilised surface EMG during dynamic 
exercise.  Maximal exercise to exhaustion is commonly used to investigate fatigue 
and has contributed to the generation of theories regarding the origin of fatigue 
during dynamic exercise. 
 
Researchers have thus acknowledged the limitations of a static MVC for normalising 
data and have improved the type of normalisation techniques by developing 
techniques used for dynamic activities. These techniques have used normalisation 
procedures which have involved the same movement as the movement being 
examined (198). Since in dynamic contractions, such as walking, cycling and running 
the use of isometric MVC as a reference is debatable (31; 89; 198). Several investigators 
have found that EMG activity recorded during dynamic activities can exceed 
measurements from the maximal isometric efforts (29; 122; 179). Therefore the use of 
MVC normalisation could possibly be an inappropriate method for dynamic 
activities, since it may not represent the maximum activation capacity of the muscle 
either during non-isometric contractions or at muscle lengths other than those 
muscle lengths at which the MVC was performed (24). However, despite these 
limitations the MVC method of normalisation has still been used for normalisation in 
research involving both static and dynamic muscle activity (9; 44; 120; 158; 162). 
 
It is logical that the same type of movement used for the muscle activity should also 
be used for the method of normalisation. This method controls for the experimental 
errors discussed previously during dynamic movement, including changes in muscle 
length, electrode shifts and conductivity of tissues. This matter has been 
investigated in studies of gait analysis. Normalisation procedures for gait EMG have 
been comprehensively investigated (25). Different methods of normalisation have 
been developed to lessen the variability in EMG during gait analysis (43; 24; 192). The 
following are key methods used currently in gait research, however each method’s 
criteria as an appropriate method of normalisation is still debatable. 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 1 
Department of Human Biology                           - 20 - 
i) Isometric MVC Method  
 
This method divides each data point in gait EMG by the peak EMG amplitude 
from an isometric MVC of the same muscle (44). This method is recommended 
when the goal is to determine the level of muscle activity that is required to 
perform the task, in relation to its maximal static capacity (10; 35). This method has 
also been recommended for use in the clinical population until alternative 
methods are established (172). 
 
ii) Isokinetic MVC Method (which is an MVC derived from a fixed 
movement pattern) 
 
This method divides each data point in gait EMG by the peak EMG amplitude 
from an isokinetic MVC of the same muscle (98). This method also allows for 
determination of level of muscle activity required to perform a task, in relation to 
its maximal isokinetic capacity. 
 
iii) Peak Dynamic Method 
 
This method normalises EMG from each stride in gait to the peak EMG amplitude 
found during that gait cycle (104). This method allows for the determination of 
muscle activity level in relation to maximal activity obtained within a gait cycle. It 
has been proposed that this method is appropriate for examining a change in 
muscle activity recorded on different days. 
 
iv) Mean Dynamic Method 
 
This method normalises EMG from each stride in the gait cycle to the mean value 
recorded during that gait cycle. This method was more repeatable than the Peak 
Dynamic method described above (24). This method allows for muscle activity 
level determination in relation to average muscle activity obtained within a gait 
cycle. It has been proposed that this method is appropriate for examining a 
change in muscle activity over days and across interventions. Furthermore, this 
method is recommended for use in the clinical population (21). 
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Yang & Winter (198) revealed that both the peak and mean dynamic method of 
normalising EMG data reduced inter - subject variability, compared to the 50 % 
MVC method during gait analysis. Shiavi et al. (168; 169) also investigated peak and 
mean dynamic methods, and showed that mean dynamic method was slightly better 
at reducing inter-subject variability particularly during muscle quiescence because 
of relatively lower standard deviations during these periods. However, this method 
has been criticised by Knutson et al. (103), who argues that these methods remove 
true biological variation within the group, presumably due the additional 
experimental factors that contribute to the EMG signal ‘noise’ during dynamic 
activity.  
 
A comprehensive study by Burden et al. (24) compared inter-subject and intra-subject 
variability using all the above EMG normalising methods during the gait cycle. They 
reported that the Isokinetic MVC method produced the greatest intra-subject 
variability. EMG amplitude has been shown to have high repeatability during 
isokinetic knee extensions (70; 91; 115), which has been attributed to the highly 
standardised range of motion of the knee extension (115). However, Burden et al. (24) 
concluded from their study that Isokinetic method should not be used as a method 
of normalisation in gait studies. The authors argue that the Isokinetic method does 
not reduce intra or inter-subject variability, nor does it provide a more representative 
measure of muscle activation during gait than the isometric MVC Method. They 
specified that Mean and Peak Dynamic methods serve as a measure of level 
muscle activation throughout the gait cycle in relation to the average and maximum 
activity recorded during the gait cycle. However, these methods are unable to 
provide information on the maximal degree of muscle activation (in relation to the 
muscles’ maximal capabilities) that is required to perform a specific task. In contrast, 
the isometric and isokinetic MVC methods of normalisation are able to demonstrate 
the maximal muscle activity achieved in producing a specific task. 
 
There is much debate in the literature regarding the use of appropriate methods of 
normalisation in studies involving dynamic muscle activities, such as using lactate 
threshold as a measure of exercise intensity and a metabolic marker to which EMG 
should be normalised. More research needs to be undertaken to find the most 
appropriate method of normalisation best suited to conduct various investigations. 
Particularly, it is important to be able to determine a change in muscle activity over 
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various days following an intervention. Another application for normalising EMG is 
to be able to interpret a once off measurement of maximal muscle activity during a 
dynamic activity. 
 
The normalisation debate can also be extended into research performed in the 
clinical population, where the measurement of surface EMG has become more 
popular because it is non-invasive. Recently Bolgla & Uhl (21) investigated reliability 
of methods of normalisation for the evaluation of hip musculature during 
rehabilitation exercises. The study found the MVC method had ICC values 
exceeding R = 0.93 for all six rehabilitation exercises, whereas the dynamic 
methods exceeded R = 0.85 for all exercises except one. The researchers 
concluded that even though the MVC method had higher repeatability, the 
application of this method in the symptomatic population would be questionable 
since these patients might not elicit a valid MVC because of pain and muscle 
inhibition.  Bolgla & Uhl (21) highlighted that the difficulty with previous studies 
investigating EMG amplitudes using MVC method, was that they used healthy 
populations and inferred similar findings to symptomatic subject populations. There 
are few clinical studies in the literature that have conducted research on the 
appropriateness of the methods of normalisation and thus Soderberg & Knutson (172) 
have advised researchers to continue using the MVC method for normalisation in 
the clinical population until alternative methods are established. There is therefore a 
need to establish a more appropriate method of normalisation in clinical research. 
 
1.4 CONCLUSION 
 
The interpretation of EMG activity measured during dynamic exercise remains 
contentious, primarily due to differences between methods used for normalisation 
and issues relating to the reliability of the measured signal. 
 
The present review has described the contributions of intrinsic and extrinsic factors 
to the variability of the EMG measurement. Since the intrinsic factors cannot be 
controlled, the review has focused on different techniques used in minimising the 
EMG variability caused by extrinsic factors. In particular, the use of the appropriate 
method of normalisation is important to minimise EMG variability. The appropriate 
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method of normalisation is defined as a method that is capable of showing 
repeatability, reliability (low intra and inter-subject variation) and sensitivity to 
changes in EMG amplitude that is due to biological change and not the contribution 
of experimental factors. 
 
The use of an isometric maximal voluntary contraction (MVC) as a method of 
normalisation has been standard for both static and dynamic exercises. However, 
researchers have recently improved the type of normalisation techniques by 
developing alternative strategies for normalising EMG during dynamic activities. By 
using the same type of movement for normalisation, experimental errors, such as 
changes in muscle length, electrode shifts and conductivity of tissues have the 
potential to be reduced. However, most of the research testing dynamic methods of 
normalisation has involved testing the reliability and repeatability of EMG amplitude 
during gait cycle analysis. It remains important to identify the limitations in the 
measurement of surface EMG and the ability of the method to provide information 
regarding the activity of muscle. This information provides better quality data and 
therefore more well-grounded interpretation of studies involving physiological 
models of fatigue. In addition, this information would enable better use of surface 
EMG in the clinical population, where invasive methods of EMG have been 
previously used due to better sensitivity. 
 
1.5. OBJECTIVES OF THE THESIS 
 
Given the identified need for minimising extrinsic risk factors through appropriate 
normalisation, the objective of the first part of the present thesis is to evaluate 
various normalisation techniques for use during dynamic exercise such as cycling 
and running.  In determining a particular method for obtaining a reference value for 
normalisation, one must consider several issues. The important issues are the 
repeatability and reliability of the reference EMG value and the sensitivity of the 
method in detecting changes in exercise intensity. Moreover, the thesis expands on 
methods of normalisation for the clinical population, where the interpretation of EMG 
data is used diagnostically. 
 
This thesis thus focuses on identifying the most appropriate methods of 
normalisation that can be used in testing dynamic muscle activity. Specifically the 
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thesis aims to investigate the repeatability, reliability and sensitivity of the following 
methods of normalisation in measuring muscle activity in cycling and running to 
exhaustion; 
• MVC method 
• Modified Peak Dynamic method - to be used in maximal sprints of cycling 
and running 
• Modified Mean Dynamic method - to be used in submaximal exercise of 
performing at 70 % of maximal cycling power and running speed. 
 
Based on the findings of these studies the appropriate method of normalisation are 
used to address questions on muscle activity at exhaustion in cycling and running 
as well as in patients with Peripheral Vascular Disease. The clinical application has 
the potential to determine how data can be interpreted given that the appropriate 
methods of EMG analysis are used. 
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CHAPTER 2  
 
CRITICAL ANALYSIS OF METHODS FOR NORMALISATION 
OF SURFACE EMG ACTIVITY DURING CYCLING 
 
2.1  INTRODUCTION 
 
In Chapter 1, an overview of EMG activity was provided, and some of the 
experimental factors influencing EMG amplitude were discussed and described.  In 
particular, the factors that influence the measured EMG signal were divided into 
intrinsic and extrinsic factors.  Intrinsic factors include a) the electrode shift; b) the 
lengthening of muscle and possible shift of innervation zones, c) changing of 
conductivity of the muscle due to angular displacement about the joint causing 
changes in muscle fiber diameter, length and orientation (137). These factors may 
influence the measured EMG signal during a dynamic activity like cycling. In 
addition to these intrinsic factors, extrinsic or experimenter-related factors can be 
controlled for through the correct application and placement of electrodes supported 
by a thorough understanding of electrophysiology and anatomy.   
 
To measure biological variation in the EMG signal, which is important in studies 
where surface EMG is used to gain understanding of physiological regulation, it is 
important to minimise the variation caused by these factors (described in detail in 
Chapter 1).  This is in part achieved through the appropriate method of 
normalisation. 
 
Methods of normalisation for EMG activity measured during both static and dynamic 
exercise have been reviewed in detail in Chapter 1. However, normalisation of EMG 
data during dynamic activities such as cycling is relatively poorly understood, and 
there are presently few alternatives to the use of the isometric maximal voluntary 
contraction (MVC) method (119; 121; 162). The use of the MVC as a method of 
normalisation has theoretical constraints, since, during cycling there are variations 
in actions of the muscles involved.  For example, changes in joint angle, joint angle 
velocity, and muscle lengthening and shortening all occur during cycling, raising 
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questions about the efficacy of the MVC method as a normalisation tool for EMG 
data measured during cycling (88).  This is particularly the case when the EMG 
activity is being used in an attempt to quantify how much skeletal muscle may be 
active.  Researchers have in the past made direct comparisons between the EMG 
signal measured during running or cycling and the EMG activity measured during an 
isometric MVC, expressing the resultant value as a percentage of maximum (for 
example, 45 % of the muscle was active at volitional exhaustion).  Quite clearly, this 
comparison is questionable on the grounds that the two muscle contractions are 
very different in nature. This creates the need to evaluate other possible means for 
normalisation during activities such as cycling and running. 
 
Few studies however, have found alternative methods for normalisation of EMG 
activity during cycling (88; 113; 119; 165; 178) with most using the MVC method. As 
discussed in Chapter 1, this method of normalisation involves a movement of 
muscle that is different from the movement and recruitment patterns employed 
during cycling.  
 
Furthermore, the MVC typically involves an isometric knee extension movement at 
an angle of 60 degrees from full extension, a movement which does not occur 
during cycling and can be argued to be non-functional. Hunter et al. (88) investigated 
EMG methods of normalisation in cycling by using two angles (60º and 180º) with 
four types of pedal contractions. The investigation found that the isometric MVC 
produced a higher integrated EMG (iEMG) value than the protocols using knee 
angles at 60º, 180º or one dynamic maximal cycle pedal revolution. This finding 
suggests that muscle activity during cycling does not provide the highest EMG 
amplitude. This study however did not investigate the repeatability of the various 
normalisation protocols but rather only investigated which of the four protocols 
produced the greatest iEMG activity, and thus suffers from the same potential 
limitation with regards to the comparison between cycling exercise and static, 
isometric contractions. Therefore the most repeatable method for normalising 
muscle activity during cycling has yet to be established.  
 
For a method of normalisation to be considered optimal, the following three factors 
have been identified; 
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a)  Repeatability: Defined as the within and between day variation in a group. The 
intra-class correlation (ICC) is the statistical method used to 
identify repeatability. The method represents how closely the 
values of one trial track the values of another trial from individual 
to individual (84). 
 
b) Reliability:   refers to the reproducibility of values of the same individual 
performing repeated trials (84). The coefficient of variation (CV) is 
the statistical method used to evaluate variability.  
                             The CV equation =  Standard deviation     X 100  
                                                                      Mean 
 
c) Sensitivity:      The method should be able to identify changes in muscle activity        
due to the change in workload or exercise intensity. 
 
These factors are described in detail in Chapter 1 (Section 1.2.4.2.9), but briefly, it 
is important that the EMG measured during the normalisation procedure is 
consistent from one day to the next (repeatability), and also that when the EMG 
activity measured during dynamic activity is normalised against the chosen 
procedure, the value obtained must reflect changes in EMG that occur as the 
exercise workload increases (sensitivity).  
 
The present chapter therefore aims to examine and evaluate possible methods for 
normalisation of EMG measured during cycling, according to the requirements for a 
good normalisation technique which are described above. Four methods for 
normalising EMG during cycling were evaluated and their variability and sensitivity 
to change was compared to the method of normalisation using isometric MVC. 
Therefore the methods of normalisation used in this study were; 
1) MVC method - using the peak EMG amplitude of 5 second isometric MVC 
(Maximal static normalisation). This is the current widely-used “standard” 
method. 
2) Active period MVC method – isolating each active contraction of cycling and 
normalising to the mean EMG amplitude of 5 second isometric MVC 
(Maximal static normalisation). 
3) Sprint method - using the peak amplitude averaged over a 10 second cycling 
sprint activity (Maximal Dynamic normalisation). 
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4) 70 % Peak Power Output Method - using the averaged peak amplitude 
during 5 minute cycling at 70 % PPO at fixed cadence (Submaximal 
Dynamic Normalisation). 
 
2.2  METHODOLOGY 
 
2.2.1 Subject selection 
 
Thirteen well-trained cyclists were recruited from local cycling clubs to participate in 
this study. Subjects were included if they were currently between the ages of 18-35 
years old and if they were able to complete the Cape Argus cycle race (109 km) 
under 3h 30 min. The study was approved by the Research and Ethics Committee of 
the Faculty of Health Sciences within the University of Cape Town. The study was 
performed in accordance with the principles of the Declaration of Helsinki (October, 
2000), Good Clinical Practice (GCP) and the laws of South Africa. All subjects signed 
the informed consent forms and were asked to maintain their same physical activity 
pattern over the course of the study and not to begin any new training or recreational 
programs. Subjects performed the same experimental protocol on each of the three 
testing days. Each testing day was separated by 5-7 days of normal training.  
 
2.2.2 Experimental design 
 
Subjects were required to visit the laboratory on four separate occasions. During the 
first visit, a complete anthropometrical assessment was performed on each subject. 
Each subject was also familiarised with all the equipment on their first visit. A 
Physical Activity Readiness Questionnaire (PAR-Q) was administered to all subjects 
prior to participation to ensure that they represented a group at low risk for exercise. 
On trial days, subjects were firstly prepared for the placement of the electrodes on 
six muscles (Vastus medialis (VM); Vastus lateralis (VL), Rectus femoris (RF), 
Biceps femoris (BF) and Medial and Lateral gastrocnemius (MG and LG 
respectively)) on the right leg. Following this each subject performed three maximum 
voluntary contractions (MVC) using the Biodex Dynamometer 3 (Biodex Medical 
Systems, New York). Subjects were then allowed a 10 minute warm-up on the 
electronically braked cycle ergometer (Lode, Groningen, Holland), after which they 
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performed a 10 second maximal sprint, where each subject started the sprint from a 
power output of 200 Watts (W). After a 30 minute rest period, subjects performed 
their Peak Power Output (PPO) test until exhaustion on the Lode bike (80).  Subjects 
were asked to inform the researcher just prior to anticipating having to stop as a 
result of exhaustion, so that EMG could be recorded during that time period. After 
another 30 minute rest period, each subject then cycled at 70 % of their PPO for 5 
minutes at 90 revolutions per minute. Heart rate was measured continuously 
throughout the PPO test until exhaustion using Polar Accurex NV heart rate monitor 
(Polar Electro OY, Kempele, Finland). For analysis, heart rate was averaged and 
reported as the average for a 5 second interval. A summary of the experimental 
design is shown in Figure 2.1. 
 
 
 
Figure 2.1: Experimental design 
 
2.2.3 Body composition 
 
Body mass and stature of each subject was measured when subjects reported to the 
laboratory for the first time. Skinfold thickness of each subject was measured at the 
biceps, triceps, subscapular, supra-iliac, abdominal, mid-thigh and calf sites (163). 
Percent body fat was calculated using the equations of Durnin & Womersly (45) from 
the sum of seven skinfold measurements. 
Familiarisation 
Trial 
Trial 1 Trial 2 Trial 3 
5-7 days 5-7 days 
MVC’s 
 
10 s Sprint 
 
PPO test 
 
70% PPO  
(cycle for 5 minutes) 
MVC’s 
 
10 s Sprint 
 
PPO test 
 
70% PPO 
(cycle for 5 minutes)
MVC’s 
 
10 s Sprint 
 
PPO test 
 
70% PPO  
(cycle for 5 minutes) 
20 min rest 
30 min rest 
30 min rest 
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2.2.4 Maximal voluntary contractions  
 
Before the start of each trial, each subject’s peak isometric force of the lower limb 
was measured using the Biodex Dynamometer, with simultaneous EMG recordings 
captured for muscle activity measurement. The subject’s hips, thighs and upper 
bodies were firmly strapped to the seat of the dynamometer. In this position, each 
subject’s hip angle was at 100° flexion. The subjects’ crossed their arms over their 
chests for each test. All isometric tests were conducted with the knee at as angle of 
60° from full leg extension for the VM, RF and VL as well as BF muscles. The lateral 
condyle of the femur was carefully aligned with the axis of rotation of the dynometer 
and the distal end to the calf was secured to the lever arm of the dynamometer 
using a padded Velcro strap. When measuring the force output for the MG and LG, 
the right leg was elevated with the thigh resting on a holder and the foot firmly 
strapped against a foot-plate, setting a knee angle of 30°. The ankle was carefully 
aligned to the axis of rotation of the dynamometer. This test was conducted with the 
ankle at a -15° angle from full vertical (reference plane at 0°), from where the 
subjects had to push against the foot-plate using the gastrocnemius muscles. A 
standardised warm up included four isometric contractions of the knee and calf 
muscle extensors at 50 %, 60 %, 70 % followed by 80 % for each subject’s 
subjective maximum. The isometric test included three maximum voluntary 
contractions (MVC) of 5 seconds each separated by 60 second intervals. Subjects 
were verbally motivated to encourage them to achieve their maximum potential. The 
seating position and length of leg attachments of subjects were standardised over all 
three days. 
 
2.2.5 Peak power output test 
 
During the PPO, EMG activity was measured from the six muscles described above. 
Subjects performed their PPO test on the Lode bike starting at workload of 3.33 
W.kg-1 body mass. After 150 s, the workload increased by 50 W and then increased 
by 25 W every 150 s until exhaustion. Exhaustion was defined as the inability to 
maintain pedalling frequency above 60 revolutions per minute (rpm). PPO was 
defined as the highest power output the subject completed for 150 s, plus the fraction 
of time spent in the final work rate multiplied by 25 W. The vertical and horizontal 
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position of the seat, handle bar length and height were standardised for each subject 
over the three days of testing. Subjects were also required to remain seated 
throughout the PPO trials. 
 
2.2.6 EMG data collection 
 
The EMG activity of the muscles was recorded using the telemetric EMG system 
(Telemyo 900, Noraxon, USA, Inc., Arizona, USA). Two electrodes (Blue Sensor, 
Medicotest, Denmark) were placed on the belly of the following lower limb muscles 
during all the tests; Vastus lateralis (VL), Vastus medialis (VM), Rectus femoris (RF), 
Biceps femoris (BF) and Medial and Lateral gastrocnemius (MG and LG 
respectively). Prior to placing the electrodes on the skin, the skin over the muscle 
was shaved and cleaned with ethanol. The placement and location of the electrodes 
are according to the recommendations by SENIAM (Surface EMG for Non-invasive 
Assessment of Muscles) (82). Therefore, two electrodes were carefully taped to the 
belly of each muscle, parallel to the muscle fibers with an inter-electrode distance of 
20 mm. A telemetric signal was relayed to an antenna connected to an online 
computer and captured at 2000 Hz. The wire-leads connected to the electrodes were 
well secured with tape to avoid artefacts from lower limb movements during cycling. 
Before recording the EMG, each subject was asked to contract their muscles to 
verify the absence of cro stalk in the EMG signal. Since the trials were 
approximately 15 minutes of cycling, the influence of sweat on the EMG signal was 
assumed to be negligible. 
 
2.2.7 EMG analysis  
 
The raw digital EMG signal was processed using Noraxon’s Myoresearch software 
(Version 2.11).The raw EMG data was filtered using a 50 Hz notch filter to remove 
any electrical interference from external sources (MyoResearch 2.02). The signal 
was then filtered a second time using a 15-500 Hz band pass filter. This allowed 
noise or movement interference below 15 Hz and other non-physiological signals 
above 500 Hz to be removed. The data were smoothed using route mean squared 
analysis (RMS), which was calculated for a 50 ms window.  
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EMG analysis of PPO trial: 
EMG was recorded for 10 s halfway through each workload and at exhaustion during 
the PPO trials. From this recording 3 s of EMG data were extracted and analysed 
(used for MVC, Sprint and 70 % PPO method of normalisation). The method of 
sampling of the PPO trial changed when the data were normalised to the Active 
Period MVC. For this method, 3 contractions (with similar peak amplitudes) were 
isolated within each 10 s recording. The EMG value (µv⋅s) was calculated for each 
contraction and then time-normalised to one second [(µv⋅s)⋅s-1]  (referred to as mean 
amplitude). 
 
2.2.8 Methods of normalisation 
 
Four methods of normalisation were investigated in this study.  
 
2.2.8.1 MVC Method 
 
When normalising using the MVC method, 3 s of EMG data were extracted from the 
middle period of the 5 s MVC which produced the highest force. The amplitude of the 
3 s periods taken from each workload measurement during the PPO was normalised 
to the 3 s period obtained during the MVC. EMG data from the PPO trials were 
expressed as a percentage of MVC. Subjects were verbally motivated to encourage 
them to achieve their maximum potential (during both the PPO and MVC protocols). 
 
2.2.8.2 Sprint Method 
 
When normalising to the 10 s sprint, three 3 s period within the 10 s measurement 
(taken in the sprint) were isolated and averaged. The averaged amplitudes of these 
sections were used for normalisation. EMG data from the PPO trials are expressed 
as a percentage of averaged EMG amplitude during sprint (Figure 2.2). Subjects 
were verbally motivated to encourage them to achieve their maximum potential. 
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2.2.8.3 70 % PPO Method 
 
When normalising to 70% PPO, EMG was captured for 10 seconds at the end of 
each minute (of cycling at 70 % PPO for five minutes). 3 s periods were then 
analysed from each 10 s measurement, and the resulting amplitude was then 
averaged (Figure 2.2). EMG data from the PPO trials are expressed as a percentage 
of the average EMG amplitude during the 70 % PPO cycle.  
-1000
-500
0
500
1000
0
100
200
300
400
500
3 seconds
a)
b)
Am
pl
itu
de
 (
µV
)
 
Figure 2.2: The method used to analyse the PPO trials, Sprint and 70 % PPO methods of 
normalisation. (a) Raw EMG data of 10 second period from the PPO trial and the methods of 
normalisation; (b) Rectified EMG of 10 second period, showing the 3 second epoch starting at the 
beginning of muscle contraction, from the PPO trial and the methods of normalisation. 
 
2.2.8.4 Active Period MVC Method (AP MVC Method) 
 
The mean amplitudes from the PPO trial were normalised to the mean amplitude of 
the pre-trial MVC (obtained from three seconds out of the five seconds of EMG 
recorded) which produced the highest force. The EMG data from the PPO trial is 
expressed as a percentage of MVC (Figure 2.3). 
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Figure 2.3: The method used to analyse the PPO trials for AP MVC method of normalisation. From 
rectified EMG, isolation of 3 active periods (contractions) within the 10 second recording and obtaining 
the mean amplitude values. 
 
2.2.9 Statistical analysis 
 
All results were analysed using a statistical software programme (Statistica 7, 
StatSoft, Tulsa, OK, USA). Results were expressed as means ± standard deviation 
(SD) The repeatability was investigated using the Intraclass Correlation Coefficient 
(ICC). The ICC scores ranged between R = 0.80 and 1.00 were defined as 
representing “good” reproducibility, scores between R = 0.60 and 0.79 a “fair” 
reproducibility and less than R = 0.60 a “poor” reproducibility (170). The 95 % 
confidence intervals were calculated for the ICC using software downloaded from 
www.newstats.org (85). Analysis of Variance (ANOVA) with repeated measures was 
used to detect significant differences between the methods of normalisation. 
Sometimes there was a negative ICC meaning the with-in subject variance 
exceeded the between subject variance, thus ICC R = 0 which indicates no 
repeatability (115). A Tukey post hoc test was used to detected differences in muscle 
activity between the 6 stages of the PPO test. The method of normalisation 
variability over 3 days for each subject (Intra-subject variability) was assessed using 
coefficient of variation (CV) analysis. Intra-subject variability for each method of 
normalisation was calculated by dividing the overall standard deviation by the overall 
mean over 3 trials and expressing this as a percentage. Acceptable variability has 
been defined as CV values less than 10 % (127; 194), however Taylor & Bronks (178) 
have shown CV values between 9 – 12 % for the quadriceps muscles. Thus, as a 
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cautionary measure, the definition for an “acceptable” CV value is regarded as less 
than 12 % in this and the subsequent chapters. P< 0.05 has been considered as 
significant in all statistical tests.  
 
2.3 RESULTS 
 
2.3.1 Descriptive characteristics 
 
The descriptive characteristics of the cyclists are shown in Table 2.1. Based on 
these data the subjects can be considered trained cyclists.  
 
Table 2.1: Subject characteristics (n=13) 
 
 
 
 
 
 
 
 
 
 
 
                                   Predicted VO2max derived from equation of Hawley and Noakes 80 
 
2.3.2 Repeatability  
 
Table 2.2 shows the ICC values for each of the four methods of normalisation. The 
data are displayed for every load increase in power output for each muscle (n=3 
trials). The quadriceps muscles (VM) have “poor” repeatability using most methods 
of normalisation during the load 6 (which is nearing the end of the trials for most 
subjects) and the calf muscles (MG and LG) are highly repeatable over the different 
power output loads. 
Variable                                 Mean ± SD 
Age (yrs)                                     27.3 ± 8.0 
Height (m)                                     1.8 ± 0.1 
Mass (kg)                                    72.6 ± 6.1 
Max Heart Rate (bpm)                  183 ± 9 
% Body Fat                                  10.5 ± 2.7 
PPO (W)                                    370.0 ± 28.7 
Predicted VO2 max (ml/kg/min)       64.1 ± 4.5 
P/W ratio (W.kg-1)                          5.2 ± 0.5 
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Table 2.2: Intra-class correlations of EMG normalised to MVC, Sprint, 70% PPO and AP MVC methods for each load during PPO trials.  
Muscle Method Load 1 Load 2 Load 3 Load 4 Load 5 Load 6
VM MVC 0.68 (0.31-0.91) 0.74 (0.41-0.93) 0.73 (0.36-0.93)   0.86 (0.58-0.97) 0.83 (0.52-0.97) 0.39 (0.00-0.93) 
 AP MVC 0.82 (0.49-0.96) 0.76 (0.38-0.95) 0.76 (0.38-0.95) 0.81 (0.47-0.96) 0.84 (0.54-0.97)           0.38 (0.00-0.86)   
 Sprint 0.56 (0.04-0.91) 0.70 (0.34-0.91) 0.77 (0.28-0.97)  0.91 (0.56-0.99) 0.94 (0.68-1.00)           0.62 (0.00-0.97) 
 70%PPO 0.96 (0.88-0.99) 0.94 (0.83-0.98) 0.76 (0.44-0.93) 0.87 (0.61-0.97) 0.95 (0.83-0.99) 0.85 (0.37-0.99)
        
RF MVC 0.00 (0.00-1.00) 0.08 (0.00-0.58) 0.64 (0.25-0.89) 0.65 (0.27-0.90) 0.71 (0.29-0.94) 0.83 (0.41-0.98) 
 AP MVC 0.39 (0.02-0.75 0.24 (0.00-0.65) 0.54 (0.17-0.83) 0.65 (0.31-0.88) 0.82 (0.57-0.95)            0.74 (0.38-0.93) 
 Sprint 0.71 (0.40-0.90) 0.32 (0.00-0.71) 0.78 (0.52-0.93) 0.55 (0.17-0.84) 0.68 (0.31-0.91) 0.34 (0.00-0.81) 
 70%PPO 0.83 (0.59-0.95) 0.86 (0.65-0.96) 0.92 (0.79-0.98) 0.77 (0.46-0.94)  0.91 (0.73-0.98)           0.64 (0.14-0.93) 
        
VL MVC 0.72 (0.46-0.94) 0.85 (0.61-0.94) 0.85 (0.61-0.94) 0.79 (0.49-0.94) 0.85 (0.59-0.94) 0.84 (0.44-0.95) 
 AP MVC 0.68 (0.31-0.91) 0.74 (0.41-0.93) 0.72 (0.37 -0.92) 0.67 (0.30-0.90) 0.62 (0.22-0.88)            0.61 (0.21-0.88) 
 Sprint 0.55 (0.17-0.84) 0.66 (0.31-0.89) 0.73 (0.41-0.92) 0.77(0.46-0.94) 0.75 (0.41-0.93) 0.74 (0.28-0.93)   
 70%PPO 0.95 (0.87-0.98) 0.94 (0.85-0.98) 0.96 (0.90-0.99) 0.94 (0.84-0.98) 0.85 (0.63-0.96) 0.83 (0.55-0.96)
        
BF MVC 0.88 (0.70-0.97) 0.90 (0.74-0.97) 0.89 (0.72-0.97) 0.87 (0.66-0.97) 0.81 (0.53-0.95) 0.88 (0.54-0.99)
 AP MVC 0.87 (0.70-0.96) 0.88 (0.72-0.96) 0.85 (0.66-0.95) 0.90 (0.75-0.97) 0.84 (0.59-0.96)            0.66 (0.01-0.97) 
 Sprint 0.90 (0.75-0.97) 0.77 (0.50-0.92) 0.87 (0.69-0.96) 0.80 (0.53-0.94) 0.76 (0.44-0.93) 0.71 (0.33-0.93) 
 70%PPO 0.89 (0.74-0.97) 0.83 (0.62-0.94) 0.90 (0.76-0.97) 0.88 (0.70-0.96) 0.81 (0.55-0.94) 0.92 (0.74-0.98)
        
MG MVC 0.84 (0.65-0.94) 0.86 (0.69-0.95) 0.84 (0.65-0.94) 0.93 (0.83-0.98) 0.88 (0.70-0.97) 0.83 (0.55-0.96)
 AP MVC 0.63 (0.30-0.86) 0.68 (0.37-0.88) 0.69 (0.39-0.89) 0.69 (0.39-0.89) 0.69 (0.39-0.89) 0.81(0.55-0.94) 
 Sprint 0.90 (0.76-0.97) 0.91 (0.78-0.97) 0.91 (0.78-0.97) 0.96 (0.89-0.99) 0.90 (0.75-0.97) 0.85 (0.57-0.97)
 70%PPO 0.88 (0.72-0.96) 0.94 (0.85-0.98) 0.94 (0.85-0.98) 0.81 (0.55-0.94) 0.84 (0.63-0.95) 0.90 (0.68-0.98)
        
LG MVC 0.75 (0.48-0.91) 0.83 (0.62-0.94) 0.81 (0.58-0.93) 0.85 (0.66-0.95) 0.90 (0.74-0.97) 0.85 (0.67-0.87)
 AP MVC 0.80 (0.58-0.93) 0.82 (0.61-0.94) 0.85 (0.67-0.95) 0.84 (0.65-0.94) 0.83 (0.63-0.94) 0.92 (0.80-0.98)
 Sprint 0.79 (0.55-0.93) 0.81 (0.58-0.93) 0.81 (0.58-0.93) 0.92 (0.80-0.98) 0.85 (0.63-0.96) 0.78 (0.41-0.95) 
 70%PPO 0.96 (0.90-0.99) 0.92 (0.81-0.97) 0.92 (0.81-0.97) 0.97 (0.92-0.99) 0.89 (0.72-0.97) 0.90 (0.68-0.98)
Intra-class correlations with 95% confidence intervals for methods of normalisation for each muscle, Vastus medialis VM), Rectus femoris (RF), Vastus 
lateralis (VL), Biceps femoris (BF), Medial gastrocnemius (MG) and Lateral gastrocnemius (LG), over 3 separate days of cycling. Values highlighted in 
bold represent what are considered to be “good” ICC values. The section represented in the block is graphically displayed in Figure 2.4. 
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Table 2.3 depicts the mean ICC values of the six power output loads of Table 2.2 for 
each method of normalisation. 
 
Table 2.3: Mean Intra-class correlations for Peak Power Output EMG normalised to MVC, Sprint, 70 
% PPO and AP MVC methods 
Muscle  MVC Sprint 70 % PPO AP MVC 
VM 
RF 
VL 
BF 
MG 
LG 
0.70 (0.52-0.88) 
0.47 (0.11-0.85) 
0.82 (0.76-0.87) 
0.87(0.84-0.91) 
0.86 (0.82-0.92) 
0.83 (0.78-0.88) 
0.75 (0.59-0.91) 
0.56 (0.35-0.77) 
0.70 (0.61-0.79) 
0.80 (0.72-0.88) 
0.90 (0.86-0.94) 
0.82 (0.77-0.88) 
0.88 (0.80-0.97) 
0.82 (0.71-0.93) 
0.91 (0.85-0.97) 
0.87 (0.83-0.92) 
0.88 (0.83-0.94) 
0.92 (0.89-0.96) 
0.72 (0.55-0.91) 
0.56 (0.33-0.79) 
0.67 (0.62-0.73) 
0.83 (0.74-0.93) 
0.70 (0.64-0.76) 
0.84 (0.80-0.89) 
 
Mean ICC values of methods of normalisation for each muscle; Vastus medialis (VM), Rectus femoris (RF), 
Vastus lateralis (VL), Biceps femoris (BF), Medial gastrocnemius (MG) and Lateral gastrocnemius (LG), 
over 3 separate days of cycling. Values presented as mean (of 6 work loads) with 95 % confidence 
intervals. Bolded values indicate the highest ICC value for each muscle. 
 
The 70 % PPO method was the only method of normalisation to yield “good” ICC values 
for all muscles, with average ICC values for all muscles being greater than 0.82 (Table 
2.3). The MVC method was repeatable for MG, LG, VL and BF as seen by average ICC 
values greater than 0.80. This method however, showed “poor” repeatability for RF (0.47 
(0.11-0.85)).  The Sprint method showed similar repeatability patterns as the MVC 
method, where MG and LG had “high” average ICC values, (ICC R = 0.90 (0.86 - 0.94) 
and 0.82 (0.77 - 0.88) respectively), and VM, VL and BF had only “fair” repeatability 
(Average ICC between 0.70 and 0.75) but slightly less ICC values than that derived from 
the MVC method . Repeatability for the AP MVC method was “fair to good” except for 
RF, where average ICC was R = 0.56 (0.33 - 0.79).  
 
To further highlight the variation in muscle activity using different methods of 
normalisation, a subsection of ICC values from Table 2.2 (highlighted in the block) are 
graphically presented. ICC values for RF activity at Load 1 (subject body weight x 3.33 
W) were randomly chosen, as this load showed the most variation in ICC values of 
each method of normalisation, thus highlighting the individual variation in muscle 
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activity at this power output. In an attempt to clarify the results the graphs in Figure 2.4 
are arranged so that the first 6 subjects are represented on the left panel and the 
remaining subjects on the right panel. The greatest variation in muscle activity over the 
3 trials was found for the MVC Method (ICC R = 0.00 (0.00-1.00)), while the sprint 
(Figure 2.4 c) and 70 % PPO (Figure 2.4 d) methods showed less variation in muscle 
activity from day-to-day and thus show greater ICC values.  
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 Figure 2.4: Variability of  Rectus femoris (RF) muscle activity at Load 1 over three trials normalised to 
a) MVC  method, b) Active Period MVC, c) Sprint method and d) 70% PPO method. These graphs 
illustrate the intra-class correlation with 95% confidence intervals highlighted in the block in Table 2.2. The 
first 6 subjects are represented on the left panel and the remaining subjects on the right panel 
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2.3.3 Intra-subject reliability  
 
The intra-subject coefficient of variation (CV) of each subject muscle activity over the 3 
trials provides an indication of which method of normalisation produced more 
reproducible results. Figure 2.5, provides a graphical display of the CV for each method 
normalisation for each subject. The graphs showed various degrees of variation for 
each subject. To simplify the intra-subject CV’s in Figure 2.5 and to emphasize which 
method showed the lowest intra-subject CV’s, the graphs were divided into 3 zones; 
Zone 1(CV values ≤ 12 %), Zone 2 (CV values 12 % > and ≤ 20 %), Zone 3 (CV values 
> 20 %). 
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Figure 2.5: Intra-subject coefficient of variation (CV) for the four methods of normalisation for 
Vastus medialis (VM), Vastus lateralis (VL), Rectus femoris (RF), Biceps femoris (BF), Medial and 
Lateral gastrocnemius (MG and LG respectively) recorded over three trials. Dashed line represents 
the range of “low” variation, between 0 - 12 %. Solid Line representing “medium” variation (12-20 %). 
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Since there are different subject numbers for the different methods, the CV values were 
expressed as a percentage of the subject number. For example for VM 70 % PPO 
method, there are 10 CV values in Zone 1, therefore 10/13 subjects = 77 %, 1 CV value 
in Zone 2 therefore 1/13 = 7 % and 2 CV values in Zone 3 therefore 2/13 = 15 %.The 
method of normalisation with the highest percentage of CV values in Zone 1 is seen to 
show the least intra-subject variability over 3 trials. Furthermore, the method of 
normalisation with the highest percentages in Zone 3, has the most intra-subject 
variability. 
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Table 2.4: Percentage of the summed scores for the intra-subject coefficient of variation zones 
   Muscles       Norm Method           Zone 1              Zone 2                 Zone 3 
                                                             %                       %                          % 
VM 
 
 
 
 
VL 
 
 
 
 
RF 
 
 
 
 
BF 
 
 
 
 
MG 
 
 
 
 
LG 
MVC 
AP MVC 
Sprint 
70%PPO 
 
MVC 
AP MVC 
Sprint 
70%PPO 
 
MVC 
AP MVC 
Sprint 
70%PPO 
 
MVC 
AP MVC 
Sprint 
70%PPO 
 
MVC 
AP MVC 
Sprint 
70%PPO 
 
MVC 
AP MVC 
Sprint 
70%PPO 
8 
15 
58 
77 
 
8 
8 
46 
54 
 
8 
0 
0 
15 
 
0 
8 
8 
17 
 
15 
38 
61 
54 
 
15 
8 
31 
47 
46 
15 
33 
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Percentage of CV values in each zone for each method of normalisation and muscle; Vastus medialis 
(VM), Vastus lateralis (VL), Rectus femoris (RF), Biceps femoris (BF), Medial and Lateral gastrocnemius 
(MG and LG respectively). CV values summed in each zone calculated as a percentage of the subject 
number per Zone 1(CV values ≤ 12 %), Zone 2 (CV values 12 % > and ≤ 20 %), Zone 3 (CV values > 20 
%). The methods with highest percentages in each zone for each muscle, is highlighted in bold. 
 
 
This calculation highlighted that 70 % PPO method showed the least intra-subject 
variability for five out of six muscles (VL, RF, BF and LG) (Table 2.4). The Sprint 
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method produced the least intra-subject variability for MG, where 61 % of the CV values 
were in Zone 1. The MVC method showed the highest percentage intra-subject 
variability for all muscles except VM, where most of the CV values were in Zone 3 
(ranging between 46 % - 77 %).The AP MVC method also showed most of its CV 
values to be in Zone 3 (ranging between 38 % - 69 %). 
 
2.3.4 Sensitivity  
 
The PPO trial consisted of increasing workloads. For the sensitivity phase of the 
experiment the PPO trial was divided into 5 loads and a final load. The muscle activity 
was measured at each load and the data were normalised using the four methods. The 
assumption of this experimental approach was that a sensitive method of normalisation 
would detect the changes in muscle activity as the workload increased. 
 
For the purpose of this analysis the EMG measurement should detect differences in 
EMG activity with increasing workload. This however does not take into account 
peripheral factors, associated with fatigue, which may affect the amplitude of the EMG 
signal. Only the results of one of the three trials is shown (we randomly chose to 
present Trial 2 data). This approach was chosen for the reason that by averaging the 
data over three trials would cause a 2nd degree error by reducing the standard 
deviations. To clarify the data analysis a graph of EMG amplitude is shown for each 
muscle at different power output loads, where load 1 is the first power output load 
cycled and F is the final power output cycled by each subject. The graphs/tables are 
interpreted as follows; in Figure 2.5, the 70 % PPO method, the muscle activity in VM 
load 1 compared to that in VM final resulted in a significant difference of p< 0.00 and 
the muscle activity in VM load 2 compared to that in VM final resulted in a significant 
difference of p< 0.01. 
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STAGES {1} 52.6 {2} 50.4 {3} 57.1 {4} 58.0 {5} 62.6 {6} 72.4
VM 1 {1} 0.98 0.75 0.56 0.04 0.00
VM 2 {2} 0.98 0.34 0.21 0.01 0.00
VM 3 {3} 0.75 0.34 1.00 0.54 0.00
VM 4 {4} 0.56 0.21 1.00 0.72 0.00
VM 5 {5} 0.04 0.01 0.54 0.72 0.05
VMfinal {6} 0.00 0.00 0.00 0.00 0.05
STAGES {1} 42.1 {2} 42.9 {3} 48.9 {4} 50.7 {5} 55.7 {6} 62.3
VM 1 {1} 1.00 0.38 0.16 0.01 0.00
VM 2 {2} 1.00 0.53 0.25 0.01 0.00
VM 3 {3} 0.38 0.53 0.99 0.39 0.01
VM 4 {4} 0.16 0.25 0.99 0.71 0.03
VM 5 {5} 0.01 0.01 0.39 0.71 0.43
VMfinal {6} 0.00 0.00 0.01 0.03 0.43
STAGES {1} 72.7 {2} 73.6 {3} 80.8 {4} 83.8 {5} 90.9 {6} 96.4
VM 1 {1} 1.00 0.59 0.25 0.01 0.00
VM 2 {2} 1.00 0.70 0.33 0.01 0.00
VM 3 {3} 0.59 0.70 0.99 0.34 0.03
VM 4 {4} 0.25 0.33 0.99 0.71 0.13
VM 5 {5} 0.01 0.01 0.34 0.71 0.87
VMfinal {6} 0.00 0.00 0.03 0.13 0.87
STAGES {1} 31.5 {2} 32.5 {3} 37.5 {4} 38.2 {5} 41.5 {6} 45.5
VM 1 {1} 1.00 0.19 0.12 0.00 0.00
VM 2 {2} 1.00 0.38 0.26 0.01 0.00
VM 3 {3} 0.19 0.38 1.00 0.64 0.04
VM 4 {4} 0.12 0.26 1.00 0.78 0.07
VM 5 {5} 0.00 0.01 0.64 0.78 0.62
VMfinal {6} 0.00 0.00 0.04 0.07 0.62
MVC method (F5;40=8.6; p < 0.001)
Active Period MVC method  (F5;40=11.6; p < 0.001)
Sprint method (F5;30= 9.8; p < 0.005)
70% PPO method (F5;40= 7.2; p < 0.001)
 
Figure.2.6: Vastus medialis (VM) mean muscle activity at the 6 power output loads of PPO for Trial 
2, when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle activity 
significantly different between stages was shown as *P<0.05. The table provides the post hoc repeated 
measures significant differences between the stages. The bold value heading each column is the average 
EMG at each load. The column heading {1} represents VM load 1, {2} represents VM load 2 etc.  
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For VM over 6 loads (Figure 2.6), the Sprint and AP MVC methods showed muscle 
activity to be significantly different over more loads than the MVC and 70 % PPO 
methods. These two methods found muscle activity in loads 1 - 4 to be significantly 
lower than the final load, whereas MVC and 70 % PPO methods were only able to 
detect loads 1 - 3 to be significantly lower than the final load. 
 
Figure 2.7 shows AP MVC method to have the highest number of significant changes 
over loads for VL, where loads 1-5 were significantly lower than the final load. In 
addition loads 1 and 2 were significantly lower than loads 4 - final. The Sprint and 70% 
PPO methods only showed loads 1 and 2 to be significantly lower than the final load. 
The MVC method did show significant differences between loads using repeated 
measures ANOVA, however the post hoc analysis was unable to detect any specific 
significances between loads. 
 
AP MVC method showed the most significant differences over loads for RF (Figure 2.8), 
where muscle activity in loads 3 and 4 were significantly lower than the activity in the 
final load. In addition, muscle activity in loads 1 and 2 were significantly lower than 
loads 4, 5 and final. MVC and 70 % PPO methods showed similar findings where loads 
1 and 2 were significantly lower than 4, 5 and final. The MVC method showed the 5th 
and final load to be significantly higher than load 3 (p=0.03 and p=0.02 respectively) 
whereas the 70 % PPO method only showed load 3 to be tending towards significance 
compared to load 5 (p=0.07) and the final load (p=0.06). 
 
For BF (Figure 2.9), the Sprint method showed the greatest sensitivity in detecting 
change in muscle activity over the workloads, where load 1 was significantly lower than 
loads 4, 5 and final. 70 % PPO and MVC method were only able to detect significant 
differences of load 1 compared to the 5th and final load. Significant differences between 
loads were found for AP MVC, however the post hoc analysis was unable to identify 
which loads were significantly different. None of the methods were able to detect 
significant differences in muscle activity between the workloads for MG and LG (Figure 
2.10 and 2.11 respectively), even though the MVC and Sprint methods showed a 
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significant stage effect throughout the trial for MG (p = 0.029 and p = 0.032, 
respectively). 
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 P
PO STAGES {1} 77.6 {2} 79.9 {3} 87.9 {4} 91.9 {5} 100.7 {6} 98.7
VL 1 1.00 0.51 0.11 0.00 0.00
VL 2 1.00 0.77 0.26 0.01 0.02
VL 3 0.51 0.77 0.95 0.16 0.31
VL 4 0.11 0.26 0.95 0.60 0.82
VL 5 0.00 0.01 0.16 0.60 1.00
VLfina l 0.00 0.02 0.31 0.82 1.00
STAGES {1} 46.1 {2} 46.9 {3} 51.5 {4} 53.7 {5} 57.6 {6} 57.9
VL 1 1.00 0.63 0.27 0.02 0.02
VL 2 1.00 0.76 0.39 0.04 0.03
VL 3 0.63 0.76 0.99 0.52 0.47
VL 4 0.27 0.39 0.99 0.87 0.84
VL 5 0.02 0.04 0.52 0.87 1.00
VLfina l 0.02 0.03 0.47 0.84 1.00
STAGES {1} 50.6 {2} 51.2 {3} 58.6 {4} 62.4 {5} 62.9 {6} 71.3
VL 1 1.00 0.06 0.00 0.00 0.00
VL 2 1.00 0.10 0.00 0.00 0.00
VL 3 0.06 0.10 0.76 0.64 0.00
VL 4 0.00 0.00 0.76 1.00 0.03
VL 5 0.00 0.00 0.64 1.00 0.05
VLfina l 0.00 0.00 0.00 0.03 0.05
STAGES {1} 35.9 {2} 37.6 {3} 45.3 {4} 43.0 {5} 45.3 {6} 45.1
VL 1 1.00 0.06 0.27 0.06 0.07
VL 2 1.00 0.18 0.57 0.18 0.21
VL 3 0.06 0.18 0.98 1.00 1.00
VL 4 0.27 0.57 0.98 0.98 0.99
VL 5 0.06 0.18 1.00 0.98 1.00
VL fina l 0.07 0.21 1.00 0.99 1.00
MVC Method (F5;45=3.4; p < 0.010)
Active Period MVC Method (F5;55=15.7; p < 0.000)
Sprint Method (F5;40=4.2; p < 0.003)
70 % PPO Method (F5;45=6.1; p < 0.001)
 
Figure 2.7: Vastus lateralis (VL) mean muscle activity at the 5 power output loads of PPO for Trial 2, 
when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle activity 
significantly different between stages as shown as *P<0.05. The table provides the post hoc repeated 
measures significant differences between the stages. The bold value heading each column is the average 
EMG at each load. The column heading {1} represents VL load 1, {2} represents VL load 2 etc.  
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 P
PO STAGES {1} .7 {2} .8 {3} 1.0 {4} 1.2 {5} 1.3 {6} 1.3
RF 1 {1} 0.97 0.11 0.00 0.00 0.00
 RF 2 {2} 0.97 0.42 0.02 0.00 0.00
RF 3 {3} 0.11 0.42 0.63 0.07 0.07
RF 4 {4} 0.00 0.02 0.63 0.79 0.77
RF 5 {5} 0.00 0.00 0.07 0.79 1.00
RFfina l {6} 0.00 0.00 0.07 0.77 1.00
STAGES {1} 27.4 {2} 34.4 {3} 38.1 {4} 42.3 {5} 50.1 {6} 52.1
RF 1 {1} 0.53 0.12 0.01 0.00 0.00
 RF 2 {2} 0.53 0.95 0.39 0.01 0.00
RF 3 {3} 0.12 0.95 0.90 0.05 0.02
RF 4 {4} 0.01 0.39 0.90 0.41 0.19
RF 5 {5} 0.00 0.01 0.05 0.41 1.00
RFfinal {6} 0.00 0.00 0.02 0.19 1.00
STAGES {1} 23.9 {2} 23.3 {3} 27.3 {4} 31.8 {5} 38.6 {6} 47.7
RF 1 {1} 1.00 0.75 0.04 0.00 0.00
 RF 2 {2} 1.00 0.60 0.02 0.00 0.00
RF 3 {3} 0.75 0.60 0.50 0.00 0.00
RF 4 {4} 0.04 0.02 0.50 0.10 0.00
RF 5 {5} 0.00 0.00 0.00 0.10 0.01
RFfina l {6} 0.00 0.00 0.00 0.00 0.01
STAGES {1} 24.6 {2} 26.1 {3} 29.9 {4} 33.3 {5} 37.3 {6} 37.9
RF 1 {1} 0.99 0.25 0.01 0.00 0.00
 RF 2 {2} 0.99 0.56 0.04 0.00 0.00
RF 3 {3} 0.25 0.56 0.69 0.03 0.02
RF 4 {4} 0.01 0.04 0.69 0.51 0.37
RF 5 {5} 0.00 0.00 0.03 0.51 1.00
RFfinal {6} 0.00 0.00 0.02 0.37 1.00
MVC Method (F5 ;35=11.6; p  < 0.001)
Active Period MVC Method (F 5;45=27.9; p < 0.000)
Sprint M thod (F5;40=10.6; p < 0.000)
70% PPO Method (F 5;35=11.3; p < 0.000)
Figure 2.8: Rectus femoris (RF) mean muscle activity at the 5 power output loads of PPO for Trial 2, 
when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle activity 
significantly different between stages was shown as *P<0.05. The table provides the post hoc repeated 
measures significant differences between the stages. The values in blue are tending towards significance. 
The bold value heading each column is the average EMG at each load. The column heading {1} represents 
RF load 1, {2} represents RF load 2 etc.  
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STAGES {1} 16.9 {2} 18.9 {3} 21.7 {4} 22.2 {5} 27.1 {6} 27.1
BF 1 {1} 0.95 0.31 0.21 0.00 0.00
BF 2 {2} 0.95 0.84 0.72 0.01 0.01
BF 3 {3} 0.31 0.84 1.00 0.19 0.18
BF 4 {4} 0.21 0.72 1.00 0.28 0.27
BF 5 {5} 0.00 0.01 0.19 0.28 1.00
BFFinal {6} 0.00 0.01 0.18 0.27 1.00
STAGES {1} 23.8 {2} 22.5 {3} 27.3 {4} 28.0 {5} 28.2 {6} 29.2
BF 1 {1} 0.99 0.72 0.52 0.48 0.25
BF 2 {2} 0.99 0.38 0.22 0.19 0.08
BF 3 {3} 0.72 0.38 1.00 1.00 0.97
BF 4 {4} 0.52 0.22 1.00 1.00 1.00
BF 5 {5} 0.48 0.19 1.00 1.00 1.00
BFFinal {6} 0.25 0.08 0.97 1.00 1.00
STAGES {1} 29.0 {2} 31.9 {3} 38.3 {4} 38.7 {5} 45.2 {6} 44.6
BF 1 {1} 0.95 0.07 0.05 0.00 0.00
BF 2 {2} 0.95 0.39 0.32 0.00 0.00
BF 3 {3} 0.07 0.39 1.00 0.30 0.40
BF 4 {4} 0.05 0.32 1.00 0.37 0.47
BF 5 {5} 0.00 0.00 0.30 0.37 1.00
BFFinal {6} 0.00 0.00 0.40 0.47 1.00
STAGES {1} 86.8 {2} 91.0 {3} 114.6 {4} 114.9 {5} 136.7 {6} 132.0
BF 1 {1} 1.00 0.26 0.25 0.00 0.01
BF 2 {2} 1.00 0.44 0.42 0.01 0.03
BF 3 {3} 0.26 0.44 1.00 0.50 0.74
BF 4 {4} 0.25 0.42 1.00 0.52 0.75
BF 5 {5} 0.00 0.01 0.50 0.52 1.00
BFFinal {6} 0.01 0.03 0.74 0.75 1.00
MVC Method (F5;45=6.6; p < 0.000)
Active Period MVC Method (F5;50=2.4; p < 0.045)
Sprint Method (F5;45=8.0; p < 0.000)
70%PPO Method (F5;45=5.2; p < 0.000)
Figure 2.9: Biceps femoris (BF) mean muscle activity at the 5 power output loads of PPO for Trial 2, 
when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle activity 
significantly different between stages was shown as *P<0.05. The table provides the post hoc repeated 
measures significant differences between the stages. The bold value heading each column is the average 
EMG at each load. The column heading {1} represents BF load 1, {2} represents BF load 2 etc.  
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STAGES {1} .3 {2} .3 {3} .3 {4} .3 {5} .3 {6} .3
MG 1 {1} 1.00 0.21 0.76 0.12 0.95
MG 2 {2} 1.00 0.12 0.60 0.07 0.86
MG 3 {3} 0.21 0.12 0.93 1.00 0.71
MG 4 {4} 0.76 0.60 0.93 0.81 1.00
MG 5 {5} 0.12 0.07 1.00 0.81 0.54
MGfinal {6} 0.95 0.86 0.71 1.00 0.54
STAGES {1} .4 {2} .4 {3} .4 {4} .5 {5} .4 {6} .4
MG 1 {1} 1.00 0.08 0.44 0.10 0.70
MG 2 {2} 1.00 0.17 0.67 0.21 0.89
MG 3 {3} 0.08 0.17 0.94 1.00 0.77
MG 4 {4} 0.44 0.67 0.94 0.96 1.00
MG 5 {5} 0.10 0.21 1.00 0.96 0.82
MGfinal {6} 0.70 0.89 0.77 1.00 0.82
STAGES {1} 83.1 {2} 84.1 {3} 92.7 {4} 88.6 {5}92.1 {6} 85.5
MG 1 {1} 1.00 0.16 0.71 0.21 0.99
MG 2 {2} 1.00 0.25 0.84 0.32 1.00
MG 3 {3} 0.16 0.25 0.90 1.00 0.45
MG 4 {4} 0.71 0.84 0.90 0.95 0.96
MG 5 {5} 0.21 0.32 1.00 0.95 0.54
MGfinal {6} 0.99 1.00 0.45 0.96 0.54
MVC Method (F5:50=2.7; p < 0.029)
Active Period MVC Method (F5;60= 0.1; p < 0.970)
Sprint Method  (F5;50= 2.6; p < 0.032)
70%PPO Method  (F5;50= 2.2; p < 0.065)
STAGES {1} 45.4 {2} 44.9 {3} 43.6 {4} 43.8 {5} 44.1 {6} 43.9
MG 1 {1} 1.00 0.98 0.99 1.00 0.99
MG 2 {2} 1.00 1.00 1.00 1.00 1.00
MG 3 {3} 0.98 1.00 1.00 1.00 1.00
MG 4 {4} 0.99 1.00 1.00 1.00 1.00
MG 5 {5} 1.00 1.00 1.00 1.00 1.00
MGfinal {6} 0.99 1.00 1.00 1.00 1.00
*
*
Figure 2.10: Medial gastrocnemius (MG) mean muscle activity at the 5 power output loads of PPO 
for Trial 2, when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle 
activity significantly different between stages was shown as *P<0.05. The table provides the post hoc 
repeated measures significant differences between the stages. The bold value heading each column is the 
average EMG at each load. The column heading {1} represents MG load 1, {2} represents MG load 2 etc.  
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STAGES {1} .4 {2} .4 {3} .4 {4} .4 {5} .4 {6} .4
LG 1 {1} 0.99 1.00 1.00 1.00 0.98
LG 2 {2} 0.99 1.00 1.00 0.99 1.00
LG 3 {3} 1.00 1.00 1.00 1.00 1.00
LG 4 {4} 1.00 1.00 1.00 1.00 0.99
LG 5 {5} 1.00 0.99 1.00 1.00 0.99
LGFinal {6} 0.98 1.00 1.00 0.99 0.99
STAGES {1} 79.4 {2} 76.7 {3} 79.1 {4} 79.4 {5} 83.4 {6} 81.6
LG 1 {1} 1.00 1.00 1.00 0.99 1.00
LG 2 {2} 1.00 1.00 1.00 0.93 0.98
LG 3 {3} 1.00 1.00 1.00 0.99 1.00
LG 4 {4} 1.00 1.00 1.00 0.99 1.00
LG 5 {5} 0.99 0.93 0.99 0.99 1.00
LGFinal {6} 1.00 0.98 1.00 1.00 1.00
MVC Method (F5;45=0.2; p < 0.970)
Active Period MVC Method (F5;60= 0.4; p < 0.800)
Sprint Method  (F5;55=1.0; p < 0.420)
70%PPO Method (F5;50=0.2; p < 0.950)
STAGES {1} .4 {2} .3 {3} .4 {4} .4 {5} .3 {6} .4
LG 1 {1} 1.00 1.00 1.00 0.51 1.00
LG 2 {2} 1.00 1.00 1.00 0.51 1.00
LG 3 {3} 1.00 1.00 1.00 0.51 1.00
LG 4 {4} 1.00 1.00 1.00 0.52 1.00
LG 5 {5} 0.51 0.51 0.51 0.52 0.52
LGFinal {6} 1.00 1.00 1.00 1.00 0.52
STAGES {1} 79.4 {2} 76.7 {3} 79.1 {4} 79.4 {5} 83.4 {6} 81.6
LG 1 {1} 1.00 1.00 1.00 0.99 1.00
LG 2 {2} 1.00 1.00 1.00 0.93 0.98
LG 3 {3} 1.00 1.00 1.00 0.99 1.00
LG 4 {4} 1.00 1.00 1.00 0.99 1.00
LG 5 {5} 0.99 0.93 0.99 0.99 1.00
LGFinal {6} 1.00 0.98 1.00 1.00 1.00
Figure 2.11: Lateral gastrocnemius (LG) mean muscle activity at the 5 power output loads of PPO 
for Trial 2, when normalised to MVC, Active Period MVC, Sprint and 70 % PPO method. Muscle 
activity significantly different between stages was shown as *P<0.05. The table provides the post hoc 
repeated measures significant differences between the stages. The bold value heading each column is the 
average EMG at each load. The column heading {1} represents LG load 1, {2} represents LG load 2 etc.  
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An alternative method for showing the sensitivity of each method of normalisation to 
track muscle activity to power output changes, was to calculate the ratio of power 
output to EMG amplitude. The results of this analysis are graphically displayed in Figure 
2.12. The slope of the lines is an indication of the sensitivity of the methods ability to 
track changes in power output, where a slope close to zero suggests that the method is 
more sensitive. This however does not take into account peripheral factors and fatigue 
that may affect the amplitude of the EMG signal. Therefore the data between load 5 and 
the final load should be interpreted with caution due to the increase in fatigue. 
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Figure 2.12: Power output to EMG ratio for 6  power output loads of Trial 2, when normalised to 
MVC, Active Period MVC, Sprint and 70 % PPO method for a) Vastus medialis (VM),  b) Vastus 
lateralis (VL), c) Rectus femoris (RF), d) Biceps femoris (BF,  e) Medial gastrocnemius (MG),  f) 
Lateral gastrocnemius (LG). The slope and standard deviations of each method are presented. 
Significant load effect: # (P<0.05); 
Significant method effect: β (P<0.05);  
Significant interaction effect: δ (P<0.05); 
Significantly different to Sprint, AP MVC and 70 % PPO method: *(P<0.05) 
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There was no significant difference in the Power/EMG ratio between the various 
methods of normalisation except for VL, where ratio of the MVC method was 
significantly greater than the other methods at each power output load (Figure 2.12. b); 
and LG, where the Power/EMG ratio for 70 % PPO method was significantly lower than 
the AP MVC method (Figure 2.12.f). The 70 % PPO method had the most horizontal 
slopes for most of the muscles except for VM, and was therefore the most capable 
method of normalisation for tracking EMG amplitude to changes in power output, 
assuming the absence of fatigue. For VM (Figure 2.12.a), the Sprint and AP MVC 
methods showed the most horizontal slopes closest to zero of 0.06 ± 0.20 and 0.11 ± 
0.23 respectively. The MVC method had the highest slope for this VM (0.35 ± 0.27). For 
VL, 70 % PPO and AP MVC methods had the most horizontal slope with similar values 
of (0.06 ± 0.04) and  (0.09 ± 0.12) respectively. The MVC (0.02 ± 0.46) and 70% PPO 
method (0.24 ± 0.13) had the most horizontal slopes for RF, the MVC method however 
had the greatest standard deviation. The Sprint and 70 % PPO method showed 
similarly horizontal slopes for BF (0.02 ± 0.02 and 0.02 ± 0.14 respectively). For MG 
and LG, the 70 % PPO method had the most horizontal slope (0.25 ± 0.03) and (0.16 ± 
0.07) respectively. It is important to note that these slope values are relatively high 
compared to the lowest slope values for VM, VL and BF. 
 
To summarise which method is most sensitive in representing corresponding power 
output change with change in EMG amplitude, the results of the two methods used 
were tabulated, namely; sensitivity of EMG amplitude to increasing power output 
workloads (Figure 2.6-2.11) and power output to EMG ratio (Figure 2.12). The results 
are presented in Table 2.5. In summary, the AP MVC method demonstrated the 
greatest ability in detecting changes in EMG amplitude over increasing power output 
stages for most muscles. However, when analysing the data with regards to power 
output/EMG ratio, the 70 % PPO method showed the greatest ability in tracking EMG 
amplitude to power output changes. Important to note was that the MVC method was 
not seen to be ‘usable’ in detecting changes between workloads for VM and VL 
(including the gastrocnemius muscles which none of the methods were able to detect). 
This method was also not ‘usable’ for tracking EMG amplitude to power output changes 
for VM, VL and BF. The AP MVC was also found to be not ‘usable’ in detecting changes 
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in power output for BF as well as EMG/power output ratio for the gastrocnemius 
muscles. 
 
Table 2.5: The recommended and ‘usable’ methods of normalisation found for each muscle using 
the sensitivity analysis. 
Muscle Sensitivity between workloads  Sensitivity of power output to 
EMG ratio 
VM 
 
VL 
 
RF 
 
BF  
 
MG 
 
LG 
Sprint , AP MVC (70 % PPO) 
 
AP MVC (70 % PPO & Sprint) 
 
AP MVC, MVC (70 % PPO & Sprint)  
 
Sprint (70 % PPO & MVC) 
 
None 
 
None 
Sprint, AP MVC (70 % PPO) 
 
70 % PPO, AP MVC (Sprint) 
 
70 % PPO,  MVC (Sprint) 
 
Sprint and 70 % PPO (AP MVC) 
 
70 % PPO (Sprint & MVC) 
 
70 % PPO (Sprint & MVC) 
 
Most sensitive methods of normalisation found from sensitivity analysis in Figure 2.6 - 2.11 and Figure 
2.12.  VM, Vastus medialis; VL, Va tus lateralis; RF, Rectus femoris; BF, Biceps femoris; MG, Medial 
gastrocnemius and LG, Lateral gastrocnemius. The ‘usable’ methods are enclosed in brackets. 
 
2.4  DISCUSSION 
 
The aim of the study was to examine four different methods of normalising EMG activity 
measured during incremental cycling to exhaustion, with specific emphasis on 
identifying the most repeatable and suitable one for dynamic cycling exercises. These 
methods included two methods with normalisation to an isometric MVC (MVC method 
and Active Period MVC method) and two methods with normalisation to cycling (Sprint 
method and 70 % PPO method). According to the previously described requirements 
for a method of normalisation to be considered appropriate, it must display repeatability, 
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reliability and must be sensitive to changes in exercise workload during the dynamic 
cycling trial.  These three criteria are evaluated individually in the following sections. 
 
2.4.1 Repeatability of the methods of normalisation 
 
Repeatability is an indication of reproducibility, thus the method should produce similar 
results over different testing trials (within day and between days). The primary finding of 
this study was that while there are variations between the specific muscles and with 
specific loads, the highest repeatability of EMG activity of the lower limb muscles was 
found when using the  70 % PPO Method (Tables 2.2 and 2.3). Since the 70 % PPO 
method utilises a submaximal exercise profile, this finding is consistent with earlier 
research that showed submaximal exercise to more repeatable than maximal efforts in 
isometric contractions (105; 124; 197). Mathur et al. (124) studied the repeatability of RF, VL 
and VM during sustained isometric contractions at 80 % and 20 % MVC maintained to 
exhaustion. EMG amplitude was reliable (moder te to high) during 20 % MVC where 
ICC ranged from 0.58 - 0.99. In contrast, the 80 % MVC trial had a greater degree of 
variability and produced low ICC values. Likewise, Kollmitzer et al. (105) showed EMG to 
be more repeatable for 50 % MVC knee extensions than 100 % MVC, where RF was 
more reliable than VL and VM.  
 
With respect to specific muscles, Mathur et al. (124) found no differences in the 
repeatability of VM, VL and RF EMG activity during the 20 % MVC, which they 
attributed to the lower force requirement whilst performing the task. The present study 
showed that VM, RF and VL had high ICC (averaged over 6 loads, R = 0.88, 0.82 and 
0.91 respectively) when normalised to the submaximal dynamic 70 % PPO method 
(Table 2.3). Laplaud et al. (113), whose method of normalisation involved expressing root 
mean square (RMS) values as a percentage of the maximal RMS value recorded during 
the incremental cycling trial, found RF to be the least repeatable. It is important to note 
that the present study showed RF to have low ICC values when normalised to the 
‘maximal’ methods of normalisation of MVC, Sprint and AP MVC (Table 2.3). However, 
the submaximal 70 % PPO method did show RF to have good repeatability where ICC 
was R = 0.82 (0.71 - 0.93).  The fact that RF is a biarticulate muscle which is involved in 
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both leg extension and flexion cannot be the sole reason for the variability found in the 
measurements. If this was the reason, then the BF which is involved in leg flexion and 
extension would show similar trends. Yet in the present study, BF had good 
repeatability for all 4 methods of normalisation (Table 2.3). Another possible reason for 
RF variability could be that RF comprises a higher percentage of fatigable fast twitch 
muscle fibers (108; 124), which would explain the high variability found using the ‘maximal’ 
and fatiguing methods of normalisation used in the present study and in the study 
conducted by Laplaud et al. (113). The use of the submaximal 70 % PPO method may 
reduce this variability by activating fewer fast twitch fibers and not fatiguing these fibers 
to the same degree as maximal methods of normalisation.  
 
Moreover, the fact that the 70 % PPO Method is dynamic in nature may result in a more 
relevant representation of muscle activity during the trial. This method is representative 
of regular neural muscle control strategy (63) and takes into account the change in 
muscle length during cycling. Kellis & Baltzopoulos (98) found dynamic method of 
normalisation to be more appropriate because this method considers the effects of 
muscle activation, muscle length and angular velocity on EMG. The study of Kellis & 
Baltzopoulos (98) was one of the first studies to use EMG from MVC during an isokinetic 
muscle action that used the same joint angle and joint angle velocity as the task EMG 
for the denominator in the normalisation equation.  
 
Few studies have investigated the suitability of using isometric MVC methods to 
normalise EMG measured during non-isometric tasks. A study by Dubo et al. (44), where 
EMG during gait was normalised to 100 % MVC, found large inter-subject variability. 
Knutson & Richards (104) continued this research by normalising each stride in the gait 
cycle to the peak EMG amplitude during that stride. Their findings showed a lower 
variability than that reported by Dubo et al. (44), where EMG was normalised to 100 % 
MVC. Yang & Winter (198) subsequently investigated both methods of normalisation 
during gait. They normalised gait EMG to isometric methods; 50 % MVC (since they 
previously showed 100 % MVC to be less reliable) and mean EMG per unit isometric 
force (µv.Nm-1). They also used dynamic methods, peak and mean within-subject 
ensemble averages. This study found the dynamic methods reduced inter-subject 
variability.  
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The result of the present study and previous research pertaining to the repeatability of 
the methods indicates that the use of static isometric methods is not as appropriate for 
normalisation in dynamic cycling exercise. The dynamic methods of normalisation, 
predominantly the 70 % PPO method, were found to be ‘highly’ repeatable for most 
muscles. 
 
2.4.2 Intra-subject reliability of the methods of normalisation 
 
The reliability tested in this chapter refers to the reproducibility of EMG activity of the 
same individual performing repeated trials (84). This study found the best intra-subject 
reliability of EMG amplitude when normalising the cycling trials to 70 % PPO method.  
For most muscles (VM, VL, RF, BF and LG) (Table 2.4), summed percentage scores 
ranged from 14 % to 21 %. The Sprint method produced similar intra-subject CV values 
to that of the 70 % PPO method, and the MVC and AP MVC methods had the highest 
variability for all muscles (as seen by the highest scores produced). These findings 
suggest that EMG amplitude during cycling is most reliable when normalised to 
dynamic methods, preferably the submaximal methods.  
 
This finding is similar to that of Bolgla & Uhl (21). They investigated the repeatability and 
reliability of three methods of normalisation; MVC, Mean dynamic (m-Dyn) and Peak 
Dynamic (pk-Dyn) methods for analysing hip abductor rehabilitation exercises on 
healthy subjects. Subjects performed 3 open kinetic and 3 closed kinetic chain hip 
abductor exercises. Intra-subject CV’s ranged between 11 - 22 % for all methods; 
however the m-Dyn method provided the lowest intra-subject CVs for 5 out of the 6 
exercises performed.  Interestingly the pk-Dyn method had the highest CV values. 
Based on these results, Bolgla & Uhl (21) agreed with other studies (25; 196; 198), that the m-
Dyn method provides greater measurements of reliability.  
 
It is of interest to note is that the maximal methods of normalisation (MVC, AP MVC and 
Sprint methods) show the highest variability, which could possibly be explained by the 
following reasoning. An inverse relationship exits between force production and force 
variability (124) where higher forces show greater variability and hence increased intra-
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subject variability (142). By performing a maximal task/contraction, we assume the 
person is performing and providing a maximal effort, which adds to the variability of the 
method  (197) as well as the motivational factors (106). In addition, EMG measurements 
from MVC’s have previously been shown to be less reliable than submaximal 
contractions (105; 124; 198), and because some individuals are able to activate their muscles 
closer to the maximal level of activation than others  (69). Felici (64) explained that MVC 
was a poor representation of muscle function during normal activity since it represents a 
simplified version of movement. This could be a possible reason for the high intra-
subjects CV’s found for the MVC methods. 
 
The finding of the present study is in agreement with previous research that has found 
dynamic methods of normalisation to have less variability than the maximal static 
isometric method. 
 
2.4.3 Sensitivity of the methods of normalisation 
 
Sensitivity of the method of normalisation refers to the methods’ ability to track changes 
in workload or exercise intensity. For this analysis, the EMG measurement was able 
detect differences in EMG activity with increasing workload. This however does not 
take into account the presence of fatigue and the affect this has on the EMG amplitude. 
It is reasonable to expect muscle force and EMG amplitude to have a linear relationship 
(in the absence of fatigue), since they both depend on the number of motor units 
recruited (59). For this reason, EMG amplitude increases with increasing power 
output/workload (18; 51; 52; 119). Taylor & Bronks (178) found during incremental cycling, the 
relationship between EMG amplitude and exercise intensity to be linear. Similarly, in 
the present study the PPO trial consisted of increasing workloads. For the sensitivity 
phase of the experiment the PPO trial was divided into 5 loads and a final load cycled 
by each subject. The muscle activity was measured at each load and the data were 
normalised using the four methods. The assumption of this experimental approach was 
that a sensitive method of normalisation would detect the changes in muscle activity as 
the workload increased. 
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Since muscle activity has been shown to be repeatable during incremental cycling (68; 
113), it could be assumed that the changes found in muscle activity during each cycling 
load was highlighted more by the type of method of normalisation used and not entirely 
due to the variation in muscle activity caused by fatigue or from the intrinsic and 
extrinsic influences on the EMG signal. In this study the aim was to measure the ability 
of each method to detect changes in muscle activity over 5 workloads of the PPO test 
and also during the final stage of the PPO trial. The AP MVC and Sprint methods 
(Figures 2.6 - 2.11 and Table 2.5) were the most sensitive in detecting changes in 
muscle activity over all the 6 stages for all muscles except MG and LG. However, the 
AP MVC and Sprint methods were not highly repeatable for RF, VL (Table 2.2). By 
interpreting these data in an alternative manner (Figure 2.12), i.e. where the data are 
presented as a ratio of power output to EMG amplitude, it was found that the 70 % PPO 
method showed the lowest/most horizontal linear slope for all muscles except VM. This 
technique represents the ability of the method to track changes in power output with 
that of EMG amplitude. 
 
It is important to note that no method was able to detect changes in EMG amplitude 
over the 6 power out stages for MG and LG. This could possibly be answered by 
studies investigating the effects of cycling cadences on muscle activity. A study 
conducted by Marsh et al. (121) showed that an increase in cadence resulted in a 
significant increase in average EMG amplitude of the gastrocnemius muscles despite 
the cyclists’ cycling experi nces. This study was in agreement with study conducted by 
Goto et al. (72), which found gastrocnemius EMG amplitude increased linearly with an 
increase in cadence. More interestingly, Gregor et al. (74) showed gastrocnemius 
activation to be associated more strongly with cadence changes than changes in power 
output. They found similar gastrocnemius EMG amplitude when cycling at 90 rpm for 
power outputs of both 90 W and 270 W, despite significant power output differences; for 
instance when EMG amplitude was lower when cycling at a cadence of 60 rpm at 180 
W. Sarre et al. (165), found that muscle activity of the knee extensor muscles (VM and 
VL) were not significantly influenced by cadence manipulations. Even though the 
cadence was not recorded during the trials in the present study, it can thus be assumed 
that all the cyclists maintained their cadence until exhaustion, since no method of 
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normalisation showed any significant changes in gastrocnemius activity throughout the 
PPO trials. 
 
In summary, the most appropriate method of normalisation is one that reflects 
reproducibility over different testing times, has low variation and the ability to detect 
changes in EMG amplitude with changes in exercise intensity.  
 
It is important to point out that the specific, practical application of measured EMG data 
is also dependent on the research question and the nature of the study being 
performed.  For example, for a once-off trial in which the absolute EMG activity or 
percentage of total active muscle is to be estimated using surface EMG measurements, 
repeatability is less important than intra-individual CV.  Rather, in this situation, it is 
important to use a method of normalisation that represents what may be considered a 
true maximum of skeletal muscle activation.  In contrast, if the study is designed to 
measure physiological/biological changes as a result of some intervention or fatigue 
process, then the reliability, repeatability and sensitivity become more important.  
Therefore, in considering the optimal normalisation technique, the three previously 
identified factors (repeatability, reliability and sensitivity) must be interpreted in the 
context of the overall research question. 
 
Accordingly, the present study has shown that normalising EMG during cycling to the 
70 % PPO method meets the three requirements and is therefore recommended for 
studies that are investigating changes in muscle activity over different days, where 
reliability and repeatability of measurements becomes more important.  
 
However, for investigating the maximal muscle activity during a trial, the Sprint method 
of normalisation is recommended, since it provides a reliable method that is similar in 
nature to the subsequent cycling trial.  Further, the Sprint method was sensitive to 
changes in workload.  However, it is important to note that this method showed poor 
reproducibility for RF. Nevertheless, for a once-off trial where the absolute level of EMG 
activity (and hence muscle activity) is to be indirectly measured, it is still recommended 
that researchers utilise the Sprint method as a method of normalisation for cycling 
activity. 
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With regards to the MVC methods of normalisation, both MVC methods (MVC and AP 
MVC) are questionable.  Normalising to the MVC method was unable to detect changes 
in EMG amplitude over increasing power output stages as that shown by the AP MVC. 
Furthermore, the AP MVC displayed poor repeatability. If researchers choose to use the 
MVC methods, it is recommended that researchers analyse the data by taking 3 s 
epochs of trials and not 3 separate contractions (bursts) as done for AP MVC method, 
since this method is more repeatable. However it is important to note that by perhaps 
increasing the number of active periods analysed, repeatability could possibly be 
improved.  
 
The findings of this study have important clinical laboratory implications with regards to 
the method of normalisation and which muscles are being measured, since certain 
methods of normalisation are found to be better for certain muscles only. It is important 
that researchers should use a method of normalisation that is suitable to their study 
design and research question and therefore allows them to measure true biological 
variation rather than incur experimental error as a result of an inappropriate 
methodology.  
 
In conclusion, based on the results of the present study, the methods of normalisation 
most suited for use during cycling are the 70 % PPO method for trials to exhaustion and 
in repeated trial study designs, while the Sprint method is recommended for use when 
the absolute amount of muscle activity (relative to a maximum) is desired as an 
outcome. For running activity, however, these methods of normalisation may differ. 
There are a few factors that distinguish running from cycling:      
 
a)  The presence of an eccentric part of contraction, during which muscle lengthens.            
This is absent during cycling. 
b)  Greater range of motion around the joints, since cycling is constrained to a specific 
range through the cyclical pedal action. 
c)  Movement in three planes during running, whereas in cycling, movement and 
muscle action occurs across two dimensions only. 
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Therefore, it is considered necessary to evaluate the optimal methods of normalisation 
for running in a separate study.  This study is performed as Chapter 3 of the present 
thesis. 
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CHAPTER 3  
 
CRITICAL ANALYSIS OF METHODS FOR NORMALISATION 
OF SURFACE EMG ACTIVITY DURING RUNNING 
 
3.1 INTRODUCTION 
 
Running requires a complex sequence and combination of muscle activation which 
includes an interplay of muscular forces and external forces (inertial, gravitational and 
reaction forces) (63). Running also involves the shortening (concentric) and lengthening 
(eccentric) of muscle action known as the stretch shortening cycle (SSC) (73). Effective 
storage and release of elastic energy during SSC exercises plays an important role in 
force production. This ability to utilise stored elastic energy is influenced by the level of 
preactivation of active muscles as well as the increase in muscle stiffness, velocity and 
magnitude of stretch, including the time delay between eccentric and concentric phases 
(149). Muscle preactivation, which represents a central driven feedforward, anticipatory 
mechanism (43; 71) during walking and running, regulates muscle stiffness and transition 
time between pre-stretch and shortening components of SSC.  
 
EMG has been widely used during running studies (110; 134; 135; 171; 189), and has contributed 
to the understanding of the running gait and neuromuscular causes of fatigue during 
running activity. Furthermore it is known that EMG amplitude of leg muscles increases 
with increased running speed (43). Karamindis et al. (94) investigated reproducibility of 
EMG and ground reaction forces during various running techniques, however, they only 
studied at 3 different running speeds (3.5, 3.0 and 2.5 m.s-1). A study conducted by 
Guidetti et al. (75) investigated the inter and intra-subject variability of EMG in normal 
running gait profiles. This study found that intra-subject CV for peak amplitudes were low 
and resulted in repeatable waveforms near the peaks of activity, however the inter-
subject CV’s were high since there appeared to be differences in peak amplitude 
location between subjects. This study highlighted that individual peculiarities exists in the 
EMG pattern for a given muscle in running gait. It is clear from these studies that 
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quantifying the repeatability and error associated with the measurement of EMG 
obviously has important implications for interpreting and applying the data. 
 
During running activity an individual adjusts their stride frequency and length by greater 
or lesser amounts (143). According to Hanon et al. (78), EMG activity cannot be considered 
as a steady parameter, because even during the same stage, the characteristic of each 
burst or active period can vary concurrently with changes in stride length and frequency. 
This contributes to the variability in EMG activity during running. As explained in Chapter 
2, there is no reliable alternative to normalising EMG activity during dynamic exercise; 
more specifically running studies have not shown many alternatives to the use of 
isometric MVC method as a normalisation tool.  The only studies involving the 
investigation of dynamic activity has been in walking gait analysis, which was reviewed 
in Chapter 1. The studies reviewed showed that the mean dynamic method of 
normalisation of EMG activity was the most repeatable and reliable form of normalisation 
in gait analysis (169; 198). 
 
This chapter therefore aims to find the most appropriate method of normalisation for 
EMG activity during running. This ideal method of normalisation is required to show 
“good” repeatability, reliability and sensitivity to changes in exercise intensity (which 
have been previously discussed in Chapters 1 and 2). In accordance, three methods for 
normalising EMG during running were evaluated and their variability and sensitivity to 
change were compared to the MVC method of normalisation. The methods of 
normalisation used in this study were; 
1) MVC method- using the peak EMG amplitude of a 5 second isometric MVC 
(Maximal static normalisation). This is the current widely-used method. 
2) Sprint method- using the averaged peak amplitude over a 20 m sprint (Maximal 
Dynamic normalisation). 
3) 70 % Peak Running Speed Method- using the averaged peak amplitude during 
5 minutes of running at 70 % PRS at fixed speed (Submaximal Dynamic 
Normalisation). 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
                                                                                                                                       CHAPTER 3
   
   
 - 67 - University of Cape Town 
3.2   METHODOLOGY 
 
3.2.1 Subject selection 
 
Twelve well-trained runners were recruited from local running clubs to participate in this 
study. Subjects were included if they were currently between the ages of 18-35 years old 
and if they were able to complete the Two Oceans half marathon race (21 km) under 1h 
30 min. Once they had signed the informed consent, subjects were required to visit the 
laboratory on four separate occasions. The study was approved by the Research and 
Ethics Committee of the Faculty of Health Sciences within the University of Cape Town. 
The study was performed in accordance with the principles of the Declaration of Helsinki 
(October, 2000), ICH Good Clinical Practice (GCP) and the laws of South Africa. 
Subjects were asked to maintain their same physical activity pattern over the course of 
the study and not to begin any new training or recreational programs. In addition, 
subjects were asked to not consume caffeine within 3 hours of testing and to maintain 
the same diet on the morning of each trial.  Subjects performed the same experimental 
protocol on each of the three testing days. Each testing day was separated by 5 - 7 days 
of normal training.  
 
3.2.2 Experimental design 
 
During the first visit to the laboratory, subjects underwent an anthropometrical 
assessment and answered the PAR-Q as described in Chapter 2 (Section 2.2.3). Each 
subject was then familiarised with the equipment used and the testing protocol. On the 
trial days, subjects were prepared for the placement of the electrodes on 6 muscles 
(Vastus lateralis (VL), Vastus medialis (VM), Rectus femoris (RF), Biceps femoris (BF) 
and Medial and Lateral gastrocnemius (MG and LG respectively) on the right leg. 
Following this each subject performed three maximum voluntary contractions (MVC) of 
the quadriceps, Biceps femoris and gastrocnemius muscles using the Biodex 
Dynamometer 3 (Biodex Medical Systems, New York). Subjects were then allowed a 
self-paced 10 minute warm-up on the gym track, after which they performed a two 20 m 
maximal sprints. After a 30 minute resting period, subjects then performed their Peak 
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Running Speed (PRS) test until exhaustion.  After a 30 minute resting period, each 
subject then ran at 70 % of their obtained PRS for 5 laps (700 m). Heart rate was 
measured continuously throughout the PRS test using Polar Accurex NV heart rate 
monitor (Polar Electro OY, Kempele, Finland). Subjects were required to wear the same 
running shoes for all three trials. A schematic of the study design is shown in Figure 3.1. 
 
Figure 3.1: Experimental design 
 
3.2.2.1 Familiarisation trial 
 
During their first visit subjects were familiarised with the Biodex by performing maximal 
voluntary contractions of the quadriceps, Biceps femoris and calf muscles of the right leg. 
Thereafter, they performed a peak treadmill running speed test on the treadmill (which is a 
validated method of incremental running speed to exhaustion, explained in Section 3.2.5). 
By using this preliminary test on the treadmill, subjects’ peak track running speed (which 
were performed in the subsequent three trials) were compared to the validated treadmill 
method. Once the subjects completed the PTRS test, they were familiarised with the 
pacing required when running on the indoor gym track. Maintaining the required speed set 
by the pacing lights is a novel experience for many runners, therefore it was important that 
they familiarised themselves efficiently prior to the actual experimental trial days. 
 
 
Familiarisation 
Trial 
Trial 1 Trial 2 Trial 3 
5-7 days 5-7 days 
MVC’s 
 
20 m Sprints x 2 
 
PRS test 
 
70 % PRS  
(running for 5 minutes) 
30 min rest 
30 min rest 
MVC’s 
 
20 m Sprints x 2 
 
PRS test 
 
70 % PRS  
(running for 5 minutes) 
MVC’s 
 
20 m Sprints x 2 
 
PRS test 
 
70 % PRS 
 (running for 5 minutes) 
30 min rest 
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3.2.3 Maximal voluntary contractions  
 
The same protocol was used as described in Chapter 2 (Section 2.2.4). 
 
3.2.4  20 m sprints 
 
Subjects performed two maximal 20 m sprints on an indoor running track. They were 
given a 20-30 m running start to ensure a normal and maximal running gait throughout 
the 20 m distance and to exclude gait changes associated with acceleration during the 
sprint. The 10 m and 20 m running time was recorded using four photocell gates 
connected to an electronic timer (Newtest, LTD, Oulu, Finland). The muscle activity 
during the fastest 20 m was used for EMG normalisation. 
 
3.2.5  Peak running speed trial  
 
The subjects performed the peak running speed test on an indoor gym track. The track 
had pacing lights which were used to control the running speed of each subject. The 
indoor track was 140 m with the pacing lights situated on the inner circumference of the 
track at intervals of 7 m. The lights were set to blink sequentially to coincide with a given 
running velocity. The pacing lights were set to mimic the Peak Treadmill Running Speed 
test, where the speed started at 10 km.h-1 (167). Every 30 s, the pacing light speed 
increased by 0.5 km.h-1 until the subject reached exhaustion. The PRS was defined as 
the fastest running speed the subject could maintain for 30 s. Following a 30 minute 
resting period the subjects performed a submaximal run on the track at 70 % of PRS for 
5 laps. Heart rate (Polar ® Heart Rate Monitors, Polar Electro OY, Kempele, Finland) 
was measured continuously during the PRS trials. Importantly, all subjects ran around 
the track in the same direction, where the bend of the track was on the left side for all 
subjects for all trials. 
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3.2.6 EMG data collection 
 
The EMG activity of the muscles was recorded using the telemetric EMG system 
(Telemyo 900, Noraxon, USA, Inc., Arizona, USA), which has been stated to provide 
scientifically reliable data from the developers. Two electrodes (Blue Sensor, Medicotest, 
Denmark) were placed on the belly of the lower limb muscles described above during all 
the tests.  Prior to placing the electrodes on the skin, the skin over the muscle was 
shaved and cleaned with ethanol. Two electrodes were placed on the belly of each 
muscle with an inter-electrode distance of 20 mm, and carefully taped. A telemetric 
signal was relayed to an antenna connected to an online computer and captured at 2000 
Hz. The wire-leads connected to the electrodes were well secured to the subjects’ leg 
with elastoplast tape to avoid artefacts from lower limb movements during running. The 
transmitter unit was placed in a halter which was strapped to the subject’s back; this 
technique contributed to minimising the movement artefact. The mass of the halter (± 
400 grams) was assumed to have a negligible effect on each subject’s running 
technique. EMG was recorded on one straight of the track (± 35 m) as the track had a 
slight sharp bend. Thus each subject’s data were captured whilst running upright on the 
straight of the track, thereby eliminating any contribution of weight bearing when running 
around the bend. Before recording the EMG, each subject was asked to contract their 
muscles to verify the absence of crosstalk in the EMG signal. Since the trials were 
approximately 15 minutes of running, the influence of sweat rate was considered as 
negligible 
 
3.2.7 EMG analysis 
 
The same filtering procedures were performed as described in Chapter 2 Section 2.2.7.  
 
EMG analysis of PRS trial: 
 
EMG data (µv.s) were calculated for each step (active contraction) and then time-
normalised to one second (µv⋅s)⋅s-1 (referred to as mean amplitude). EMG was recorded 
on one straight of the track (± 35 m) at each running speed and at exhaustion during the 
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PRS trials. A decision was taken to analyse three strides of EMG data as Arsenault et al. 
(10) showed that three strides of EMG data per subject provided information as reliable as 
that obtained from twelve strides during gait trials. Therefore three strides with similar 
peak amplitudes in the EMG recording were analysed and the derived mean amplitude 
at each speed was averaged. The EMG data could not be time normalised into the four 
phases of the running profile i.e. a) preactivation (100 ms before ground contact) b) 
ground contact c) braking phase and d) propulsion phase, due to problems experienced 
with the footswitch.  
 
3.2.8 Methods of normalisation  
 
There were three methods of normalisation which were investigated in this study. 
 
3.2.8.1  MVC Method  
 
The EMG from the PRS trial were normalised to the mean amplitude of the MVC 
(obtained from 3 s out of the 5 s of EMG recorded) which produced the highest force. 
EMG data from the PRS trials were expressed as a percentage of MVC. 
 
3.2.8.2 Sprint Method 
 
The EMG from the fastest sprint was analysed by isolating three peak amplitude 
contractions from the middle of the sprint recording. The resultant mean amplitudes were 
averaged and used for normalisation. The EMG data from PRS trials were expressed as 
a percentage of the fastest sprint.  
 
3.2.8.3 70 % PRS Method 
 
EMG was recorded for 10 s in each of the five laps run at 70 % PRS. Three peak 
amplitudes were then isolated from each of the five measurements and the resulting 
mean amplitude was then averaged. The EMG data from PRS trials were expressed as 
a percentage 70 % PRS.  
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Figure 3.2: The method used to analyse EMG from the PRS trials, Sprint and 70 % PRS methods of 
normalisation. (a) Raw EMG data from the PRS trial, Sprint, 70 % PRS; (b) Rectified EMG of 10 second 
period, isolating the 3 contraction within the recording and taking the mean amplitude values from the PRS 
trial, Sprint, 70 % PRS. 
 
The reason for not investigating the MVC method, as in the cycling trial in Chapter 2 (by 
taking 3 s epochs), was due to the EMG data in the running trials being slightly noisy 
between active contractions for certain subjects. This would have added false amplitude 
to the filtered and rectified signal, resulting in the possible misinterpretation of the EMG 
data. The EMG data were thus analysed by isolating the active periods and not by 
analysing 3 s epochs as described in Chapter 2. 
 
3.2.9 Statistical analysis 
 
All results were analysed using a statistical software programme (Statistica 7, StatSoft, 
Tulsa, OK, USA.). Results were expressed as means ± standard deviation (SD). 
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Correlation analysis was performed to measure relationship between the peak running 
speeds during the PTRS and the PRS protocols. Repeatability was investigated using 
the Intraclass Correlation Coefficient (ICC). The ICC values of between R = 0.80 and 
1.00 were defined as representing “good” reproducibility, scores between R = 0.60 and 
0.79 a “fair” reproducibility and scores less than R = 0.60 a “poor” reproducibility (170). 
The 95 % confidence intervals were calculated for the ICC using software downloaded 
from www.newstats.org (85). Analysis of Variance (ANOVA) with repeated measures was 
used to detect significant differences between the methods of normalisation. 
Sometimes there was a negative ICC, meaning the with-in subject variance exceeded 
the between subject variance, thus ICC R = 0 indicates no repeatability (115). A Tukey 
post hoc test was used to detect differences in muscle activity between the running 
speeds during the PTR test. Reliability of method of normalisation over 3 days for each 
subject (Intra-subject reliability) was assessed using coefficient of variation (CV) 
analysis. This was calculated by dividing the overall standard deviation by the overall 
mean over 3 trials and expressing this as a percentage. As in Chapter 2, CV values 
less than 12 % were defined as “acceptable”. P< 0.05 has been considered as 
significant in all statistical tests.  
 
 
3.3 RESULTS 
 
3.3.1 Descriptive characteristics 
 
The descriptive characteristics of the runners are shown in Table 3.1. Based on the 
data, subjects can be considered well trained.  
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Table 3.1: General subject characteristics (n=12) 
 
 
 
 
 
 
 
 
 
 
 
 
The relationship between the PTRS and PRS was defined as r = 0.86 resulting in a r2 = 
0.74, which suggests that about 74 % of the change in the PRS test could be explained 
by the PTRS test (Figure 3.3). Since the PRS test was performed on an indoor track of 
135 m and the presence of two sharp bends whereas the PTRS was performed on a 
treadmill, this could possibly contribute to the 26 % variance in data. 
 
16 17 18 19 20 21 22 23
16
17
18
19
20
21
22
23
P < 0.0004
r = 0.86
PTRS (km.h-1)
PR
S 
(k
m
.h
-1
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Figure 3.3: Relationship between the Peak Treadmill Running Speed (PTRS) and 
Peak Track Running Speed (PRS). 
 
Variable                                                           Mean ± SD 
 
Age (yrs)                                                                25.0 ± 5.7 
Height (m)                                                                1.7 ± 0.1 
Mass (kg)                                                               72.3 ±10.8 
Max Heart Rate (bpm)                                            199 ± 5 
% Body fat                                                              13.1 ± 4.2 
Peak Treadmill Running Speed (PTRS) (km.h-1)   19.2 ± 1.3 
Peak Track Running Speed (PRS) (km.h-1)            18.8 ± 1.2 
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3.3.2 Repeatability  
 
Table 3.2 shows the ICC values for every 2 km.h-1 increase in running speed for each 
muscle, normalised to the three methods for three trials. The repeatability of muscle 
activity with increasing running speed is seen to be variable for all methods of 
normalisation. However, the 70 % PRS method was the least repeatable with 
increasing running speed. 
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Table 3.2: Intra-class correlations for EMG normalised to MVC, Sprint and 70 % PRS methods for every 2 km.h-1 running speed during PRS 
trials. Values highlighted in bold represent what are considered to be “good” ICC values 
Muscle Method 10 km.h-1 12 km.h-1 14 km.h-1 16 km.h-1         18 km.h-1 
VM MVC 0.89 (0.68-0.97) 0.87 (0.64-0.97) 0.90 (0.68-0.98) 0.92 (0.72-0.99) 0.93(0.63-1.00) 
 Sprint 0.94 (0.84-0.98) 0.89 (0.72-0.97) 0.90 (0.73-0.97) 0.87 (0.66-0.97) 0.75 (0.31- 0.96) 
 70%PPO 0.10 (0.00-0.57) 0.50 (0.11-0.82) 0.78 (0.50-0.93) 0.76 (0.41-0.94) 0.45 (0.00-0.88) 
       
RF MVC 0.53 (0.00-0.93) 0.47 (0.00-0.91) 0.59 (0.00-0.96) 0.78(0.20-0.98) 0.96(0.66-1.00) 
 Sprint 0.80 (0.24-0.98) 0.73 (0.11-0.98) 0.83 (0.31-0.99) 0.73 (0.13-0.98) 0.85 (0.19-1.00) 
 70%PPO 0.57 (0.01-0.94) 0.62 (0.05-0.95) 0.86 (0.39-0.99) 0.60 (0.00- 0.96) 0.75 (0.00-0.99) 
       
VL MVC 0.66 (0.33-0.88) 0.79 (0.53-0.93) 0.67(0.34-0.89) 0.57 (0.19-0.85) 0.73(0.39-0.92) 
 Sprint 0.71 (0.36-0.92) 0.78 (0.48-0.94) 0.65 (0.27-0.90) 0.68 (0.28-0.92) 0.81(0.47-0.96) 
 70%PPO 0.00 (0.00-1.00) 0.41 (0.00-0.79) 0.41 (0.00-0.79) 0.58 (0.15-0.88) 0.36 (0.00-0.82) 
       
BF MVC 0.86 (0.54-0.98) 0.85 (0.52-0.98) 0.87 (0.57-0.98) 0.65 (0.16-0.93) 0.70(0.16-0.96) 
 Sprint 0.80 (0.34-0.97) 0.83 (0.41-0.98) 0.83 (0.41-0.98) 0.77 (0.28-0.97) 0.00 (0.00-1.00) 
0.52 (0.04-0.88)  70%PPO 0.77(0.40-0.95) 0.74 (0.34-0.94) 0.69 (0.26-0.93) 0.78 (0.41-0.95) 
   
MG MVC 0.85 (0.65-0.95) 0.92 (0.79-0.98) 0.91 (0.76-0.97) 0.90 (0.73-0.97) 0.89(0.66-0.98) 
 Sprint 0.11 (0.00-0.58) 0.71 (0.38-0.91) 0.69 (0.35-0.90) 0.71 (0.36-0.92)   0.80 (0.51-0.96) 
 70%PPO 0.75 (0.59-0.96) 0.70 (0.37-0.91) 0.45 (0.06-0.80) 0.11 (0.00-0.60) 0.00 (0.00-1.00) 
       
LG MVC 0.84 (0.54-0.97) 0.34 (0.00-0.81) 0.00 (0.00-1.00) 0.93 (0.70-0.99) 0.97(0.73-1.00) 
 Sprint 0.85 (0.52-0.98) 0.79 (0.39-0.96) 0.79 (0.39-0.96) 0.78 (0.67-0.97) 0.13 (0.00-0.87) 
 70%PPO 0.79 (0.43-0.96) 0.70 (0.28-0.93) 0.60 (0.09-0.92) 0.69 (0.21-0.94) 0.00 (0.00-1.00) 
 
Intra-class correlations with 95% confidence intervals for methods of normalisation for each muscle, Vastus medialis (VM), Rectus femoris (RF), Vastus 
lateralis (VL), Biceps femoris (BF), Medial gastrocnemius (MG) and Lateral gastrocnemius (LG), over 3 separate days running. Values highlighted in 
bold represent what are considered to be “good” ICC values. The section represented in Figure 3.4 is highlighted in the block.
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Table 3.3: Average Intra-class correlations (ICC) for Peak Running Speed test EMG normalised 
to MVC, Sprint and 70 % PRS methods 
 
Muscle MVC Sprint 70 % PRS 
Vastus medialis 
Rectus femoris 
Vastus lateralis 
Bicep femoris 
Medial gastrocnemius 
Lateral gastrocnemius     
0.90 (0.87-0.93) 
0.66 (0.42-0.92) 
0.68 (0.58-0.79) 
0.84 (0.78-0.90) 
0.89 (0.86-0.93) 
0.61 (0.09-1.00) 
0.87 (0.78 -0.96) 
0.79 (0.72-0.86) 
0.73 (0.64-0.81) 
0.65 (0.20-1.00) 
0.60 (0.26-0.95) 
0.67 (0.30-1.00) 
0.51(0.17-0.86) 
0.68 (0.53-0.83) 
0.27 (0.01-0.52) 
0.70 (0.57-0.83) 
0.40 (0.00-0.82) 
0.56 (0.16-0.95) 
 
Values presented as mean ICC (10 km.h-1 to 18 km.h-1) with 95 % confidence intervals. ICC for 
methods of normalisation, of each muscle, over 3 trials. Bolded values indicate the highest mean ICC 
value for each muscle. 
 
The MVC and Sprint methods were the most repeatable for normalising EMG 
activity during running.  The MVC method had the highest average ICC values for 
VM, BF and MG (“good” repeatability where ICC R > 0.80). The MVC method had 
“fair” repeatability for RF, VL and LG, where ICC values were between R = 0.61 - 
0.68. The Sprint method had the highest repeatability for RF, VL and LG 
normalisation. In addition, this method had “good” repeatability when normalising 
VM (0.87(0.78 - 0.96)) and “fair” repeatability for normalising BF and MG (0.65 (0.20 
- 1.00) and 0.60 (0.26 - 0.95) respectively).The 70 % PRS method had “poor” 
repeatability for most muscles except for BF (0.70 (0.57 - 0.83)) and RF (0.68 (0.53 - 
0.83)), which was “fairly” repeatable. 
 
To further highlight the variation in muscle activity using different methods of 
normalisation a subsection of ICC values from Table 3.2 (highlighted in the block) 
have been graphically represented. The ICC values for MG activity at 16 km.h-1 
were randomly chosen, as this speed showed the most variation in ICC values of 
each method of normalisation, thus highlighting the individual variation in muscle 
activity at this running speed. In an attempt to clarify the results the graphs in Figure 
3.4 are arranged so that the first 6 subjects are represented on the left panel and the 
remaining subjects on the right panel. When normalised to the MVC method (Figure 
3.4.a), ICC R = 0.90 (0.73 - 0.97), only subjects’ 1 and 11 showed “high” variations 
in MG muscle activity over 3 days.  The Sprint method (Figure 3.4.b) showed more 
subjects to have distinct variation in MG muscle activity and thus the ICC was lower 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 3                     
Department of Human Biology - 78 - 
at R = 0.71 (0.36 - 0.92) (subjects 3, 8, & 9). Most individuals showed variation in 
MG muscle activity when normalised to 70 % PRS method, where ICC R = 
0.17(0.00 - 0.60) (subjects 1, 3, 5, 8, 9, 10 & 11). 
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Figure 3.4: Variability of Medial gastrocnemius (MG) muscle activity at 16 km.km-1 over the three 
trials normalised to a) MVC method, b) Sprint method and c) 70% PRS method. The graphs illustrate 
the intra-class correlation with 95 % confidence intervals highlighted in the block in Table 3.2. The first 
six subjects 6 subjects are represented on the left panel and the remaining subjects on the right panel. 
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3.3.3    Reliability  
 
The intra-subject coefficient of variation (CV) of each subject muscle activity over 
the 3 trials provides an indication of which method of normalisation produced more 
reproducible results. Figure 3.5 provides a graphical display of the CV of each 
method of normalisation for each subject. The graphs showed various degrees of 
variation for each subject. To simplify the intra-subject CV’s in Figure 3.5 and to 
emphasise which method showed the lowest intra-subject CV’s, the graphs were 
divided into 3 zones; Zone 1(CV values ≤ 12 %), Zone 2 (CV values 12 % > and ≤ 
20 %), Zone 3 (CV values > 20 %). 
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Figure 3.5: Intra-subject coefficient of variation (CV) of the three methods of normalisation for 
Vastus medialis (VM), Vastus lateralis (VL), Rectus femoris (RF), Biceps femoris (BF), Medial 
and Lateral gastrocnemius (MG and LG respectively) recorded over three trials. Dashed line 
represents the range of low variation, between 0 - 12 %. The solid line represents the range of high 
variation, above 20 %. Note that for Subject 3, 2, 8 and 1; RF and BF muscle activity was not captured, 
for 2 trials, thus unable to calculate CV value. 
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The percentages were calculated for each zone as described in Chapter 2 Section 
2.3.3. The method of normalisation with the highest percentage of CV values in 
Zone 1 and 2 would have the least intra-subject variability over 3 trials. 
 
Table 3.4: Percentage of the summed scores for the intra-subject coefficient of variation zones 
   Muscles     Norm Method           Zone 1                  Zone 2                      Zone 3 
                                                            %                          %                             % 
VM 
 
 
 
VL 
 
 
 
RF 
 
 
 
BF 
 
 
 
MG 
 
 
 
 
LG 
MVC 
Sprint 
70%PPO 
 
MVC 
Sprint 
70%PPO 
 
MVC 
Sprint 
70%PPO 
 
MVC 
Sprint 
70%PPO 
 
MVC 
Sprint 
70%PPO 
 
MVC 
Sprint 
70%PPO 
25 
18 
27 
 
25 
0 
25 
 
20 
22 
22 
 
25 
9 
33 
 
17 
33 
25 
 
25 
10 
42 
33 
64 
55 
 
25 
55 
42 
 
20 
22 
45 
 
25 
54 
12 
 
66 
58 
58 
 
33 
60 
42 
 
 
42 
18 
18 
 
50 
45 
33 
 
60 
56 
33 
 
50 
27 
45 
 
17 
9 
17 
 
42 
30 
16 
 
Percentage of CV values in each Zone for each method of normalisation and muscle; Vastus medialis 
(VM), Vastus lateralis (VL), Rectus femoris (RF), Biceps femoris (BF), Medial and Lateral 
gastrocnemius (MG and LG respectively). CV values summed in each zone calculated as a percentage 
of the subject number per Zone 1(CV values ≤ 12 %), Zone 2 (CV values 12 % > and ≤ 20 %), Zone 3 
(CV values > 20 %). The methods with highest percentages in each zone for each muscle, is 
highlighted in bold. 
 
The calculation highlighted that 70 % PRS method had the highest CV values for 
most muscles, amongst the methods of normalisation, in Zone 1 (except MG) (Table 
3.4). This method showed to have most of its CV values in Zone 2, where the 
percentages ranged from 11 % - 58 %. Important to note is that this method also 
has the least CV values in Zone 3 ranging between 17 % - 45 %. Whereas, the MVC 
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method had the highest CV values amongst the methods of normalisation in Zone 3 
for all muscles (17 % - 60 %), resulting in the highest intra-subject variability. This 
method does however show to have high CV values in Zone 2 (20 % - 66 %). 
 
 The Sprint method had the highest CV values (amongst the methods of 
normalisation) for MG (33 %) and RF (22 %) in Zone 1. The greater CV values for 
this method were found in Zone 2, ranging between 22 % - 64 %.  
 
3.3.4 Sensitivity  
 
The same method that was used in Chapter 2 Section 2.3.4 was used to determine 
the sensitivity of each method of normalisation in detecting changes in muscle 
activity as the running speed increased. For the purpose of this analysis the EMG 
measurement should detect differences in EMG activity with increasing running 
speed. This however does not take into account peripheral factors, associated with 
fatigue, which may affect the amplitude of the EMG signal. Only the results of one of 
the three trials is shown (Trial 2 data were randomly chosen). To clarify the data 
analysis a graph of EMG amplitude is shown for each muscle at different running 
speeds. A table showing the p-values for differences between running speeds are 
also shown (Tukey post hoc analysis).  
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                  MVC METHOD (F5;35=1.98;  p < 0.110)
SPRINT METHOD (F5;30= 0.96; p < 0.450)
70% PRS METHOD   (F5;35=3.33; p < 0.015)
STAGES {1} 50.1 {2} 49.8 {3} 50.6 {4} 53.4 {5} 60.9 {6} 64.0
VM10 {1} 1.00 1.00 0.99 0.51 0.24
VM12 {2} 1.00 1.00 0.99 0.48 0.22
VM14 {3} 1.00 1.00 1.00 0.56 0.27
VM16 {4} 0.99 0.99 1.00 0.82 0.53
VM18 {5} 0.51 0.48 0.56 0.82 1.00
VM Final {6} 0.24 0.22 0.27 0.53 1.00
STAGES {1} 47.2 {2} 48.1 {3} 49.6 {4} 51.4 {5} 52.1 {6} 57.8
VM10 {1} 1.00 1.00 0.97 0.95 0.40
VM12 {2} 1.00 1.00 0.99 0.98 0.49
VM14 {3} 1.00 1.00 1.00 1.00 0.67
VM16 {4} 0.97 0.99 1.00 1.00 0.85
VM18 {5} 0.95 0.98 1.00 1.00 0.90
VM Final {6} 0.40 0.49 0.67 0.85 0.90
STAGES {1} 87.0 {2} 88.2 {3} 92.8 {4} 98.5 {5} 105.0 {6} 119.9
VM10 {1} 1.00 0.99 0.84 0.44 0.02
VM12 {2} 1.00 1.00 0.89 0.52 0.03
VM14 {3} 0.99 1.00 0.99 0.80 0.08
VM16 {4} 0.84 0.89 0.99 0.98 0.26
VM18 {5} 0.44 0.52 0.80 0.98 0.64
VM Final {6} 0.02 0.03 0.08 0.26 0.64
 
Figure 3.6: Vastus medialis (VM) muscle activity in Trial 2, normalised to MVC, Sprint and 70 % 
PRS, methods. F indicates the final speed that each subject reached during Trial 2. Differences 
between running speeds was shown as * p<0.05. The corresponding table indicates the significant 
difference in muscle activity between the 6 running speeds using Tukey post hoc analysis (highlighted 
in red). The bold value heading each column is the average EMG at each running speed. The column 
heading {1} represents VM 10, {2} represents VM 12 etc.  
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SPRINT  METHOD   (F5;40= 5.92; p < 0.000)
70% PRS METHOD   (F5;45=8.96; p < 0.000)
STAGES {1} 42.8 {2} 45.6 {3} 50.2 {4} 48.9 {5} 55.6 {6} 64.1
VL10 {1} 0.99 0.53 0.71 0.05 0.00
VL12 {2} 0.99 0.90 0.97 0.21 0.00
VL14 {3} 0.53 0.90 1.00 0.81 0.03
VL16 {4} 0.71 0.97 1.00 0.64 0.01
VL18 {5} 0.05 0.21 0.81 0.64 0.37
VL Final {6} 0.00 0.00 0.03 0.01 0.37
STAGES {1} 86.4 {2} 92.9 {3} 99.9 {4} 101.6 {5} 113.6 {6} 139.9
VL10 {1} 0.98 0.66 0.54 0.04 0.00
VL12 {2} 0.98 0.97 0.93 0.22 0.00
VL14 {3} 0.66 0.97 1.00 0.65 0.00
VL16 {4} 0.54 0.93 1.00 0.77 0.00
VL18 {5} 0.04 0.22 0.65 0.77 0.06
VL Final {6} 0.00 0.00 0.00 0.00 0.06
STAGES {1} 42.5 {2} 45.2 {3} 48.3 {4} 49.5 {5} 54.2 {6} 64.0
VL10 {1} 0.99 0.78 0.63 0.12 0.00
VL12 {2} 0.99 0.98 0.93 0.35 0.00
VL14 {3} 0.78 0.98 1.00 0.77 0.01
VL16 {4} 0.63 0.93 1.00 0.89 0.03
VL18 {5} 0.12 0.35 0.77 0.89 0.26
VL Final {6} 0.00 0.00 0.01 0.03 0.26
 
Figure 3.7: Vastus lateralis (VL) muscle activity in Trial 2, normalised to 70% PRS, Sprint and 
MVC methods. F indicates the final speed that each subject reached during Trial 2. Differences 
between running speeds was shown as * p<0.05. The corresponding table indicates the significant 
difference in muscle activity between the 6 running speeds using Tukey post hoc analysis (highlighted 
in red).The blue highlighted values are the values tending towards significance. The bold value heading 
each column is the average EMG at each running speed. The column heading {1} represents VL 10, 
{2} represents VL 12 etc.  
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SPRINT METHOD   (F5;20=28.59; p < 0.000)
70% PRS METHOD (F5;25= 16.93; p < 0.000)
STAGES {1} 15.3 {2} 16.8 {3} 18.4 {4} 19.8 {5} 27.2 {6} 34.6
RF10 {1} 0.99 0.78 0.45 0.00 0.00
RF12 {2} 0.99 0.98 0.81 0.00 0.00
RF14 {3} 0.78 0.98 0.99 0.01 0.00
RF16 {4} 0.45 0.81 0.99 0.05 0.00
RF18 {5} 0.00 0.00 0.01 0.05 0.05
RF Final {6} 0.00 0.00 0.00 0.00 0.05
STAGES {1} 25.9 {2} 29.4 {3} 30.5 {4} 32.2 {5} 44.1 {6} 53.8
RF10 {1} 0.83 0.60 0.27 0.00 0.00
RF12 {2} 0.83 1.00 0.91 0.00 0.00
RF14 {3} 0.60 1.00 0.99 0.00 0.00
RF16 {4} 0.27 0.91 0.99 0.01 0.00
RF18 {5} 0.00 0.00 0.00 0.01 0.03
RF Final {6} 0.00 0.00 0.00 0.00 0.03
STAGES {1} 90.6 {2} 99.6 {3} 113.7 {4} 113.2 {5} 166.9 {6} 181.1
RF10 {1} 0.98 0.48 0.51 0.00 0.00
RF12 {2} 0.98 0.88 0.89 0.00 0.00
RF14 {3} 0.48 0.88 1.00 0.00 0.00
RF16 {4} 0.51 0.89 1.00 0.00 0.00
RF18 {5} 0.00 0.00 0.00 0.00 0.87
RF Final {6} 0.00 0.00 0.00 0.00 0.87
 
Figure 3.8: Rectus femoris (RF) muscle activity in Trial 2, normalised to 70% PRS, Sprint and 
MVC methods. F indicates the final speed that each subject reached during Trial 2. Differences 
between running speeds was shown as * p<0.05. The corresponding table indicates the significant 
difference in muscle activity between the 6 running speeds using Tukey post hoc analysis (highlighted 
in red). The bold value heading each column is the average EMG at each running speed. The column 
heading {1} represents RF10, {2} represents RF 12 etc.  
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SPRINT METHOD (F5;35=13.76; p < 0.000)
70% PRS METHOD (F5;35=18.01; p < 0.000)
STAGES {1} 44.7 {2} 48.8 {3} 53.0 {4} 58.5 {5} 80.7 {6} 84.7
BF10 {1} 0.97 0.65 0.14 0.00 0.00
BF12 {2} 0.97 0.97 0.49 0.00 0.00
BF14 {3} 0.65 0.97 0.92 0.00 0.00
 BF16 {4} 0.14 0.49 0.92 0.00 0.00
BF18 {5} 0.00 0.00 0.00 0.00 0.98
BF Final {6} 0.00 0.00 0.00 0.00 0.98
STAGES {1} 32.3 {2} 34.9 {3} 38.3 {4} 42.4 {5} 60.9 {6} 63.0
BF10 {1} 1.00 0.84 0.37 0.00 0.00
BF12 {2} 1.00 0.98 0.69 0.00 0.00
BF14 {3} 0.84 0.98 0.97 0.00 0.00
 BF16 {4} 0.37 0.69 0.97 0.01 0.00
BF18 {5} 0.00 0.00 0.00 0.01 1.00
BF Final {6} 0.00 0.00 0.00 0.00 1.00
STAGES {1} 73.7 {2} 78.2 {3} 83.9 {4} 96.5 {5} 126.3 {6} 132.8
BF10 {1} 0.99 0.83 0.10 0.00 0.00
BF12 {2} 0.99 0.98 0.28 0.00 0.00
BF14 {3} 0.83 0.98 0.67 0.00 0.00
 BF16 {4} 0.10 0.28 0.67 0.01 0.00
BF18 {5} 0.00 0.00 0.00 0.01 0.97
BF Fina l {6} 0.00 0.00 0.00 0.00 0.97
 
Figure 3.9: Biceps femoris (BF) muscle activity in Trial 2, normalised to 70% PRS, Sprint and 
MVC methods. F indicates the final speed that each subject reached during Trial 2. Differences 
between running speeds was shown as * p<0.05. The corresponding table indicates the significant 
difference in muscle activity between the 6 running speeds using Tukey post hoc analysis (highlighted 
in red). The bold value heading each column is the average EMG at each running speed. The column 
heading {1} represents BF 10, {2} represents BF12 etc.  
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SPRINT METHOD    (F5;45=10.98; p < 0.000)
70% PRS METHOD   (F5;40=10.16; p < 0.000)
STAGES {1} 41.8 {2} 49.2 {3} 48.9 {4} 55.4 {5} 56.1 {6} 62.7
MG10 {1} 0.18 0.22 0.00 0.00 0.00
MG12 {2} 0.18 1.00 0.36 0.25 0.00
MG14 {3} 0.22 1.00 0.31 0.21 0.00
MG16 {4} 0.00 0.36 0.31 1.00 0.19
MG18 {5] 0.00 0.25 0.21 1.00 0.29
MG Final {6} 0.00 0.00 0.00 0.19 0.29
STAGES {1} 85.6 {2} 95.5 {3} 95.9 {4} 109.8 {5} 110.8 {6} 126.4
MG10 {1} 0.64 0.61 0.01 0.00 0.00
MG12 {2} 0.64 1.00 0.26 0.19 0.00
MG14 {3} 0.61 1.00 0.28 0.21 0.00
MG16 {4} 0.01 0.26 0.28 1.00 0.13
MG18 {5] 0.00 0.19 0.21 1.00 0.17
MG Final {6} 0.00 0.00 0.00 0.13 0.17
STAGES {1} 61.4 {2} 72.3 {3} 72.1 {4} 82.1 {5} 82.7 {6} 91.6
MG10 {1} 0.17 0.19 0.00 0.00 0.00
MG12 {2} 0.17 1.00 0.28 0.22 0.00
MG14 {3} 0.19 1.00 0.25 0.20 0.00
MG16 {4} 0.00 0.28 0.25 1.00 0.31
MG18 {5] 0.00 0.22 0.20 1.00 0.38
MG Final {6} 0.00 0.00 0.00 0.31 0.38
 
Figure 3.10: Medial gastrocnemius (MG) muscle activity in Trial 2, normalised to 70 % PRS, 
Sprint and MVC methods. F indicates the final speed that each subject reached during Trial 2. 
Differences between running speeds was shown as * p<0.05. The corresponding table indicates the 
significant difference in muscle activity between the 6 running speeds using Tukey post hoc analysis 
(highlighted in red). The bold value heading each column is the average EMG at each running speed. 
The column heading {1} represents MG10, {2} represents MG 12 etc.  
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70% PRS METHOD (F5;35=5.62; p < 0.001)
STAGES {1} 72.8 {2} 72.9 {3} 74.9 {4} 84. {5} 92.9 {6} 101.9
LG10 {1} 1.00 1.00 0.63 0.08 0.00
LG12 {2} 1.00 1.00 0.65 0.09 0.00
LG14 {3} 1.00 1.00 0.81 0.16 0.01
LG16 {4} 0.63 0.65 0.81 0.82 0.16
LG18 {5} 0.08 0.09 0.16 0.82 0.81
LG Final {6} 0.00 0.00 0.01 0.16 0.81
STAGES {1} 46.9 {2} 47.8 {3} 48.4 {4} 53.2 {5} 59.6 {6} 65.6
LG10 {1} 1.00 1.00 0.68 0.05 0.00
LG12 {2} 1.00 1.00 0.80 0.08 0.00
LG14 {3} 1.00 1.00 0.86 0.11 0.00
LG16 {4} 0.68 0.80 0.86 0.65 0.06
LG18 {5} 0.05 0.08 0.11 0.65 0.71
LG Fina l {6} 0.00 0.00 0.00 0.06 0.71
STAGES {1} 86.5 {2} 86.9 {3} 88.0 {4} 97.2 {5} 108.2 {6} 114.0
LG10 {1} 1.00 1.00 0.66 0.04 0.01
LG12 {2} 1.00 1.00 0.70 0.05 0.01
LG14 {3} 1.00 1.00 0.79 0.07 0.01
LG16 {4} 0.66 0.70 0.79 0.63 0.19
LG18 {5} 0.04 0.05 0.07 0.63 0.96
LG Final {6} 0.01 0.01 0.01 0.19 0.96
 
Figure 3.11: Lateral gastrocnemius (LG) muscle activity in Trial 2, normalised to 70% PRS, 
Sprint and MVC methods. F indicates the final speed that each subject reached during Trial 2. 
Differences between running speeds was shown as * p<0.05. The corresponding table indicates the 
significant difference in muscle activity between the 6 running speeds using Tukey post hoc analysis 
(highlighted in red).The blue highlighted values are the values tending towards significance. The bold 
value heading each column is the average EMG at each running speed. The column heading {1} 
represents LG 10, {2} represents LG 12 etc.  
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For VM over 6 running speeds (Figure 3.6), the 70 % PRS method showed muscle 
activity to be significantly different over more loads than the MVC and Sprint 
methods. The 70 % PRS method found muscle activity in loads 1 and 2 to be 
significantly lower than the final load, whereas MVC and Sprint methods were 
unable to detect significant differences between loads. 
 
For VL (Figure 3.7), 70 % PRS and MVC methods both had the most sensitivity to 
increasing running speed, where muscle activity at 10 km.h-1 was significantly lower 
than during 18 km.h-1 and the final speed ran by all subjects. Muscle activity during 
12, 14 and 16 km.h-1 for both methods was significantly lower than the final load. 
However, the 70 % PRS method showed muscle activity during the 18 km.h-1 tended 
towards a significant difference to that during the final speed (p = 0.06), resulting in 
this method possibly having a slighter greater sensitivity to increasing exercise 
intensity. 
 
The Sprint method of normalisation showed the most significant differences between 
running speeds for RF (Figure 3.8). Muscle activity at 10, 12, 14 and 16 km.h-1 was 
significantly lower than at 18 km.h-1 and the final speed. Muscle activity during 18 
km.h-1 bout was significantly lower than muscle activity during the final speed. The 
70 % PRS method was unable to highlight significant difference between 18 km.h-1 
and final speed. The MVC method was able to highlight this significance; however 
muscle activity during 16 km.h-1 was not lower than muscle activity at 18 km.h-1. 
 
For BF (Figure 3.9), all the methods of normalisation showed the same significant 
difference between running speeds (10, 12, 14 and 16 km.h-1 significantly lower than 
18 km.h-1 and final speed). For MG (Figure 3.10) all methods also had the same 
significant differences over various running speeds. All methods showed that muscle 
activity at 10 km.hr-1 was significantly lower than at 16 km.h-1, 18 km.h-1 and final 
speeds, and that muscle activity at 12 km.h-1 and 14 km.h-1 was significantly lower 
than the final speed. 
 
70 % PRS and MVC methods showed the most significant differences between 
running speeds for LG activity (Figure 3.11), where muscle activity during 10 km.h-1 
and 12 km.h-1 was significantly lower than during 18 km.h-1 and final speed;  
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14 km.h-1 was also significantly lower than muscle activity during the final speed. 
However, 70 % PRS method showed muscle activity at 14 km.h-1 tended towards 
being significantly lower than the activity during 18 km.h-1 (p = 0.07).  
 
An alternative method for showing the sensitivity of each method of normalisation to 
track muscle activity to running speed changes, was to calculate the ratio of running 
speed to EMG amplitude. The results of this analysis are graphically displayed in 
Figure 3.12. As explained in Chapter 2, the slope of the line represents the ability of 
the method of normalisation to track changes in running speed. A slope of close to 
zero suggests that the method is more sensitive. 
 
There was a load effect for the running speed/EMG ratios of VM, VL, MG and LG. 
The 70% PRS method had the most horizontal slopes and therefore was the most 
capable method of normalisation for EMG amplitude to changes in running speed for 
all muscles. For VM, VL and RF (Figure 3.12a), the Sprint and MVC methods had 
similar horizontal slopes. For BF, all the methods had similar slope values (70 % 
PRS = 0.003 ± 0.004; MVC = 0.002 ± 0.007 and Sprint = 0.004 ± 0.008) therefore it 
was not possible to differentiate methods of normalisation based on this analysis. 
For MG, the 70 % PRS method had the lowest slope (0.008 ± 0.002). For LG, 70 % 
PRS had the lowest slope of 0.009 ± 0.003; however MVC method’s slope was 
similar at 0.012 ± 0.003. 
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Figure 3.12: Running speed  to EMG ratio for 6  power output loads of Trial 2, when normalised 
to MVC,  Sprint and 70% PRS method for a) Vastus medialis (VM), b) Vastus lateralis (VL), c) Rectus 
femoris (RF), d) Biceps femoris (BF,  e) Medial gastrocnemius (MG),  f) Lateral gastrocnemius (LG). 
The slope and standard deviations of each method are presented. Significant load effect # (P<0.05) 
 
To summarise which method was the most sensitive in representing corresponding 
running speed change with change in EMG amplitude, the results of the two 
sensitivity methods were reviewed for sensitivity of EMG amplitude to increasing 
running speed (Figures 3.6 - 3.11) and running speed to EMG ratio (Figure 3.12), 
the results represented in Table 3.5. 
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The 70 % PRS method had the greatest ability to detect changes in EMG amplitude 
over increasing running speed for all muscles. Moreover, when analysing the data 
with regards to running speed/EMG ratio, the 70 % PRS method also had the 
greatest ability to track EMG amplitude to running speed changes. The Sprint and 
MVC methods had similar running speed/EMG ratios for all muscles. 
 
Table 3.5: The recommended and ‘usable’ methods of normalisation found for each muscle 
using the sensitivity analysis 
 
Muscle Sensitivity between workloads  Sensitivity of power output to 
EMG ratio 
VM 
 
VL 
 
RF 
 
BF 
 
MG 
 
LG 
70 % PRS 
 
70 % PRS and MVC (Sprint) 
 
Sprint ( 70% PRS & MVC) 
 
All 
 
All 
 
70% PRS and MVC (Sprint) 
70 % PRS (Sprint & MVC) 
 
70 % PRS (Sprint & MVC) 
 
70 % PRS (Sprint & MVC) 
 
All 
 
70 % PRS (Sprint & MVC) 
 
70 % PRS (Sprint & MVC) 
 
 
Most sensitive methods of normalisation found from sensitivity analysis in Figures 3.6 - 3.12. VM, 
Vastus medialis; VL, Vastus lateralis; RF, Rectus femoris; BF, Biceps femoris; MG, Medial 
gastrocnemius and LG, Lateral gastrocnemius. The ‘usable’ methods are enclosed in brackets. 
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3.4  DISCUSSION 
 
The aim of the study was to examine the reliability of three different methods of 
normalising EMG activity during incremental running to exhaustion. These methods 
included normalisation to an isometric MVC (MVC method) and two methods 
involving dynamic movement of running, namely the Sprint method and the 70 % 
PRS method. According to the previously described requirements (Chapter 1), for a 
method of normalisation to be considered appropriate, it should display “good” 
repeatability, reliability and sensitivity to changes in work output of the active 
muscles. These three criteria are evaluated individually in the following sections. 
 
3.4.1 Repeatability of methods of normalisation 
 
Repeatability is an indication of reproducibility, thus the method should produce 
similar results over different testing trials (within day and between days). The main 
finding of this chapter was that the MVC and Sprint methods were the most 
repeatable methods of normalisation for running EMG activity. The Sprint method 
was the most repeatable for the quadriceps and the LG muscles. The MVC method 
had the best repeatability for the VM, BF and MG muscles. This differs from the 
results of Chapter 2 which showed the submaximal dynamic activity method was the 
most repeatable during cycling trials.  
 
Soderberg & Knutson (172) advised researchers to normalise their data using the 
MVC method, and to use proper subject training (for performing MVCs) since there 
is no clarification within the literature with regard to the most appropriate method of 
normalisation, and also because the use of dynamic contractions are “confounded 
by the EMG/force velocity relationship and other factors such as change of muscle 
mass under the electrode site”. The magnitude of the EMG signal is likely to be 
affected by these variables, resulting in the questionable ability of using the dynamic 
contractions for normalisation. Other studies have found the MVC method of 
normalisation to be repeatable during dynamic exercise. For example, Earl et al. (46) 
studied quadriceps muscle activation during dynamic mini-squat exercises and 
reported ICC values of R = 0.99 when normalising to the MVC. Furthermore, Bolgla 
& Uhl (21) investigated the repeatability and reliability of three methods of 
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normalisation for analysing hip abduction activation during rehabilitation exercises 
(using the gluteus medias muscle). The MVC method in this study had ICC values 
exceeding R = 0.93 for all exercises, whereas the ICC values for the mean and peak 
dynamic methods exceeded R = 0.85. 
 
Previously, studies have shown the MVC method to be repeatable for the 
normalisation of dynamic activities (103). However, this study has shown that using 
maximal dynamic movement was as repeatable as the MVC method and possibly 
more appropriate, due to representing the same muscle movement for running. In 
this study, the submaximal dynamic method of 70 % PRS had ‘poor’ repeatability in 
muscle activity for most muscles measured except the biarticulate RF and BF (R = 
0.68 (0.53 - 0.83) and 0.70 (0.57 - 0.83) respectively) muscles. This finding could 
possibly be explained by the study conducted by Shiavi et al. (169), which showed 
that at slower walking speeds, muscle activity was more variable than at faster 
speeds. In fact, as walking speed increased, all lower leg muscle patterns became 
more repeatable (66). Shiavi et al. (169) also stated that at slower speeds muscle 
activity patterns are more individualised and are reactive to individual motion 
requirements. The authors explain that at faster speeds, “some type of motor 
programming is dominant and everyone tends to utilise the same patterns”. 
Therefore it may be concluded that muscle activity is affected by speed; at slower 
running speeds, there is greater ground contact time and less preactivation resulting 
in a decrease in muscle stiffness and duration of the transition between the 
lengthening and shortening phases of the stretch shortening cycle (SSC).  
 
Changes in the preactivation may be associated with increased ground contact time 
and increased energy requirement during the propulsion phase of the running stride 
as well as muscle fatigue (11). This increase in ground contact time could be greater 
during the 70 % PRS run than during the faster speeds achieved in the PRS, thus 
accounting for the variability in the data. For example, when calculating the average 
speed the subjects ran for the 70 % PRS (from Table 3.1, the mean peak track 
running speed was 18.8 km.h-1) where 70 % of PRS equalled 13.2 km.h-1 (therefore 
subjects ran the 70 % PRS between 12 km.h-1 and 14 km.h-1). The best repeatability 
between 12 km.h-1 and 14 km.h-1 for the 70 % PRS method was ‘fair’ to ‘good’ for all 
muscles except VL where ICC remained at R = 0.41 (0.00 - 0.79) (Table 3.2). This 
possibly indicates the effect of normalising EMG running activity to a slower running 
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speed than the speed the subjects ran in the trial, and could therefore explain the 
low repeatability which occurred for the submaximal method of normalisation. A 
study by Paavolainen et al. (149), found EMG amplitude to decrease significantly 
during a 20 m sprint after a constant speed 10 km run. The preactivation, which is 
affected by fatigue-induced changes reported in prolonged running, also decreased 
substantially in the 20 m maximal run (149). This fatigue-induced change could 
explain the variability in the EMG amplitude normalised to 70 % PRS, since the 70 
% PRS was measured after the PRS trial.  However, the 30 min resting period after 
the PRS trial could be a sufficient fatigue recovery period for all the subjects. 
Unfortunately, due to methodological constraints, it was not possible to analyse 
preactivation in this study. 
 
A study conducted by Karamindis et al. (94) investigated reproducibility of EMG 
amplitude and ground reaction forces during various stride frequencies and running 
speeds. Twelve subjects ran on the treadmill at 3.5, 3.0 and 2.5 m.s-1 at 3 different 
stride frequencies; namely preferred and ± 10 % of preferred stride frequency, for 3 
trials. They found that EMG amplitude was more repeatable in the calf muscles than 
the quadriceps muscles over the trials. Importantly, they found that the timing of 
preactivation was highly variable producing ICC values of R < 0.60, but the EMG 
amplitude of preactivation was reproducible (ICC R > 0.70 except for VL R < 0.69). 
Ground reaction forces parameters during all running conditions showed high ICC 
values averaging R = 0.87. The authors highlighted the fact that repeatability of 
EMG data does not depend primarily on running velocity or deliberate change in 
stride frequency, but rather how one analyses the data (with regards to timing of 
preactivation, ground contact phase etc). This emphasises the point that EMG 
parameters assigned for analysis should be carefully chosen. This could be an 
additional reason for the variability in the data of the present study, where the active 
periods were isolated from the start of activity to the end of activity and not 
distinguished between the contribution of preactivation and ground contact. 
Furthermore, it should be acknowledged that different gait patterns and economy of 
running of the subjects could possibly contribute to the variability in the data. 
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3.4.2 Reliability of the methods of normalisation 
 
The reliability measured in this chapter refers to the reproducibility of EMG activity of 
the same individual performing repeated trials (84). This study has similar findings to 
that of Chapter 2, where the submaximal dynamic method of normalisation had the 
least intra-subject variability for most muscles except MG. The 70 % PRS method 
displayed 22 % - 42 % of its CV values in Zone 1. The results of the present study 
are in agreement with Shiavi et al. (169), where the authors stated that at slower 
speeds muscle activity patterns are more individualised and are reactive to 
individual motion requirements. This has been demonstrated by the 70 % PRS 
method, where the intra-subject variation was the lowest (demonstrating the 
individualised EMG pattern), possibly due to the relatively slow running speed 
subjects ran in the 70 % PRS method. 
 
Guidetti et al. (75) studied the inter and intra-subject reliability of running gait profile 
(normalised to peak amplitude of the running gait; thus Peak Dynamic method), 
where 5 subjects ran on a treadmill at 15 km.h-1 (for 3 trials) and found that intra-
subject variability was lower than inter-subject variability. However, the CV values 
were higher than those found in the present study, where their minimum CV ranged 
between 19 % - 40 % and the highest CV values ranged between 75 % - 122 %. 
Furthermore, EMG peak amplitudes times were highly repeatable among trials for a 
given subject. The authors infer that gait is a programmed (i.e. defined as high 
repeatability in neuromuscular output) process in running as suggested in walking 
(9). However, it is important to note that the study conducted by Guidetti et al. (75) 
looked at the running profile (i.e. the four stages of the active contraction) whereas 
the current study analysed the entire active contraction. 
 
The findings of the present study are also similar to the findings of Bolgla & Uhl (21). 
They investigated the repeatability and reliability of three methods of normalisation 
when analysing six hip abductor rehabilitation exercises. The methods of 
normalisation used were MVC, Mean dynamic (m-Dyn) and Peak Dynamic (pk-Dyn) 
methods. Intra-subject CV’s ranged between 11 - 22 % for all methods; however the 
m-Dyn method provided the lowest intra-subject CVs for 5 out of the 6 exercises 
performed.  A possible reason for the high intra-subject variability found in the MVC 
method could be that each subjects’ generation of MVC ultimately depends on the 
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level of motivation of the subject. Varying levels of motivation could be an 
explanation for the high intra-subjects CV’s associated with the MVC methods. This 
explanation, however, does not explain or account for the lower intra-subject CV of 
the Sprint method. Sprinting is also a maximal activity and depends on motivation. 
However, since the muscle activity during the Sprint method is the same dynamic 
movement as the muscle activity during the trial measured, the extrinsic factors 
mentioned in Chapter 1 could possibly be lessened and not have influenced the 
data to the same extent that occurred for the MVC method of normalisation. 
 
3.4.3 Sensitivity of the methods of normalisation 
 
Sensitivity of the method of normalisation refers to the methods’ ability to track 
changes in workload or exercise intensity. For this analysis, the EMG measurement 
was able detect differences in EMG activity with increasing workload. This however 
does not take into account the presence of fatigue and the affect this has on the 
amplitude of the EMG signal. The findings of this study are in accordance with 
previous research, where EMG activity increases with increasing running speed 
(Figures 3.6 - 3.11) (110; 134; 148). The 70 % PRS method had the greatest ability to 
detect changes in EMG with increases in running speed for most muscles except RF 
(Table 3.7). All methods were ‘usable’ in detecting EMG amplitude change over 
increasing running speeds for most muscles, except for VM, where neither the MVC 
nor the Sprint method were able to detect any changes in EMG amplitude with 
running speed changes. 
 
The hip and knee extensors and the plantar flexors, need higher muscle activity to 
tolerate the higher impact loads experienced with increasing running speed  (111). 
Hanon et al. (78) showed that RF and BF (biarticular and biphasic muscles) were 
influenced more by the increase in running speed than other leg muscles (running 
speed of 4, 5, 5.5, 6 and 7 m.s-1 interspersed with resting periods). The level of 
activation in these muscles increased linearly with increasing running speed. The 
biarticulate muscles are seen as modulators in transferring power between 
articulations  (79) and this could account for the increasing level of activation with 
running speed. Kyröläinen et al. (111) also displayed clear changes in RF and BF due 
to running speed. The present study concurred with the literature, where it was 
found that one could distinguish greater changes in muscle activity in RF and BF 
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with increasing running speed (Figure 3.8 and 3.9) than the other muscles 
measured, when using the 70 % PRS method for RF and all methods of 
normalisation for BF.  
 
The 70 % PRS method was also the best method of normalisation for tracking 
changes in EMG amplitude to running speed (EMG/running speed ratio). Although, 
the Sprint and MVC methods also showed low slope values and thus could also be 
considered as good methods for tracking EMG to exercise intensity. Interestingly, 
the EMG/running speed slope values were much higher in cycling power output 
increase (in Chapter 2, Figure 2.12) where the slope values ranged from 0.02 ± 0.08 
to 2.97 ± 1.26. This can be compared to the present study where the ranges were 
between 0.001 ± 0.002 - 0.020 ± 0.004.  
 
In conclusion, as mentioned in Chapters 1 and 2, the most appropriate method of 
normalisation is one that reflects reproducibility over different testing times, has low 
variation and the ability to detect changes in EMG amplitude with changes in 
exercise intensity. This study has shown that normalising running EMG to the Sprint 
and MVC method displays the highest repeatability for VL, RF and LG; and VM, BF 
and MG respectively. Considering the practical application of measured EMG data 
(as mentioned in Chapter 1), the Sprint and MVC methods are recommended for 
researchers who are investigating maximal muscle activity over different days. 
However for investigating the maximal muscle activity during a trial, the Sprint 
method of normalisation is recommended, especially since it is sensitive in detecting 
EMG amplitude changes and is similarly capable of tagging changes in exercise 
intensity with EMG amplitude. The Sprint method of normalising also has lower 
intra-subject variation compared to MVC method.  
 
Indeed, the Sprint and MVC methods also showed similar reproducibility. However, 
it is still recommended that researchers utilise the Sprint method as a method of 
normalisation for running activity. The reason for this is that this method best 
represents the dynamic muscle activity for the trial being investigated, by accounting 
for the experimental factors influencing EMG amplitude during dynamic exercise as 
described in Chapter 1. Furthermore, if one is using a once-off and repeated 
measurement (if wanting to investigate a change in muscle activity within a subject 
due to an intervention), the 70 % PRS method could also be recommended, since it 
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has the lowest intra-subject variability and the greatest ability in tracking changes in 
muscle activity with an increase in exercise intensity. This method was also found to 
be ‘fairly’ repeatable for RF and BF. 
 
This study does present certain limitations such as the inability to analyse the EMG 
into the 4 running profile divisions of preactivation, ground contact phase, braking 
phase and propulsion phase. By analysing the data this way, the study would have 
possibly provided more clarity on why the repeatability of the 70 % PRS method was 
poor for most muscles, yet highly sensitive to changes in exercise intensity and 
having the least intra-subject variability.  
 
In conclusion the data from this study shows it is important that researchers use a 
method of normalisation that is suitable to their study design and research question.  
Choosing the most appropriate method of normalisation reduces experimental error 
and increases the chance of detecting biological variation and hence improves the 
interpretation of the data. 
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CHAPTER 4  
 
MODELS OF FATIGUE: EMG MEASUREMENT OF SKELETAL MUSCLE 
ACTIVITY AT EXHAUSTION 
 
REVIEW OF THE LITERATURE 
 
4.1 INTRODUCTION 
 
In Chapters 2 and 3, the various methods of normalisation during dynamic exercise 
were evaluated.  The appropriate use of these methods of normalisation will reduce 
the non-biological variability of the measured surface EMG signal and maximise the 
opportunity to detect those changes produced by biological systems.  This will, in 
turn, improve the precision of using surface EMG as an investigative tool to evaluate 
skeletal muscle activation during exercise trials. 
 
Specifically, one of the practical applications of surface EMG is to evaluate skeletal 
muscle activation during dynamic exercise trials to fatigue both in athletes and 
patients with a clinical condition.  Numerous studies have evaluated fatigue during 
static, isometric tasks, but the uniform, reliable interpretation of EMG during dynamic 
exercise, is less well understood.  There are numerous challenges with the use of 
surface EMG during dynamic exercise – these were described in Chapter 1.  One of 
the key limitations is the method used for normalisation of the EMG signal.  As a 
result of the findings of Chapter 2 and Chapter 3, the following sections of the 
present thesis addresses one of the practical applications of using surface EMG 
during dynamic exercise.  Most importantly, by improving the precision of surface 
EMG, research in clinical studies can be performed with confidence, sensitivity and 
with less invasiveness. Sensitivity in EMG is often required for diagnosis and 
therefore most clinical studies have used invasive techniques to measure muscle 
activity (specifically muscle fiber conduction velocity and median frequency). Thus 
by ensuring the precision in recording true biological variation using surface EMG, 
credible research in the clinical population is possible. 
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The following chapters aim to review the most appropriate methods for 
normalisation during exercise to exhaustion in two different populations: 
i) A healthy athletic population, during a standardised exercise trial to volitional 
exhaustion during both cycling and running exercise, and; 
ii) A population of patients with Peripheral Vascular Disease (PVD), during 
exercise trials to volitional exhaustion during walking. 
 
PVD has been selected as the clinical condition because this condition can be 
rapidly reversed through intervention and therefore provides a good research model. 
PVD is defined as atherosclerotic occlusion of the blood vessels of the lower 
extremities. Narrowing of the blood vessels reduces blood flow to the lower limb and 
results in claudicant type pain (intermittent claudication). This pain is induced during 
physical activity, specifically walking and is relieved by rest (57). Therefore the pain 
significantly reduces functional capacity and exercise tolerance in these patients. 
The intervention used in some patients to alleviate the symptoms of the disease is 
angioplasty (unblocking of the affected artery), resulting in “reversing” occlusive 
vascular component of the disease. 
 
By using a method of normalisation that is sensitive to changes in muscle activity, a 
possible alteration in muscle activity could resolve the underlying contributions to the 
decline in functional capacity and exercise tolerance experienced in these patients. 
It is unclear whether changes, if any, in the EMG signal may be attributed to the 
unblocking of the affected artery and blood flow to active muscles. 
 
In both populations (athletes exercising to exhaustion and patients with PVD), 
measurements of surface EMG have the potential to provide insight to explain 
mechanisms of fatigue, as has been described in the literature (174).  A detailed 
discussion of the models and theories of fatigue, and the application of EMG activity 
as a means to evaluate these models, lies beyond the scope of this review. 
However, it is still an issue worthy of a brief discussion as this theme has application 
for both groups in exercise trials to exhaustion. The possibility exists that the use of 
EMG may provide insight to evaluate the theories of fatigue. Accordingly, the 
following sections will briefly discuss the physiological models of fatigue and the 
measurement of muscle activity at exhaustion. 
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4.2 MODELS OF FATIGUE 
 
Fatigue is usually defined “as a decrease in force production or an inability to 
regenerate the original force in the presence of an increase in perception of effort” 
(173). Various physiological models of fatigue attempt to explain muscle recruitment 
patterns, point of muscle failure as well as the onset of the symptoms of fatigue. The 
Peripheral Model (146), proposes that exercise performance is limited by chemical 
factors, often associated with metabolism, that acts on the exercising muscle, 
introducing what is termed “peripheral fatigue” (65). 
 
In this model of fatigue, the physiological changes include metabolite accumulation 
or substrate depletion in the active muscles (65), and the inability of the cardio-
respiratory structure to maintain oxygen delivery to the active muscles (14). 
Furthermore, this model proposes that during maximal exercise or incremental 
exercise to exhaustion, the heart is unable to supply oxygen to the muscles at a 
sufficient rate to prevent the development of skeletal muscle anaerobiosis (144). 
Oxygen independent glycolysis results in an increase production rate of lactic acid 
and other metabolites which accumulate and directly impair skeletal muscle 
contractile function. Thus, the impairment of muscle function ultimately leads to 
fatigue and the termination of exercise. In this model, the primary factor responsible 
for fatigue is the inability of the skeletal muscle to produce the required force. 
 
According to this model the skeletal muscle is unable to produce the necessary force 
during fatigue, and a key logical prediction is that all skeletal muscle motor units 
involved in producing force must be active at the point where volitional fatigue occurs 
(146).  It is logical to assume this model predicts that at fatigue there is maximal 
recruitment of skeletal muscle to counteract the gradual decline in the ability of each 
motor unit to produce the required force output.  However, this model does not 
consider or explain why exercise is terminated when muscle fibers are still available 
to be co-activated. This suggests that inactive muscles are impaired without ever 
being active. 
 
An alternative model of fatigue, the Central Fatigue Model, is generally described in 
terms of a reduction in motor command or neural drive to active muscles which 
results in a reduced force output (69; 95; 185). In the Central Fatigue Model, reductions of 
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power output during exercise or cessation of exercise are not caused by any limiting 
physiological changes in the muscle, or in any peripheral organ. Rather, these 
changes are caused by changes in, or altered efferent command from the brain 
structures which occur prior to the onset of maximal use of the peripheral structures 
or physiological systems (144).  This model has been studied extensively during static 
or isometric exercise.  During these types of exercise, surface EMG has been widely 
used to evaluate the activation of skeletal muscle motor units.  These studies are 
summarised below. 
 
4.3 MAXIMAL RECRUITMENT OF MUSCLE FIBERS 
 
By definition, a maximal contraction implies that all motor units are firing at their 
maximal capacity (197). This was documented in 1954 by two studies Bigland & 
Lippold (16) and Merton(136). Both studies used electrical stimulation of the ulnar nerve 
to compare the maximal force during stimulated tetanic contractions and the maximal 
voluntary force produced by the adductor pollicis muscle (without external 
stimulation). Both studies showed that the m ximum force of voluntary isometric 
contractions matched the force output reached during the maximal tetanic stimulation 
of the ulnar nerve. Furthermore, Merton (136), demonstrated that this activation 
remained at maximum when the contraction was maintained for 3 minutes, since 
nerve stimulation failed to cause an increase in the declining force output (restoration 
of force output). If positioned properly, this muscle can be isolated and results in 
contraction of only the thumb adductor, which simplifies the measurement. However, 
when measuring muscle activity in larger muscle groups, isolation of one muscle 
becomes complicated and difficult due to co-activation of synergist/surrounding 
muscles. Therefore, when producing a movement, the resultant contraction could be 
due to not only the targeted muscle, but by the contribution of a number of 
synergistic muscles which may not all be contracting maximally and simultaneously 
during maximal effort (197). 
 
In an extensive review of the literature, Gandevia (69) emphasised that it has not been 
shown that complete recruitment of all available motor units occurs in any form of 
voluntary exercise. Furthermore, muscle activation during submaximal exercise to 
exhaustion remains well below maximal levels at the point of maximal effort 
immediately preceding volitional fatigue. A study by Hunter et al. (90), which 
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measured muscle activity during 20 % MVC, found that exhaustion during 
submaximal contraction occurred at muscle activity levels of between 30 % - 50 % of 
MVC. These findings suggest that fewer than 50 % of available motor units are 
active at exhaustion during submaximal exercise (146). 
 
This finding is in agreement with a recently developed model of fatigue, the central 
regulation model of exercise (145; 146), which is specifically relevant in whole body, 
dynamic exercise. This model proposes that the peripheral skeletal muscles are 
never recruited maximally during maximal voluntary activity. Rather, muscle 
recruitment is regulated either consciously or subconsciously from the onset of 
exercise, and is characterised by the presence of ‘reserve’ recruitment capacity (173). 
It is proposed that a ‘reserve’ regulatory mechanism is designed to protect body 
organs from being damaged during exercise (145; 146; 173; 190). 
 
The investigation of this model presents an opportunity to utilise surface EMG as a 
marker of the proposed regulation of skeletal muscle activation.  As explained in 
Chapter 1, EMG is an indirect measure of the degree of skeletal muscle motor unit 
activation.  During static or isometric exercise trials, techniques including fine-wire, 
intramuscular EMG and Transcranial magnetic stimulation have been used as 
methods to determine direct activation of motor units.  However, in dynamic 
exercise, these techniques are not practical (reasons discussed in Chapter 1), 
therefore surface EMG is a more practical alternative for evaluating the models of 
fatigue during dynamic exercise.  
 
During dynamic exercise trials, such as cycling or running, where the athlete is 
allowed to ‘select’ his/her own pace during a time-trial task for performance, it has 
been hypothesised that the central nervous system regulates exercise performance 
by integrating feed-forward control with afferent sensory feedback from multiple 
organs during exercise activity (173). This integration results in a specific skeletal 
muscle recruitment pattern, leading to a pacing strategy, which is continuously 
modified on the basis of neural feedback during exercise (173; 184). This specific 
muscle recruitment pattern was demonstrated in a study where 10 subjects cycled a 
20 km time trial in hot (35 ºC) and cool (15ºC) conditions (183). Power output and 
iEMG activity of the VL decreased early in the heat, while core temperatures, heart 
rate and ratings of perceived exertion (RPE) were similar between conditions. The 
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reduction in muscle activity was interpreted as being part of an anticipatory 
response where the brain adjusted muscle recruitment and power output to reduce 
heat production, thereby ensuring that thermal homeostasis was maintained during 
exercise in the heat. 
 
Several other studies have provided evidence that fatigue during maximum dynamic 
exercise to exhaustion occurs when fewer than 100 % of the available muscle units 
in the active limbs are active. For example Kayser et al. (96) had subjects cycle at 75 
% of VO2 max until exhaustion, at sea level and high altitude. They found that lower 
limb iEMG did not increase during hypoxic conditions as was found at sea level. 
Furthermore, when supplemental oxygen was supplied at the point of exhaustion, 
after a few breaths, the iEMG activity increased, and the subjects were able to 
continue cycling for a longer period. This demonstrated that muscle activity could 
not have been 100 % at exhaustion.  Earlier fatigue had thus occurred despite the 
presence of a motor unit reserve. After supplemental oxygen was provided the 
motor unit reserve was partly utilised. Therefore, this study suggests that a 
reduction in neural recruitment occurs to protect the tissues from hypoxia when 
available oxygen may be insufficient.  
 
4.4 CENTRAL GOVERNOR MODEL IN CLINICAL POPULATION 
 
Another practical application to test the models of fatigue is in special populations, 
including patients with specific diseases. For example, patients with peripheral 
vascular disease who have active occlusion of the vasculature of the lower limb, 
terminate exercise due to intermittent claudication (pain in the leg). It is of interest 
that exercise terminates at blood lactate concentrations lower than those found in 
healthy age-matched controls and in patients with other chronic diseases (152). It has 
been presumed that the poor exercise intolerance of these patients’ is determined 
by the excessive lactate accumulation in their ischemic muscles (177). This theory is 
consistent with the peripheral model of fatigue. The alternative central regulation 
model suggests that exercise would be limited before profound skeletal muscle 
ischemia develops.  The use of surface EMG to measure the degree of skeletal 
muscle activation in patients with PVD presents an opportunity to use EMG to 
evaluate models of fatigue and exercise intolerance in a clinical population.   
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A key conceptual challenge with the use of surface EMG during dynamic exercise is 
that EMG activity is usually normalised by comparison with the EMG activity 
measured during a static MVC, as was evaluated in Chapters 2 and 3 of the present 
thesis. This challenge further highlights the necessity for a more appropriate method 
of normalisation of EMG activity, a need which the present thesis aims to address.  
In Chapters Two and Three, the most appropriate methods for normalisation in 
terms of reliability, repeatability and sensitivity were identified.  The next challenge is 
to evaluate the validity of these methods for use in evaluating the central regulation 
model of fatigue during dynamic exercise. 
 
4.4 MEASUREMENTS OF MAXIMAL MOTOR UNIT RECRUITMENT 
 
Validity of the central governor model has been debated by many exercise 
physiologists. Weir et al. (191) specifically questions the ability of the central governor 
model to explain muscle activity reserve capacity since the studies supporting the 
central governor model have all used surface EMG as a measurement of muscle 
activity and as an interpretation of central drive contributions to fatigue. Weir et al. 
(191) advised that researchers should use techniques, which artificially induce 
maximal recruitment, including magnetic supraspinal stimulation or twitch 
interpolation through electrical stimulation of the muscle or nerve.  
 
4.4.1 Twitch interpolation 
In theory, twitch interpolation shows an increase in force output above the voluntary 
level, and denotes electrical activation of the motor units that were not recruited 
under voluntary conditions, suggesting the presence of a reserve. An example of 
this reserve is shown in Figure 4.1. However, evidence for using twitch interpolation 
as a technique for measuring central activation failure is also unconvincing. Even 
though studies using small muscle groups (adductor pollicis) have revealed a linear 
relationship between voluntary force and superimposed twitches (117), in larger 
muscle groups (elbow flexors), the relationship between voluntary force and 
superimposed twitches is shown to be non-linear at higher efforts (3). 
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Fig 4.1: Representative torque data from a single subject from unpublished data. A = 5sec MVC 
1, B = Twitch Stimulation 1, C = 2min MVC, D = 5sec MVC 2, E = Twitch Stimulation 2 
 
4.4.2 Transcranial magnetic stimulation 
 Transcranial magnetic stimulation is a method used to determine the contribution of 
the cerebral cortex and central nervous system to muscle activation, through the 
stimulation of different areas of the brain and recording the responses from the 
skeletal muscle. A study by Todd et al. (180) attempted to compare voluntary 
activation using twitch interpolation by motor nerve stimulation and transcranial 
magnetic stimulation. The study showed that transcranial magnetic stimulation 
elicited a superimposed force in 92 % of all maximal efforts. In contrast, motor nerve 
stimulation elicited superimposed forces in only 68 % of maximal efforts suggesting 
that twitch interpolation techniques using percutaneous muscle stimulation are not 
able to measure central activation failure accurately for maximal and near maximal 
efforts. This finding confirms that fatigue occurs in the presence of a motor unit 
reserve, because the administration of motor nerve and then motor cortex 
stimulation produces graded increases in force output. 
 
4.4.3 M-wave measurement 
Weir et al. (191) also questions the interpretation of EMG amplitudes that have been 
used in studies showing submaximal recruitment of motor units, and because 
authors normalised surface EMG to a static, isometric MVC performed before the 
trial as a measurement of maximal muscle activity, rather than techniques that 
stimulate the muscle such as twitch interpolation. Weir et al. (191) recommend 
normalising EMG amplitude to changes in the size of M-waves. The supramaximal 
stimulation is seen as the equivalent of recruiting all motor units (26) and provides 
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information on the stability of neuromuscular propagation (50). This method has only 
been shown to be repeatable for Biceps brachii (26), Tibialis anterior muscle (129) and 
Vastus medialis (130) muscles. However, Merletti et al. (129) found the M-wave shape 
appeared to be consistent over days and within day experiments (a number 
experiments conducted on the same day), but the amplitude and duration varied. In 
addition, repeatability of this method has only been found for relatively static 
exercise, unlike exercise which is used to evaluate physiology and fatigue during 
tasks like cycling and running. 
 
However, the use of this method could possibly have adverse effects on the 
subjects, especially when both the major nerve supplies to the upper and lower limb 
are stimulated before a trial, as might occur during studies involving cycling and 
running. The common M-wave protocol involves stimulating the motor nerve in 4 
Volt increments until a maximal M-wave is achieved, after which additional 
supramaximal stimulation is given to confirm no further enlargement in peak-to-peak 
M-wave amplitude (26). This type of measurement is viewed as uncomfortable and 
possibly painful, and utilising this technique on the same person performing 
repeated trials would be impractical. 
 
4.5 CONCLUSION 
 
It is acknowledged that the measurement and interpretation of surface EMG during 
dynamic exercises is a complex and technical method and is influenced by intrinsic 
and extrinsic factors as discussed in Chapter 1. However, with few reasonable 
alternatives, this method has been shown to be repeatable, reliable and has the 
ability to detect changes in muscle activity with increasing exercise intensity (for 
cycling and running exercises). By using the most appropriate method of 
normalisation established in Chapters 2 and 3, the next studies described in 
Chapters 5 and 6 aims to investigate muscle activity at exhaustion in healthy athletic 
populations. The hypothesis tested in these studies is that muscle activity is 
submaximal at exhaustion. The objective of each study is to measure voluntary 
activation of muscle activation at exhaustion. In addition, the study in Chapter 7 
examines a diseased population using an appropriate method of normalisation to 
measure possible changes in muscle activity after an intervention and the effect on 
functional capacity and exercise tolerance. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 4   
Department of Human Biology - 110 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
                                                                                                        CHAPTER 5 
 - 111 - University of Cape Town 
CHAPTER 5  
 
MUSCLE ACTIVITY AT EXHAUSTION DURING CYCLING 
 
 
5.1 INTRODUCTION 
 
In previous chapters, various methods for normalising the EMG signal measured 
during dynamic exercise were evaluated.  As explained in these chapters the 
purpose of identifying the most reliable and repeatable method for normalisation is 
to ensure that appropriate conclusions can be drawn from studies where surface 
EMG measurements are made.  One such application for using surface EMG 
measurements is during exercise to volitional exhaustion, particularly to investigate 
various models which describe the aetiology of fatigue.  
 
In the present chapter, the use of surface EMG as a research technique for exercise 
to exhaustion is considered during cycling trials to exhaustion to evaluate the merits 
of the peripheral model and the central governor model described briefly in Chapter 
4.  
 
As discussed, the peripheral model suggests that voluntary exercise is terminated 
due to a failure of the contractile properties of skeletal muscle. This model predicts 
that all the motor units will be active at exhaustion. In contrast, the main principle of 
the complex, regulatory central governor model is that the active muscle is never 
maximally recruited even during maximal voluntary exercise. It is hypothesised that 
the submaximal recruitment of muscle is due to the conscious or subconscious 
inhibition of muscle activation (173). Several studies have shown that muscle activity 
is indeed not maximal at exhaustion during maximal exercise performances (95; 96; 
182). However, one of the main limitations of these studies is that the authors 
normalise surface EMG to a static, isometric MVC performed before the trial as a 
measurement of maximal muscle activity, rather than techniques that stimulate the 
muscle such as twitch interpolation.  
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The use of surface EMG in determining maximal voluntary activation of skeletal 
muscle during dynamic exercise can also be contentious due to the intrinsic and 
extrinsic factors (e.g. electrode shift, amplitude cancellation), which can affect the 
EMG signal. These factors are discussed in Chapter 1. Chapter 2 of the present 
thesis showed that the measurement of muscle activity normalised to dynamic 
cycling exercise was the most repeatable, reliable and able to detect changes in 
muscle activity corresponding to changes in cycling exercise intensity.  
 
In determining a particular method for obtaining a reference value for normalisation, 
one must consider several issues (as discussed in Chapters 1, 2 and 3). The 
important issues are 1) repeatability and reliability of the reference EMG value, 2) 
the sensitivity of the method in detecting changes in exercise intensity, 3) the 
similarity between the muscle activity in the method of normalisation and the activity 
of interest and 4) the relevance of the normalising contraction to the specific 
question being addressed. Accordingly, the present chapter aims to apply the 
previously determined appropriate method of normalisation for cycling trials to 
measure maximal muscle activity during progressive cycling exercise to exhaustion.  
This is done with the aim of evaluating whether the degree of muscle activation at 
fatigue is maximal, compared to various pre-exercise ‘maximum’ contractions, and 
whether muscle activity at the point of exhaustion is repeatable.  
 
In selecting the most appropriate method for EMG normalisation, it is recognised 
that the 70 % PPO method was established to be most reliable and appropriate for 
use during cycling trials, particularly where repeated trials would be performed 
(Chapter 2).  However, considering that the present study aims to investigate if 
muscle activation is maximal at volitional exhaustion, the present chapter 
alternatively utilises the MVC and Sprint methods as normalisation techniques. 
These techniques measure maximal muscle activity during static isometric 
contraction and dynamic sprint cycling respectively. 
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5.2 METHODS 
 
5.2.1 Subject selection 
 
Thirteen well-trained cyclists were recruited from local cycling clubs to participate in this 
study. Subjects were included if they were currently between the ages of 18-35 years 
old and if they were able to complete the Cape Argus cycle race (109 km) in under 3 h 
30 min. The study was approved by the Research and Ethics Committee of the Faculty 
of Health Sciences within the University of Cape Town. The study was performed in 
accordance with the principles of the declaration of Helsinki (October, 2000), ICH Good 
Clinical Practice (GCP) and the laws of South Africa. Subjects performed the same 
experimental protocol on each of the three testing days. Each testing day was 
separated by 5-7 days of normal training.  
 
5.2.2 Experimental trial 
 
These methods have been described in Chapter 2 Section 2.2.2. A summary of the 
experimental design is shown in Figure 5.1. 
 
Figure 5.1: Experimental design 
 
 
5.2.3 Anthropometry 
 
The same protocol was used as described in Chapter 2 (Section 2.2.3) 
 
 
Familiarisation 
Trial 
Trial 1 Trial 2 Trial 3 
5-7 days 5-7 days 
MVC’s 
 
10 s Sprint 
 
PPO test 
MVC’s 
 
10 s Sprint 
 
PPO test 
MVC’s 
 
10 s Sprint 
 
PPO test 
20 min rest 
30 min rest 
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5.2.4 Maximal voluntary contractions  
 
These methods have been described in Chapter 2 (Section 2.2.4) 
 
5.2.5 Peak power output test 
 
These methods have been described in Chapter 2 (Section 2.2.5) 
 
 
5.2.6 EMG data collection 
 
These methods have been described in Chapter 2 (Section 2.2.6) 
 
5.2.7 EMG analysis  
 
These methods have been described in Chapter 2 (Section 2.2.7) 
 
5.2.8 Methods of normalisation  
 
5.2.8.1 MVC Method 
 
 These methods have been described in Chapter 2 (Section 2.2.8.1) 
 
5.2.8.2 Sprint Method 
 
These methods have been described in Chapter 2 (Section 2.2.8.2) 
 
In selecting an appropriate method of normalisation which meets most of the 
requirements as described in Chapter 1 and evaluated in Chapter 2, the following 
table is used to present the advantage and disadvantage for using each method 
during cycling; 
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Table 5.1: Advantages and disadvantages for using the MVC and Sprint method of normalisation for 
muscle activity during cycling to exhaustion 
Norm 
Method 
Advantages Disadvantages 
MVC 
 
• Higher repeatability for VL and BF
 
• Sensitivity to tracking EMG over  
increasing exercise intensities, 
only usable for RF and BF 
muscles 
 
• Intra-subject CV is high, thus 
reliability  is  weaker 
 
• Static movement thus not 
representative of muscle activity 
during cycling (does not account for 
electrode shift and tissue 
conductivity) 
 
• Constant activity, compared to ‘on-
off’ bursts of activity during cycling 
 
• Lower repeatability for VM, RF and 
MG 
 
• Low sensitivity to tracking EMG over  
increasing exercise intensities, for 
VM,VL, MG and LG 
Sprint • Higher reliability, Intra-subject 
variability is lower 
 
• High repeatability for VM, RF 
and MG 
 
• Dynamic movement thus better 
representation of muscle activity 
during cycling trial (by 
accounting for electrode shift and 
tissue conductivity) 
 
• Higher sensitivity in tracking 
EMG over increasing exercise 
intensities for VM, VL, RF and 
BF 
• Lower repeatability for VL and BF 
 
• Low sensitivity to tracking EMG over 
increasing exercise intensities, MG 
and LG 
 
Considering the advantages and disadvantages of each method as outlined above, 
the Sprint method was deemed more appropriate for normalisation of muscle activity 
during cycling to exhaustion for the purpose of this study. The sprint method was 
considered to be the most reliable and repeatable method. It is also representative of 
the muscle movement used in cycling.  
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5.2.9 Statistical analysis 
 
All results were analysed using a commercially available software programme 
(Statistica 7, StatSoft, Tulsa, OK, USA. Inc.©). Results were expressed as means ± 
standard deviation (SD). The degree of repeatability of muscle activity at exhaustion 
was investigated using the Intraclass Correlation Coefficient (ICC). When ICC 
ranged between R = 0.80 and 1.00 the reproducibility was defined as “good”, 
between R = 0.60 and 0.79 as “fair” reproducibility and less than R = 0.60 as “poor” 
(170). Reliability of muscle activity at exhaustion over 3 trials for each subject (Intra-
subject reliability) was assessed using coefficient of variation (CV) analysis. Intra-
subject variability was calculated by dividing the standard deviation by the mean 
over 3 trials. If CV values were less than 12 %, the data were co sidered to have 
good variability.  
 
 
5.3 RESULTS 
 
5.3.1 Descriptive characteristics 
 
The descriptive characteristics of the cyclists are reported in Chapter 2 Table 2.2. 
 
5.3.2 Muscle activity at exhaustion 
 
Figure 5.2 shows the average muscle activity at exhaustion for the thirteen subjects, 
each muscle was expressed as a percentage of muscle activity during a maximal 
sprint. Muscle activity at exhaustion was similar over three trials for all muscles. It is 
important to note that all muscles were less active at exhaustion than when 
performing a maximal sprint. The mean muscle activity at exhaustion over 3 trials 
(expressed as a range of the percentage of sprint value) was; VM (59 % - 65%), VL 
(54 % - 60%), RF (44 % - 51%), BF (42 % - 45%), MG (40 % - 46%) and LG (36 % - 
44%). The summed average EMG of all the muscles was also shown to be lower 
than muscle activity during a maximal sprint. 
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Fig 5.2: Muscle activity of Vastus medialis (VM), Rectus femoris (RF), Vastus lateralis (VL), 
Biceps femoris (BF), Medial and Lateral gastrocnemius (MG and LG respectively) at exhaustion 
for 3 PPO trials. The graph also shows the mean EMG activity of all muscles summed during each 
trial. 
 
5.3.3 Intra-subject reliability of muscle activity at exhaustion 
 
To further highlight the variation in muscle activity at exhaustion, the data for each 
subject at exhaustion (with accompanying ICC values), over 3 separate days of 
testing, are presented in Figure 5.3 and 5.4. The muscle activities of the quadriceps 
muscles at exhaustion have the greatest variability for each subject and lowest ICC. 
The VM, VL and RF showed “poor” repeatability. 
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a) VM    ICC = 0.38 (0.00-0.80)
b) VL ICC = 0.08 (0.00-0.55)
c) RF  ICC = 0.40 (0.01-0.77)
 
Figure 5.3: Variability of each subjects muscle activity at exhaustion over 3 trials with 
corresponding ICC values (95% confidence intervals). Representing muscle activity of a) Vastus 
medialis (VM), b) Vastus lateralis (VL) and c) Rectus femoris (RF) 
 
 
The gastrocnemius muscles and BF showed less variability in muscle activity at 
exhaustion, and “fair” to “good” ICC values. 
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a) BF ICC = 0.72 (0.40-0.91)
b) MG ICC = 0.72 (0.42-0.91)
c) LG ICC = 0.83 (0.62-0.94)
 
 
Figure 5.4: Variability of each subjects muscle activity at exhaustion over 3 trials with 
corresponding ICC values (95 % confidence intervals). Representing muscle activity of d) Biceps 
femoris (BF), e) Medial gastrocnemius (MG) and f) Lateral gastrocnemius (LG). 
 
 
The intra-subject CV of muscle activity over the 3 trials gave an indication of the 
reliability of muscle activity at exhaustion (Table 5.2). Only six out of the thirteen 
subjects showed CV values less than 12 % for at least 3 muscles. Most subjects (5 
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out of 13) showed low CV values for VM. The average muscle activity of all muscles 
of each subject was highly variable at exhaustion. 
 
          Table 5.2: Intra-subject coefficient of variation of EMG activity at exhaustion for six muscles 
 
Subject VM VL RF BF MG LG Average 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
5 
30 
1 
11 
6 
35 
11 
31 
16 
3 
29 
16 
56 
5 
31 
9 
6 
33 
20 
6 
16 
16 
14 
16 
11 
19 
19 
29 
11 
9 
29 
23 
4 
18 
32 
50 
5 
15 
18 
3 
6 
35 
23 
52 
20 
12 
14 
15 
8 
3 
18 
18 
4 
8 
42 
18 
36 
30 
29 
32 
12 
31 
10 
27 
6 
4 
33 
22 
20 
62 
12 
40 
7 
31 
11 
45 
18 
44 
7 ± 7 
23 ± 12 
20 ±  16 
14 ± 7 
36 ±  19 
23 ± 8 
17 ± 14 
20 ± 10 
20 ± 10 
19 ± 18 
18 ± 16 
18 ± 5 
27 ± 20 
     
 Intra-subject CV of muscle activity of Vastus medialis (VM), Rectus femoris (RF), Vastus 
lateralis (VL), Biceps femoris (BF), Medial and Lateral gastrocnemius (MG and LG respectively) 
at exhaustion for 3 PPO trials. The values highlighted in bold represent “good” CV values ≤ 12 %. 
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5.4 DISCUSSION 
 
This study examined EMG activity at volitional exhaustion during maximal cycling 
trials. By tabulating the advantages and disadvantages of the methods of 
normalisation evaluated in Chapter 2, the most appropriate method of normalisation 
for the present study was determined.  Although the 70 % PPO method was the 
most repeatable and reliable (Chapter 2) this method was not used in this study 
because comparison of EMG during a maximal cycling bout to a 70 % PPO bout 
would reveal little insight into the degree of maximal muscle activation.  Instead, the 
chosen methods for normalisation were the MVC method (a maximal static, 
isometric contraction), and the Sprint method (maximal dynamic movement). 
 
In view of the advantages and disadvantages of these two methods, the Sprint 
method was selected as the most appropriate method of normalisation for use in the 
present study. In particular, this method had greater reliability, repeatability 
(predominantly for VM, RF and MG) and sensitivity (predominantly for VM, VL, RF 
and BF) than the MVC method. Most importantly the muscles used in the Sprint 
method involves the same dynamic muscle contractions as the exercise bout being 
investigated, thus better representing muscle activity during cycling.  In contrast, the 
static, isometric MVC method has often limited conclusions based on the 
comparison of a dynamic bout with a static maximal muscle contraction of short 
duration. Thus the Sprint method for normalisation of EMG during cycling to 
exhaustion was used. 
 
The main finding of this study was that muscle activity at exhaustion in all the major 
muscles during cycling was submaximal (Figure 5.2) compared to EMG activity 
during maximal sprint cycling. All six muscles measured in the study achieved peak 
activation of between 44 % - 65 % of that achieved during a 10 second all-out sprint. 
This finding suggests that peripheral skeletal muscles are never maximally recruited, 
even during maximal volitional effort during incremental exercise. It has been 
suggested that mechanisms of fatigue regulation may also incorporate neural 
mechanisms, which regulate the number of motor units that are recruited or 
derecruited during exercise in order to prevent any peripheral system reaching 
maximal capacity (145; 173).  
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These findings support the findings of other studies that show muscle activity during 
cycling to be less than maximal at the end of maximal cycling performances. A 
recently published study by Tucker et al. (182) investigated muscle activity during self-
paced 20 km time- trials performed in normoxic and hyperoxic conditions. The study 
found that muscle activity at the end of the 20 km time-trial in normoxia was only 26 
% - 46% of MVC. Furthermore, Kay et al. (95) studied muscle activity in cyclists 
during a 60 min time-trial with six 1 min maximal sprints at 10 min intervals, in warm 
humid conditions. The study showed that muscle activity (normalised to the first 
sprint) decreased in sprints 2-5 where iEMG values were 71 %, 71 %, 73 % and 77 
% of the initial sprint. However, in the final sprint, muscle activity increased to 90 % 
of the initial sprint value, with associated increase in measured power output. These 
subjects were able to increase neural drive to the peripheral muscles resulting in an 
increase in power output at the end of the bout of exercise (endspurt) (95; 182). 
 
The peripheral model of fatigue fails to explain how power output in the final sprint of 
the trial can increase to levels similar to that of the initial sprint. This occurs in the 
presence of metabolite accumulation which according to this model impairs muscle 
function. Kay et al. (95) suggest that there is a neuromuscular reserve present during 
self-paced exercise which maintains the ability to activate and deactivate muscles 
so as to maintain work output and therefore optimal exercise performance. In a 
similar study by St Clair Gibson et al. (175), muscle activity was also submaximal 
during a 100 km time-trial, interspersed with high intensity bouts. During the trials, 
power output decreased incrementally during the high intensity cycling bouts, 
despite verbal encouragement of the subjects. Similarly EMG amplitude decreased 
in parallel to the decrease in power output. These changes occurred despite only 
activating approximately 20 % of muscle activity during a MVC. It thus appears that 
the central nervous system down regulated power output by decreasing motor 
command to the skeletal muscles, despite the attempts of the subjects to maintain 
power output. Ansley et al. (6) has also shown muscle activity to be approximately 25 
% of MVC at the point of peak power output during three consecutive 4 km cycling 
time-trials (separated by 17 min). The authors interpreted their findings as being due 
to centrally regulated pacing strategies.  
 
The key consideration in the above mentioned studies is that EMG activity during 
cycling was normalised according to EMG measured during a sustained isometric 
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contraction. However, this has two potential limitations; firstly muscle activity during 
the MVC is not representative of muscle activity during cycling, secondly the 
analysis compares EMG during 3 or 5 seconds of sustained activity during the MVC 
to the same time period of cycling activity.  Because cycling consists of ‘on-off’ 
bursts of muscle activation (intermittent activity, with muscle being inactive for part 
of the pedal stroke) in this time period, the MVC method therefore compares the 
intermittent muscle activity during cycling to the sustained muscle contraction of the 
MVC.  Thus, by using the Sprint method to normalise muscle activity during cycling, 
the potential problems outlined above are reduced. Moreover the use of Sprint 
method (dynamic) of normalisation would possibly also reduce the contributions of 
extrinsic factors which affect the EMG amplitude (Chapter 2).  
 
In addition, the present study has highlighted the variability of intra-subject muscle 
activity at exhaustion, where very few muscles showed CV values less than 12 %. 
Such variations are an indication that muscle activity at exhaustion varies from one 
day to the next. Whilst part of the variation could however be due to electrode 
placement and other influential factors, precautionary steps were taken to minimise 
these, as described in the Methods (Chapter 2).  In addition, the intra-subject 
variation using the Sprint method is not as low as using the 70 % PPO method, but 
this variation was deemed less significant for the present study, given that the 
primary objective was the application of EMG to evaluate muscle activity at fatigue.  
However, given the variability of the Sprint method of normalisation, the variability in 
EMG activity at fatigue was greater than can be explained through these previously 
described extrinsic factors which would contribute to the variation in the EMG signal. 
 
A possible limitation of the study could have been not additionally using twitch 
interpolation at exhaustion to verify a decrease in central drive. 
 
In conclusion, by using the most appropriate method of EMG normalisation, the 
findings of this study indicate that muscle activity is sub-maximal at exhaustion 
during graded cycling exercise to volitional fatigue. Furthermore, the findings confirm 
that only a certain percentage of the limb muscle mass is active during maximal 
exercises. These findings are not compatible with the peripheral model of fatigue, as 
this model assumes that the total muscle mass is active at exhaustion. 
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CHAPTER 6  
 
MEASUREMENT OF MUSCLE ACTIVITY AT EXHAUSTION IN RUNNING 
 
 
6.1 INTRODUCTION 
 
This chapter continues to address the application of the most appropriate method of 
normalisation during dynamic exercise, specifically in running. As discussed in 
Chapters 4 and 5, using surface EMG in determining maximal voluntary activation 
during dynamic exercise is seen as questionable due to the intrinsic and extrinsic 
factors (e.g. electrode shift, amplitude cancellation) affecting the EMG signal (as 
discussed in Chapter 1). No other research has been published on the repeatability 
and reliability of the EMG amplitude with increasing running speed. Thus the 
findings of Chapter 3 of the present thesis are indeed novel, as it has shown that 
the measurement of muscle activity during dynamic running exercise to be 
repeatable, reliable and able to detect changes in muscle activity corresponding to 
increasing running speed.  
 
Accordingly, this chapter aims to apply the most appropriate method of 
normalisation, to measure maximal muscle activity during progressive running 
exercise to exhaustion and to investigate if muscle activity is indeed submaximal at 
exhaustion. In selecting the most appropriate method for EMG normalisation, it must 
be recognised that the 70 % PRS method does not provide information on the 
absolute level of muscle activation and is therefore not suitable for normalising the 
data in this context. The MVC and Sprint methods are more appropriate methods of 
normalisation as explained in Chapter 5. 
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6.2 METHODOLOGY 
 
6.2.1 Subject Selection 
 
Twelve well-trained runners were recruited from local running clubs to participate in 
this study. The same subject criteria were applied as in Chapter 3 Section 3.2.1. 
Once each subject signed the informed consent, they were required to visit the 
laboratory on four separate occasions. During the first visit to the laboratory, subjects 
underwent an anthropometrical assessment and answered the PAR-Q as described 
in Chapter 2 (Section 2.2.1 and 2.2.3). Each subject was then familiarised with the 
equipment used and the testing protocol. The study was approved by the Research 
and Ethics Committee of the Faculty of Health Sciences within the University of Cape 
Town. The study was performed in accordance with the principles of the declaration 
of Helsinki (October, 2000), ICH Good Clinical Practice (GCP) and the laws of South 
Africa. Subjects performed the same experimental protocol on each of the three 
testing days. Each testing day was separated by 5-7 days of normal training.  
 
6.2.2 Experimental trial 
 
The same methods have been described in Chapter 3 (Section 3.2.2). A summary of 
the experimental design is shown in Figure 6.1. 
 
 
Figure 6.1: Experimental design 
Familiarisation 
Trial 
Trial 1 Trial 2 Trial 3 
MVC’s 
 
20m Sprints x 2 
 
PRS test 
20 min 
30 min 
MVC’s 
 
20m Sprints x 2 
 
PRS test 
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6.2.3 Familiarisation trial 
 
The same protocol has been described in Chapter 3 (Section 3.2.2.1) 
 
6.2.4 Maximal voluntary contractions  
 
The same protocol was used as described in Chapter 2 (Section 2.2.4) 
 
6.2.5 20 m sprints 
 
These methods have been described in Chapter 3 (Section 3.2.4) 
 
6.2.6 Peak running speed trial (PRS) 
 
These methods have been described in Chapter 3 (Section 3.2.5) 
 
6.2.7 EMG collection and analysis  
 
These methods have been described in Chapter 3 (Section 3.2.6 and 3.2.7) 
 
6.2.8 Methods of normalisation 
 
These methods have been described in Chapter 3 (Section 3.2.8). From Chapter 3 it 
was concluded that normalising EMG to the Sprint and MVC methods resulted in the 
most repeatable EMG amplitudes. This study aims to investigate the maximal muscle 
activity at exhaustion, thus the use of the 70 % PRS method is not feasible.  
6.2.8.1 MVC Method 
 
These methods have been described in Chapter 3 Section 3.2.8.1 
 
6.2.8.2 Sprint Method 
 
These methods have been described in Chapter 3 Section 3.2.8.2. 
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In selecting an appropriate method of normalisation which meets most of the 
requirements as described in Chapter 1 and evaluated in Chapter 3, the following 
table is used to present the advantages and disadvantages for using each method 
during running; 
 
Table 6.1: Advantages and disadvantages for using the MVC and Sprint methods of 
normalisation for muscle activity during running to exhaustion. 
 
Norm 
Method 
Advantages Disadvantages 
MVC 
 
• Higher repeatability for VM, BF 
and MG. 
• Sensitivity to tracking EMG over 
increasing exercise intensities is 
similar to Sprint method but 
slightly better in detecting 
changes in VL and LG. 
 
• Intra-subject CV is high, thus 
reliability is weaker. 
• Static movement, thus not 
representative of muscle activity 
during running (does not account 
for electrode shift and tissue 
conductivity). 
• Lower repeatability for VL, RF and 
LG. 
 
Sprint • Higher reliability–Intra subject        
variability is lower. 
• High repeatability for VL, RF and 
LG. 
• Dynamic movement thus better 
representation of muscle activity 
during running (by accounting for 
electrode shift and tissue 
conductivity). 
• Sensitivity to tracking EMG 
over increasing exercise 
intensities is similar to MVC 
method but slightly better in 
detecting changes in RF. 
• Lower repeatability for VM, BF and 
MG 
 
 
Considering the advantages and disadvantages of each method as outlined above, the 
Sprint method was deemed the more appropriate method to normalise muscle activity 
during running to exhaustion for the purpose of this study. The sprint method was the 
most reliable and repeatable method. It is also representative of the muscle movement 
used during running.  
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6.2.9 Statistical analysis 
 
All results were analysed using a commercially available software programme 
(Statistica 7, StatSoft, Tulsa, OK, USA. Inc©.). Results were expressed as means ± 
standard deviation (SD). The degree of repeatability of muscle activity at exhaustion 
was investigated using the Intraclass Correlation Coefficient (ICC). When ICC 
ranged between R = 0.80 and 1.00 the reproducibility was defined as “good”, 
between R = 0.60 and 0.79 as “fair” reproducibility and less than R = 0.60 as “poor” 
(170). Reliability of muscle activity at exhaustion over 3 trials for each subject (Intra-
subject reliability) was assessed using coefficient of variation (CV) analysis. Intra-
subject variability was calculated by dividing the standard deviation by the mean 
over 3 trials. If CV values were less than 12 % a good variability was considered.  
 
6.3 RESULTS 
 
6.3.1 Descriptive characteristics 
 
The descriptive characteristics of the runners are shown in Chapter 3 (Table 3.1). 
 
6.3.2 Muscle activity at exhaustion 
 
Due to EMG lead failure, the muscle activity of certain subjects was not captured. 
Figure 6.2 shows the average muscle activity at exhaustion for twelve subjects, 
expressed as a percentage of muscle activity during a maximal sprint for each 
muscle. Muscle activity at exhaustion was similar over three trials for all muscles. 
Important to note is that all muscles were less active at exhaustion than when 
performing a maximal sprint. The mean muscle activity at exhaustion over 3 trials 
(expressed as a range of the percentage of sprint value) was; VM (53 % - 58 %), RF 
(55 % - 64 %), VL (42 % - 51%), BF (58 % - 59 %), MG (60 % - 66 %) and LG (61 % 
- 63 %). The summed mean EMG of all the muscles was less than 100 % sprint. As 
seen from the above the muscle activity ranges, the Medial and  
Lateral gastrocnemius muscles are the most activated during running followed by 
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the bilateral RF and BF. The summed EMG of all the muscles was lower than 
muscle activity during a maximal sprint. 
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Figure 6.2: Muscle activity of Vastus medialis (VM), Rectus femoris (RF), Vastus lateralis (VL), 
Biceps femoris (BF), Medial and Lateral gastrocnemius (MG and LG respectively) at exhaustion 
for 3 PRS trials. The graph also shows the mean EMG activity of all muscles summed during each 
trial. 
 
Trial to trial reliability, using EMG data at exhaustion of each subject, was applied to 
further highlight the variation in muscle activity at exhaustion. The muscle activity of 
each subject at exhaustion, over 3 separate days of testing, are presented in 
Figures 6.3 and 6.4 with accompanying ICC values. The quadriceps muscles and 
BF are seen to have the least variability and “good” ICC values at exhaustion 
(Figure 6.3). The MG and LG muscles had “poor” repeatability at exhaustion (Figure 
6.4). 
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a) VM   ICC = 0.98 (0.48-0.98)
b) VL  ICC = 0.92 (0.76-0.98)
c) RF ICC = 0.85 (0.46-0.98)
 
 
Figure 6.3: Variability of each subjects muscle activity at exhaustion over 3 trials with 
corresponding ICC values (95% confidence intervals). Representing muscle activity of a) Vastus 
medialis (VM), b) Vastus lateralis (VL) and c) Rectus femoris (RF). Note only one data point was 
available for Subject 9’s VM, RF and VL. For RF, only one data point was available for subjects 3, 6 
and 8. 
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d) BF  ICC = 0.82 (0.39-0.98)
e) MG  ICC = 0.29 (0.00-0.91)
f) LG ICC = 0.55 (0.03-0.91)
 
 
Figure 6.4: Variability of each subjects muscle activity at exhaustion over 3 trials with 
corresponding ICC values (95% confidence intervals). Representing muscle activity of d) Biceps 
femoris (BF), e) Medial gastrocnemius (MG) and f) Lateral gastrocnemius (LG). Note only one data 
point was available for Subject 9’s BF and LG. For BF, only one data point was available for subject 8 
and 12. 
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6.3.3 Intra-subject reliability of muscle activity at exhaustion 
 
The intra-subject CVs of muscle activity over the 3 trials at exhaustion (with 
accompanying ICC values) are shown in Table 6.2. Only two out of the eleven 
subjects showed CV values less than 12 % for at least 4 muscles and only four 
subjects showed CV values of less than 12 % for 2 muscles. Most subjects (6 out of 
11) showed low CV values for MG. however, overall muscle activity variation was 
seen to be high at exhaustion. 
 
Table 6.2: Intra-subject coefficient of variation of EMG activity at exhaustion for six muscles 
Subject VM VL RF BF MG LG Average 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
 
37 
18 
33 
0 
26 
16 
7 
11 
 
14 
9 
2 
13 
7 
39 
19 
21 
14 
22 
3 
 
41 
8 
8 
9 
50 
 
28 
18 
 
48 
 
 
1 
31 
50 
14 
19 
13 
16 
21 
21 
 
22 
 
 
0 
9 
14 
4 
12 
1 
6 
21 
32 
26 
22 
7 
6 
11 
17 
17 
3 
24 
13 
15 
45 
13 
 
39 
16 
45 
17 ± 10 
19 ± 16 
20 ±  15 
15 ± 11 
18 ±  7 
17 ± 3 
31 ± 17 
15 ± 9 
22 
20 ± 18 
12 ± 11 
21 ± 21 
 
Intra-subject CV of muscle activity of Vastus medialis (VM), Rectus femoris (RF), Vastus lateralis (VL), 
Biceps femoris (BF), Medial and Lateral gastrocnemius (MG and LG respectively) at exhaustion for 3 
PRS trials. The values highlighted in bold represent “good” CV values ≤ 12 %. 
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6.4 DISCUSSION 
 
The aim of this study was similar to Chapter 5 i.e. to use the most appropriate 
method of normalisation to measure maximal muscle activity during progressive 
exercise to exhaustion and to investigate whether muscle activity is indeed 
submaximal at exhaustion, specifically in running. The results of Chapter 3 provided 
novel data on the ability of static and dynamic methods of normalisation to show 
repeatability, reliability and sensitivity. The most appropriate method of 
normalisation in this study was decided upon by tabulating the advantages and 
disadvantages of the MVC and Sprint methods (Table 6.1). In view of the 
advantages and disadvantages, the Sprint method was selected as the most 
appropriate method of normalisation to answer the question of whether muscle 
activity is indeed submaximal at exhaustion during running exercise. In particular, 
this method had greater reliability, repeatability (predominantly for VL, RF and LG) 
and sensitivity to changes in exercise intensity.  
 
More importantly this method involves the same dynamic movement as the trial 
being investigated (i.e. running). Whereas using the MVC method, the analysis 
compares EMG during 3 s of sustained activity (during the MVC) to ‘on-off’ bursts of 
muscle activity (running trial). This could create further variability in the data, since 
the characteristic of each burst or active period can vary concurrently with changes 
in stride length and frequency (78). 
 
As discussed in Chapter 3, running requires a complex sequence and combination 
of muscle activation which includes an interplay of muscular forces and external 
forces (inertial, gravitational and reaction forces) (63). By using a running method as 
an EMG reference, would better represent the muscle activity of trial being 
investigated.  
 
The main finding of this study showed that muscle activity in all muscles during 
running at exhaustion was submaximal (Figure 6.2) (as compared to EMG activity 
during 20 m sprint). This finding is in agreement with results of Chapter 5. All six 
muscles measured in the study achieved an average maximal activity range of 
between 42 % - 66 % of that achieved during a 20 m maximal sprint.  Indeed, these 
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findings suggest that peripheral skeletal muscles are never maximally recruited, 
even during maximal volitional effort during sustained exercise.  
 
These findings are in agreement with other studies that have shown muscle activity 
to be less than maximal in running. Sloniger et al. (171) investigated muscle activity 
during horizontal and uphill running to exhaustion (at 115 % peak oxygen uptake). 
The authors used magnetic resonance imaging to measure muscle activity. The 
active muscle volume was divided by the post-exercise muscle volume to obtain the 
percentage of muscle volume that was active. The study found that lower leg 
muscles were not maximally activated for both running trials. The percentage of 
volume of muscle activated varied from 41 % - 90 % during horizontal and 44 % - 88 
% during uphill running. It is important to note that this method of measurement has 
not been fully investigated for its repeatability in measuring muscle activity volumes. 
 
In addition, the present study has found that the agonist and antagonist muscles are 
‘highly’ activated (RF (55 % - 64 %) and BF (58 % - 59 %) respectively) to possibly 
assist in creating high joint stiffness, to prevent unnecessary yielding of the ankle, 
knee and hip joints (111). The hip and knee extensors as well as the plantar flexors 
need higher muscle activity to endure the higher impact loads experienced with 
increasing running speed (111).  The high muscle activity of MG (60 % - 66 %) and 
LG (61% - 63 %), could be due to the contribution of increased preactivation in 
gastrocnemius activity with increasing running speed, which has been demonstrated 
by Komi et al. (107). Kyröläinen et al. (111) interprets preactivity to be a preparatory 
requirement for the enhancement of EMG activity during the braking phase, and for 
the timing of muscular actions with respect to the ground contact with increased 
running speeds. 
 
Furthermore, the present study has highlighted the variability of intra-subject muscle 
activity at exhaustion, where very few muscles showed CV values to be less than 12 
%. This is an indication that muscle activity is never totally fixed at exhaustion. In 
addition the variation in each muscle over the different trials could be indicative of 
compensatory motor unit firing. However, this study has found lower intra-subject 
variability than in cycling (Chapter 5). This could be due to either the loss in 
captured data of certain subjects (due to EMG lead failure); or it could be due to the 
fact that muscle activity during running profile is seen to be ‘programmed’ within an 
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individual especially during faster running speeds (75). A study by Guidetti et al. (75) 
investigated the intra and inter-subject variability of EMG patterns during running. 
They found little variation within individuals EMG profiles but differences between 
subjects were significant.  
 
In conclusion, by using the most appropriate method of EMG normalisation, this 
study found that muscle activity was sub-maximal at exhaustion during incremental 
running. However, certain individuals have shown muscle activity to be greater than 
muscle activity during maximal sprint at exhaustion, but they were never the same 
maximal activity values over the three trials. Furthermore, the findings confirm that 
only a certain percentage of the limb muscle mass is active during maximal 
exercises, which is in agreement with the findings in Chapter 5. These findings are 
not compatible with the peripheral model of fatigue, as this model assumes that the 
total muscle mass is active at exhaustion. 
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CHAPTER 7  
 
METHODS OF NORMALISATION OF EMG IN CLINICAL SETTINGS: 
CASE STUDIES OF MUSCLE ACTIVITY IN PATIENTS WITH 
PERIPHERAL VASCULAR DISEASE BEFORE AND AFTER 
ANGIOPLASTY 
 
 
7.1 INTRODUCTION 
 
In Chapters 2 and 3 of this thesis, the most appropriate method for normalisation of 
EMG activity during dynamic exercise was evaluated.  Based on the findings of 
these studies, the application of EMG measurements to specific exercise conditions 
was examined in Chapters 5 and 6, in which EMG activity was measured during 
maximal volitional exercise. 
 
A further application of EMG measurement in dynamic exercise is to assess muscle 
activity and effort tolerance in clinical populations. This method of evaluation is 
important to assist in the understanding of how interventions or exercise training 
might affect effort tolerance and functional capacity. One such condition is 
Peripheral Vascular Disease (PVD). 
 
The predominant pathology in PVD is atherosclerotic occlusion of the blood vessels 
of the lower extremities. The occlusion reduces blood flow to the lower limb at rest 
and during exercise (192) and results in claudicant type pain (intermittent 
claudication). Typically this pain is induced by walking and is relieved by rest (57). 
This pain limits walking activity and it is not uncommon for patients to walk only 
short distances at a time.  
 
It was traditionally believed that the exercise intolerance experienced by patients 
with PVD was due to ischemia of the lower limbs resulting in accumulation of lactate 
in the skeletal muscles and blood (118; 177). This theory is consistent with a peripheral 
model of fatigue. Yet findings from studies concluded in our laboratory, suggest that 
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patients with PVD terminate exercise at lower blood lactate concentrations 
compared to healthy age matched controls or patients with other chronic disease 
states (152).  
 
The central regulation model of fatigue suggests that exercise in patients with PVD 
terminates before profound skeletal muscle ischemia develops, thus preventing 
possible damage to muscle from either a result of ischemia or metabolite 
accumulation/depletion (146). Termination of exercise would therefore occur as the 
result of reduced motor drive to the lower limb (measured as a decrease in muscle 
activity). Thus, altered skeletal muscle activity might be responsible for the exercise 
intolerance experienced by these patients.  Furthermore, when patients with PVD 
undergo angioplasty to remove the restriction of blood flow, the resultant 
improvement in exercise tolerance could be measured as an increase in surface 
EMG activity that might translate to an increased capacity to tolerate higher exercise 
workloads.  Therefore a primary aim of the study was to investigate muscle activity 
during exercise in patients with PVD before and after angioplasty. 
 
EMG methods of normalisation in clinical populations have been an issue of 
contention. The use of the standard method of normalisation, the MVC method, 
seems to be somewhat limited, as it often causes pain in patients during the 
maximal contraction. Studies have evaluated the repeatability of surface EMG in 
clinical population and rehabilitation of injuries (21; 33; 34; 114; 142). The researchers 
concluded that even though the MVC method had higher repeatability the 
application of this method in the symptomatic population might not be accurate, as 
these patients might not elicit a true MVC due to pain and/or muscle inhibition.   
 
Using the MVC method of normalisation in studies of gait profiles has also been 
questioned (44; 198), as muscle activity from an MVC (isometric contraction) is used to 
normalise muscle activity during gait cycles (which are non-isometric contractions). 
Yet, it is of interest that the MVC method of normalisation of the EMG signal 
continues to be advocated for use in clinical practice (172). 
 
An alternative method for normalisation of the EMG signal in the clinical population 
is the Mean Dynamic method. This method was developed to use EMG as a 
diagnostic tool in gait analysis (198). The limitation of the Mean Dynamic method is 
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that it serves only as a measurement of muscle activity throughout the gait cycle in 
relation to the average EMG recorded during gait, thus not providing information on 
the degree of muscle activation, as would a maximal contraction (25). 
 
Therefore in order to analyse the EMG activity in the clinical population group 
accurately, the appropriate methods of normalisation need to be applied. Due to the 
findings of the previous chapters and the above mentioned research, both the MVC 
and Mean Dynamic methods of normalisation were selected. Thus, a further aim of 
this chapter is to apply an appropriate method of normalisation to measure and 
evaluate muscle activity in patients with PVD. This chapter describes the detailed 
findings in a case series of patients with PVD and functional incapacity, who 
underwent angioplasty. 
 
7.2 METHODS 
 
7.2.1 Patient recruitment 
 
Patients with Peripheral Vascular Disease were recruited from the Department of 
Vascular Surgery at Kingsbury Hospital (Cape Town, South Africa) to participate in 
this pilot study. To protect the identities of these patients they are referred to by 
initials only. 
 
In order to be included into the trial, patients with PVD and intermittent claudication 
had to show significant evidence for their disease as documented by the vascular 
surgeon using Color Flow Doppler and angiography. Patients were not recruited if 
they had exclusion criteria including; absence of claudication; pain at rest or tissue 
loss, dyspnea, exercise limiting arthritis, active cancer, liver disease or renal 
disease. Patients were also excluded based on the contraindications specified by 
the ACSM guidelines (12). 
 
Two patients, Case number 1 (AA) a habitual walker and Case number 2 (AB) a 
Western Province League squash player were diagnosed with peripheral vascular 
disease and were scheduled to have percutaneous transluminal angioplasty (PTA). 
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The patients agreed to be examined and performed the exercise tests three days 
before and again three days after the angioplasty procedure.  
 
On the first visit to the laboratory, each patient was examined by a sports physician 
at the clinical practice of the Sports Science Institute of South Africa before they 
performed the required exercise trials. The physician recorded each subject’s 
medical history and examined the patient to ensure that there were no 
contraindications to exercise. Thereafter the patients signed consent to participate in 
the study. The study was approved by the Research and Ethics Committee of the 
Faculty of Health Sciences within the University of Cape Town. The study was 
performed in accordance with the principles of the Declaration of Helsinki (October, 
2000), ICH Good Clinical Practice (GCP) and the laws of South Africa. The methods 
used to assess body composition are described in Chapter 2 (Section 2.2.3). 
 
7.2.2 Experimental design 
 
After the evaluation by the sports physician, each patient was familiarised with the 
equipment. Patients first performed MVC’s on the Biodex Dynamometer and then 
were familiarised with walking on the treadmill (methods described in Section 7.2.4 
and 7.2.5 respectively). Patients were also familiarised with the ratings of perceived 
exertion and pain scores as described in Section 7.2.7 and 7.2.8. 
 
On the second visit to the laboratory (Pre-Angioplasty trial), subjects were prepared 
for the placement of the electrodes on four muscles of both the right and left legs 
namely, Vastus medialis (VM), Vastus lateralis (VL), Medial gastrocnemius (MG) 
and Lateral gastgrocnemius (LG). Subjects then performed maximal voluntary 
contractions on the Biodex Dynamometer. Following this, subjects were instructed to 
walk on the treadmill until exhaustion using the Graded Treadmill Exercise Test 
(GTET) protocol as explained in Section 7.2.6. Exhaustion was defined as the 
moment the patients could not walk any further due to pain or fatigue. Heart rate and 
brachial blood pressure were monitored every two minutes during exercise. Patients 
were asked to report their perceived pain using perception of pain scale and rate 
their perceived exertion, by indicating a value on the Borg scale. During exercise, 
total inspiratory ventilation, oxygen uptake and respiratory exchange ratio were 
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measured using the Oxycon Alpha Analyzer (Oxycon, Viasis, Hoechberg, 
Germany).  
 
Prior to the initiation of exercise, a resting venous blood sample (two millilitres) was 
drawn from a subcutaneous forearm vein in patient AB.  An additional two millilitre 
blood sample was collected at three, four and five minutes after exercise. The blood 
was then analysed to determine blood lactate concentrations. 
 
Three days after the Pre-Angioplasty trial, patient AA underwent angioplasty of the 
popliteal artery of the left leg and patient AB underwent angioplasty of the femoral 
artery of the right leg. Before and after angioplasty the same radiographer measured 
the blood flow velocity across the lesion using a duplex Doppler, to measure change 
in blood velocity. Following a three day recovery period from the angioplasty, 
subjects returned to the laboratory where they repeated the exercise trial (Post-
Angioplasty trial).  
 
7.2.3 Ankle and brachial pressure measurements 
 
After subjects remained supine in a quiet environment for a period of fifteen minutes 
the resting brachial blood pressure (Korotoff Phase I and IV) was measured and 
recorded by means of audible sphygmomanometry using a calibrated mercury 
column sphygmomanometer with an appropriately sized cuff. Left and right brachial 
pressures were measur d with a Doppler (©Huntleigh Technology PLC 1997 
Dopplex ® Advanced Pocket Dopplers United Kingdom) and blood pressure cuffs 
were affixed just above the ankles. The Doppler probe was placed over the posterior 
tibial or dorsalis pedis artery. The cuff was then inflated until the sound disappeared; 
the cuff was then slowly deflated until the sound returned. The pressure at which the 
sound returned was recorded as the ankle systolic pressure. Ankle brachial index 
(ABI) was calculated for each patient by dividing the ankle pressure reading by the 
brachial pressure reading. An additional brachial and ankle systolic blood pressure 
was taken immediately post-exercise.  
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7.2.4 Maximal voluntary contractions 
 
The same procedure was used as described in the previous chapters. Only two 
MVC attempts of the quadriceps and gastrocnemius muscles of both the diseased 
and healthy legs were performed prior to the exercise trials. 
 
7.2.5 Graded treadmill exercise test (GTET) to maximal claudication 
 
On the first visit to the laboratory, subjects were familiarised with the treadmill. 
During this visit, they were given the opportunity to walk on the treadmill for three 
bouts of two minutes at a comfortable speed.  
 
On the second visit to the laboratory, patients performed the GTET. During the 
GTET protocol the treadmill speed was initially set at 3.2 km.h-1 with a 2 % gradient 
(156). The gradient was then increased by 2 % every two minutes. Pain free walking 
distance was recorded from the start of the test until the moment when the patient 
first noticed calf pain. Maximum walking dist nce was defined as the distance 
covered on the treadmill before the patient chose to discontinue exercise because of 
severe claudication pain. 
 
7.2.6 Heart rate and ECG 
 
Heart rate during the GTET was recorded using an electrocardiogram monitor 
(Cardio Perfect® 3.3, Rijswijk, Netherlands) with self-adhering electrodes placed on 
the patient in a modified 10-electrode (Maser-Likar) configuration (1).  
 
7.2.7 Ratings of perceived exertion scale (RPE scale) 
 
Ratings of subjective perceived exertion were quantified using the Borg 6-20 Scale  
(22). During their first laboratory visit patients were provided with printed instructions 
to familiarise themselves with the scale prior to testing. Instructions were given for 
the RPE scale as suggested by Pandolf (150). The Borg scale was used to quantify 
overall exertion experienced during the trials.  Once instructions were given and the 
patients were familiarised with the scale, no further assistance was provided by the 
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investigator in translating sensations to the numerical ratings on the RPE scales 
during the GTET. 
 
7.2.8 Pain scores 
 
The pain scale ranges from 0 to 10, where 0 is no pain felt and 10 is the most pain 
ever felt (112). Subjects were familiarised with this scale on their first laboratory visit 
and once again before the testing trials. 
 
7.2.9 Blood sample collection and analysis 
 
Prior to the start of the GTET, a resting venous blood sample was drawn from the 
subcutaneous forearm vein of patient AB. Two millilitres of blood was drawn directly 
into a sodium oxalate lined glass test tube and immediately placed on ice for later 
analysis of plasma lactate concentrations. Additional two millilitres blood samples 
drawn at minute 3, 4 and 5 post-exercise. The blood samples were then centrifuged 
using a Sigam 302-K centrifuge (Munich, Germany) at 3000 rpm for 10 minutes at 
4°C. Blood lactate concentrations was measured in plasma by means of an 
enzymatic kit technique (bioMerieux SA, lactate PAP 69280, Marcy I Etoille, 
France).  
 
7.2.10 EMG data collection 
 
The identical procedure for EMG data collection was used as in all previous 
chapters. However, in this trial only muscle activity of Vastus medialis (VM), Vastus 
lateralis (VL), Medial and Lateral gastrocnemius (MG and LG respectively) from both 
the symptomatic (Disease) and asymptomatic (Healthy) leg of each patient was 
examined. 
 
7.2.11 EMG analysis  
 
EMG data were analysed as described in Chapter 2 Section 2.2.7. EMG was 
recorded for 10 s at the end of each minute. Three strides with similar peak 
amplitudes in each 10 s EMG recording were averaged and the resultant mean 
amplitudes were normalised. 
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7.2.12 Methods of normalisation 
 
Due to the nature of the clinical patient population being investigated, it is important 
to carefully choose the appropriate testing parameters for these patients due to risk 
factors of possible illness or injury as outlined in the ACSM guidelines (12). For 
example, in the previous chapters subjects were able to perform maximal static and 
dynamic activities. However, using a maximal dynamic protocol (in this instance a 
sprint on the treadmill) would be an inappropriate method for this clinical population. 
In addition, due to the stringent exclusion criteria in this study, insufficient numbers 
of patients were recruited to test the repeatability of methods of normalisation. 
Therefore, the most appropriate methods of normalisation are based on previously 
published literature.  
 
7.2.12.1 Mean Dynamic Method of normalisation 
 
EMG was normalised as described by Burden et al. (24) and Yang & Winter (198). The 
method analyses each stride of the gait cycle to the mean value recorded during 
that gait cycle. However, this method has been shown to be repeatable on level 
ground only whereas the protocol for this study measured EMG activity on an 
increasing gradient. Averaging the EMG amplitude of the entire trial was therefore 
not possible due to the increasing gradient. Therefore, a 10 s recording of walking 
on the treadmill at 0 degree gradient (level surface) at a speed of 3.2 km.h-1 was 
measured. The mean amplitude from this recording (as described in Chapter 3 
Section 3.2.8.3) was then used as the normalisation value for muscle activity at 
each increase in gradient. This method will only provide information about the level 
muscle activation throughout the GTET in relation to the average activity recorded 
whilst walking at 0 % gradient at speed of 3.2 km.h-1. Nevertheless, this method 
allows detection of a change in muscle activity when comparing EMG 
measurements taken before and after angioplasty. 
 
7.2.12.2 MVC Method of normalisation 
 
This method of normalisation is described in Chapter 3 section 3.2.8.1. 
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Table 7.1 tabulates the advantages and disadvantages of both methods of 
normalisation which were derived from the findings in Chapter 3 and the published 
literature. 
 
Table 7.1: Advantages and disadvantages in using MVC and Mean Dynamic Method for 
normalisation during gait 
Normalisation 
Method 
Advantages Disadvantages 
MVC 
 
• Provides a degree of muscle 
activation in relation to 
maximal static activation 
capacity. 
 
• Still debatable if best to use in 
gait studies, however still 
recommended by Soderberg & 
Knutson (172).  
 
• Maximal effort required, in 
patient population this could 
cause pain and discomfort. 
 
• Static movement is not  
representative of muscle activity 
during walking (does not account 
for electrode shift and tissue 
conductivity). 
 
• Shown not to be repeatable and 
shown to have large variability 
when used to normalised gait 
studies (44; 198). 
 
• Self limiting performance, unable 
to control their performance 
output. 
Mean Dynamic  • High reliability–Intra subject 
variability is low (25; 198). 
 
• High repeatability  
 
• Dynamic movement, thus 
better representation of muscle 
activity. 
 
• Walking pace is controlled for 
by walking at 0 % gradient at 
3.2 km.h-1. 
• Only provides us with muscle 
activation in relation to a  
submaximal walk 
 
 
Both methods of normalisation were chosen to determine which method was more 
sensitive to change in workload before and after the intervention. 
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7.3 CASE STUDIES 
 
7.3.1 Case 1 
 
7.3.1.1 Case history 
 
AA, a 65 year old male who participated in daily recreational walking, walking an 
average of 6 - 8 km per day, reported to the vascular surgeons with increasing 
claudicant type discomfort of the lower leg. AA achieved smoking cessation in 1978. 
He was diagnosed with coronary artery disease and underwent subsequent CABG 
in 1992. Thereafter, he developed occlusion in a vein graft to the circumflex artery 
which was successfully stented. He had an abnormal ECG at rest and on effort; 
however this pattern has not changed over the past 14 years and he did not have 
active angina pectoris. His risk factors included hypertension and elevated blood 
cholesterol concentration. His medication included Atorvastatin (10 mg.day-1), 
Moducren (10 mg.day-1) and Ecotrin (125 mg.day-1). AA had prior history of injury to 
the Achilles tendon of his right leg. 
 
Color flow Doppler and subsequent angiography revealed Peripheral Vascular 
Disease with a 70 % stenosis in the popliteal artery above the level of the knee of 
his left leg. Due to the fact that this was a single localised lesion, vascular surgeons 
advised management of the occlusion with balloon angioplasty.  
 
Blood velocity at the area of stenosis was measured by flow duplex Doppler 
evaluation at 206 cm.s-1 before angioplasty and reduced to 97 cm.s-1 after the 
procedure. Figure 7.1 demonstrates the area of stenosis in the lower leg. 
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Figure 7.1: Lower limb indicating area of stenosis, arteries of the lower leg and affected 
muscles (modified from the public domain: http://www.bartleby.com/107/151.html). 
 
7.3.1.2  Clinical evaluation and special investigations 
 
AA weighed 82 kg, was 1.76 m tall, and had a body mass index (BMI) of 26.5. Table 
7.2 shows measurements of ABI at rest and after exercise before and after 
angioplasty. Prior to angioplasty, ABI at rest was measured as 0.89 and reduced 
after exercise to 0.67. However ABI after angioplasty was 1.07 at rest and was 0.99 
after exercise. 
 
                Table 7.2: Ankle Brachial Index measurements Pre and Post Angioplasty 
Trial ABI at rest ABI after exercise 
Pre-A 
Post-A 
0.89 
1.07 
0.67 
0.99 
 
Ratio of ankle pressure to brachial pressure in Pre-Angioplasty (Pre – A) and Post-Angioplasty (Post – 
A) trials. 
 
Vastus 
Medialis 
Medial  
Gastrocnemius 
Lateral 
Gastrocnemius 
Area of 70 % stenosis 
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AA developed pain in his left leg (Diseased leg) in the Pre - A trial at 4 min 23 s 
resulting in a pain free walking distance of 230 m. AA walked a total distance of 467 
m at a final gradient of 8 % at minute 08:30 as the trial was discontinued by the 
supervising physician due to ST-segment depression of more than 2 mm was 
noticed on the ECG. 
 
Following angioplasty, AA’s pain free walking distance increased to 384 m. 
However, in the Post - A trial, AA once again experienced significant ST-segment 
changes and the test was terminated by the attending physician at minute 08:30.  
 
7.3.1.3 Measurement of physiological variables during exercise 
 
Both oxygen consumption (Figure 7.2 a) and heart rate (Figure 7.2 b) were lower 
throughout the exercise trial after angioplasty.  
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Figure 7.2: Changes in (a) Oxygen consumption and (b) Heart rate measured 
in    Pre-Angioplasty (Pre – A) and Post Angioplasty (Post – A) trials. 
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Blood lactate concentration was not measured because the patient reported history 
of a profound vasovagal response to needles, and declined consent for this part of 
the clinical trial. 
 
Figure 7.3 shows the changes in pain and RPE scores during exercise, before and 
after angioplasty. Prior to angioplasty, pain was reported at minute 4 during exercise 
but only presented at minute 7 of exercise after angioplasty. The peak pain score 
was also lower following angioplasty (Figure 7.3 a).  Furthermore the RPE scale 
indicated that AA’s perception of effort also decreased from minute 4 after 
angioplasty compared to the Pre- A trial.  
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Figure 7.3: Changes in (a) Pain Scores and (b) RPE in Pre-Angioplasty (Pre – A) and Post 
Angioplasty (Post – A) trials. 
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7.3.1.4 Force output from MVC 
 
Table 7.3 shows the changes in maximal and average force output during the MVC 
of the quadriceps muscles before and after angioplasty. Peak force output of the 
diseased leg increased by 19 Nm after angioplasty. Peak force also increased in his 
healthy right leg after angioplasty by 18 Nm. Furthermore, average force was also 
increased after angioplasty in both the disease and healthy leg. 
 
Table 7.3: Force output measurements during maximal voluntary contractions of the 
quadriceps muscles of the right (Healthy) and left (Diseased) leg in the Pre and Post 
Angioplasty trial. 
 
Healthy and Diseased leg force output in the Pre-Angioplasty (Pre-A) and Post-Angioplasty 
(Post-A) trials. Average force of 2 maximal contractions. Force output in Newton meters (Nm). 
 
Table 7.4 shows the changes in maximal and average force output during the MVC 
of the calf muscles before and after angioplasty. The calf muscles of the diseased 
leg produced a greater peak force after angioplasty (with an increase of 20 Nm) and 
the average force produced by the calf muscles over 2 MVC’s increased by 60 Nm. 
Interestingly, the force output increased slightly in the healthy leg after angioplasty. 
 
 
 
 
 
 
 
 
 
 
 
Trial Right Leg (Healthy) 
 Force output (Nm) 
Left Leg (Diseased) 
 Force output (Nm) 
Peak Average Peak Average 
Pre - A  
Post - A  
213 
225 
201 
221 
185 
204 
179 
191 
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Table 7.4: Force output measurements from maximal voluntary contractions of the calf 
muscle of the right (Healthy) and left (Diseased) leg, Pre and Post Angioplasty trial. 
 
 
Healthy and Diseased leg force output in the Pre-Angioplasty (Pre-A) and Post-Angioplasty 
(Post-A) trials. Average force of 2 maximal contractions. Average force resultant of 2 maximal 
contractions. Force output in Newton meters (Nm). 
 
7.3.1.5 Methods of normalisation to measure muscle activity pre and 
post - angioplasty 
 
EMG activity of the leg muscles before and after angioplasty using the two methods 
of normalisation are shown in Figures 7.4 – 7.7. 
 
 
Figure 7.4 shows the differences in muscle activity between the healthy and 
diseased leg before angioplasty, using the MVC and Mean Dynamic methods of 
normalisation. Muscle activity normalised using the MVC method displayed similar 
trends where muscle activity of all 4 muscles of the healthy leg was greater than in 
the diseased leg (Figure 7.4 a, c, e and g). This pattern was similar for VM and LG 
when EMG was normalised using the Mean Dynamic method. However VL and MG 
activity normalised to the Mean Dynamic method in the healthy leg was not 
considerably greater than in the diseased leg. 
 
 
 
 
 
 
Trial Right Leg (Healthy)  
Force output (Nm) 
Left Leg (Diseased) 
 Force output (Nm) 
Peak Average Peak Average 
Pre - A 
Post - A 
89 
99 
85 
96 
132 
152 
87 
147 
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Figure 7.4: Muscle activity normalised to the MVC Method (left column) and the Mean Dynamic 
Method (right column) of the Healthy and Diseased leg during the Pre-Angioplasty trial (Pre- A) 
(a) & (b) Vastus medialis (VM); (c) & (d) Vastus lateralis (VL) (e) & (f) Medial gastrocnemius and (g) & 
(h) Lateral gastrocnemius 
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Figure 7.5 displays EMG activity during exercise, normalised to both methods, in the 
diseased leg before and after angioplasty. The quadriceps muscle activity displays 
different muscle activity patterns when normalised using the two methods. VM and 
VL activity normalised using the MVC method (Figures 7.5 a and c), shows no 
difference in activity levels in the diseased leg before and after angioplasty. 
Whereas, EMG activity normalised using the Mean Dynamic method (Figures 7.5 b 
and d) showed muscle activity to be greater after angioplasty. The Mean Dynamic 
method also appears more sensitive in showing increasing muscle activity in the 
diseased leg with increasing exercise intensity over time for the quadriceps muscles, 
unlike the MVC method. MG activity normalised using the MVC method, showed a 
decrease in the diseased leg activity after angioplasty (Figure 7.5 e), whereas when 
normalised using the Mean Dynamic method, MG activity was similar in both trials, 
but demonstrated a sensitivity to increasing workload after angioplasty (Figure 7.5 f). 
LG activity was the same when normalised to both methods, showing greater 
muscle activity after angioplasty (Figures g and h). 
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Figure 7.5: Muscle activity normalised to the MVC Method (left column) and the Mean Dynamic 
Method (right column)  of the Diseased leg during the Pre-Angioplasty (Pre- A) and Post-
Angioplasty (Post-A) trial, (a) & (b) Vastus medialis (VM); (c) & (d) Vastus lateralis (VL) (e)& (f) 
Medial gastrocnemius and (g) & (h) Lateral gastrocnemius 
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Figure 7.6 Muscle activity normalised to the MVC Method (left column) and the Mean Dynamic 
Method (right column) of the Healthy and Diseased leg during the Post-Angioplasty trial (Post - 
A), (a) & (b) Vastus medialis (VM); (c) & (d) Vastus lateralis (VL) (e)& (f) Medial gastrocnemius and 
(g) & (h) Lateral gastrocnemius. 
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Muscle activity of the healthy and diseased leg after angioplasty, normalised using 
both methods during exercise, is shown in Figure 7.6. The quadriceps activity in the 
healthy and diseased leg was similar after angioplasty, when normalised using the 
MVC method. However, normalised using the Mean Dynamic method, quadriceps 
activity in the diseased leg increased to levels greater than the healthy leg activity 
after angioplasty (Figure 7.6 b and d). Furthermore, the quadriceps activity was 
sensitive to increasing exercise intensity, which was not found by normalising using 
the MVC method. 
 
Normalising gastrocnemius muscle activity using the MVC method, demonstrated a 
notably greater muscle activity in the healthy leg than the diseased leg after 
angioplasty (Figure 7.6 e and g). MG activity normalised using the Mean dynamic 
method also showed a greater activity level in the healthy leg. However, when 
normalising LG activity using the Mean Dynamic method, the activity in the diseased 
leg was greater than in the healthy leg after angioplasty (Figure 7.6 h). 
 
7.3.2      Case 2  
 
7.3.2.1 Case history 
 
AB, a 58 year old male elite squash player, presented to his doctor with leg pain 
during vigorous exercise. This discomfort increased to an extent where participation 
in squash was no longer possible, walking however was unaffected. The discomfort 
started after approximately 30 minutes of squash and would disappear at rest. His 
risk factors included hypertension, hypercholesterolaemia and cigarette smoking (20 
per day). Medications at the time of testing included Enalapril (10 mg.day-1) and 
Atorvastatin (10 mg.day-1). AB had no prior history of injury to the limb or lower back. 
 
He was referred to Vascular Surgeons at Kingsbury Hospital where he was 
diagnosed with Peripheral Vascular Disease. Color flow Doppler evaluation and 
subsequent angiography revealed PVD with a greater than 80 % stenosis in the 
proximal femoral artery of his right leg. Due to the fact that this was a single 
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localised lesion, the vascular surgeons advised management of the occlusion by 
balloon angioplasty. 
 
Blood velocity at the area of stenosis was measured by flow duplex Doppler 
evaluation at 328 cm.s-1 before angioplasty and reduced to 159 cm.s-1 after the 
procedure. Figure 7.7 demonstrates the area of stenosis in AB’s proximal femoral 
artery. 
 
 
 
Figure 7.7: Lower limb indicating area of stenosis and arteries of the lower leg. (modified from 
the public domain: http://www.bartleby.com/107/157.html) 
 
7.3.2.2 Clinical evaluation and special investigations 
 
AB weighed 89.3 kg, was 1.78 m tall, and had a BMI of 28. Table 7.5 shows ABI 
measurements at rest and after exercise in both before and after angioplasty trials. 
Prior to angioplasty, ABI at rest was measured as 0.80 and increased after exercise 
to 0.87. However ABI after angioplasty was 1.09 at rest and decreased to 0.98 after 
exercise. 
 
 
 
Area of 80% 
stenosis 
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Table 7.5: Ankle Brachial Index measurements Pre and Post Angioplasty 
Trial ABI at rest ABI post exercise 
Pre - A 
Post - A 
0.80 
1.09 
0.87 
0.98 
       
     Ratio of ankle pressure to brachial pressure in Pre-Angioplasty (Pre – A) and  
                              Post-Angioplasty (Post – A) trials. 
 
In the Pre - A Trial, AB was able to walk up to the maximal treadmill gradient of 15 
%, which was reached after 16 minutes of walking. At 15 minutes into the trial, he 
developed pain in his right leg (Diseased leg), equivalent to 849 m. In the Post - A 
Trial, AB experienced no pain in his diseased leg throughout the trial. 
 
7.3.2.3 Measurement of physiological variables during exercise 
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Figure 7.8: Changes in (a) Oxygen consumption and (b) Heart rate measured in Pre-Angioplasty 
(Pre – A) and Post Angioplasty (Post – A) trials. 
 
Oxygen consumption was similar during exercise in both the pre and post - 
angioplasty trials (Figure 7.8.a). Heart rate started at similar values in both trials but 
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increased more rapidly in the Pre - A trial. Heart rate during exercise was 
substantially lower after angioplasty. For example heart rate was 90 bpm at minute 
15 of exercise trial prior to angioplasty but reached 79 bpm at the same time after 
angioplasty. 
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Figure 7.9: Changes in blood lactate concentration in Pre-Angioplasty (Pre – A) and Post 
Angioplasty (Post – A) trials. 
 
Figure 7.9 shows the changes in blood lactate concentrations before and after 
angioplasty. Peak blood lactate concentrations were similar before the start of both 
trials. However, 3 minutes after the trials, peak blood lactate concentration was 
lower in the Post-A trial, and remained lower at the 4th and 5th minute post exercise. 
Blood lactate concentrations from the 3rd to 5th minute post exercise ranged between 
2.00 - 1.75 mmol.l-1 in the Pre - A trial and decreased to the range of 1.75 - 1.50 
mmol.l-1 in the Post - A trial. The pain and RPE score are shown in Figure 7.10. 
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Figure 7.10: Changes in (a) Pain Scores and (b) RPE in Pre-Angioplasty (Pre –A) and Post 
Angioplasty (Post – A) trials. 
 
Despite 80 % occlusion of the femoral artery, AB displayed few symptoms related to 
exercise intolerance during the GTET test (Pre - A). AB only experienced pain in his 
diseased leg at the 15th minute of the Pre - A trial whilst no pain was felt at any time 
during the Post - A trial. RPE was seen to increase in stages in the Pre - A trial and 
reached a maximum rating of 12. In the Post - A trial, AB’s rating of perceived 
exertion remained at 6 until the 12th minute of exercise after which the rating only 
increased to 7 for the remainder of trial.  
 
7.3.2.4 Force output from MVC 
 
Table 7.6 shows the changes in peak and average force output in the diseased and 
healthy leg before and after angioplasty. Peak force increased by 24 Nm after 
angioplasty in the diseased leg. Interestingly, the peak force decreased by 20 Nm in 
his healthy leg after angioplasty. 
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Table 7.6: Force output measurements during maximal voluntary contractions of the 
quadriceps muscles of the right and left leg, Pre and Post-angioplasty. 
 
 
Healthy and Diseased leg force output in the Pre-Angioplasty (Pre-A) and Post-Angioplasty   
(Post-A) trials. Average force of 2 maximal contractions. Force output in Newton meters (Nm) 
 
 
Table 7.7 shows the changes in peak and average force output of the calf muscles. 
The diseased leg produced a greater peak force in the Post-A trial (increased by 16 
Nm). The average force of his calf muscles (2 MVC’s), increased by 19 Nm in the 
diseased leg. There was a slight decrease in force production in the healthy leg after 
angioplasty. 
 
Table 7.7: Force output measurements during maximal voluntary contractions of the calf 
muscle of the right and left leg, Pre and Post angioplasty. 
 
 
Healthy and Diseased leg force output in the Pre-Angioplasty (Pre-A) and Post-Angioplasty   
(Post-A) trials. Average force of 2 maximal contractions. Force output in Newton meters (Nm) 
 
 
 
 
Trial Right Leg (Diseased)  
Force output (Nm) 
Left Leg (Healthy) 
 Force output (Nm) 
Peak Average Peak Average 
Pre - A 
Post - A 
142 
166 
142 
159 
262 
242 
251 
220 
Trial Right Leg (Diseased) 
 Force output (Nm) 
Left Leg (Healthy)  
Force output (Nm) 
Peak Average Peak Average 
Pre - A 
Post - A 
86 
102 
83 
102 
121 
117 
118 
117 
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7.3.2.5 Methods of normalisation to measure muscle activity pre and 
post angioplasty 
 
EMG activity from the VM was not measured in the Pre - A trial due to technical 
problems with the EMG leads. Thus only results of VL, MG and LG are displayed in 
the following graphs. 
 
The differences in EMG activity between the healthy and diseased leg before 
angioplasty are shown in Figure 7.11. VL, MG and LG normalised using the MVC 
method (Figure 7.11 a, c and e) of the diseased leg had greater muscle activity than 
the healthy leg prior to angioplasty, MG and LG specifically demonstrates a 
considerable difference between healthy and diseased leg. However, when 
normalising VL and MG using the Mean Dynamic method, the VL and MG activity in 
the healthy leg was slightly greater than in the diseased leg.  Furthermore, LG 
activity in the healthy was considerably greater than the diseased leg (Figure 7.11 f). 
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Figure 7.11: Muscle activity normalised to the MVC Method (left column) and the Mean Dynamic 
Method (right column) of the Healthy and Diseased leg during the Pre-Angioplasty trial (Pre- A) 
(a) & (b) Vastus lateralis (VL) (c) & (d) Medial gastrocnemius and (e) & (f) Lateral gastrocnemius 
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Figure 7.12: Muscle activity normalised to the MVC Method (left column) and the Mean Dynamic 
Method (right column)  of the Diseased leg during the Pre-Angioplasty (Pre- A) and Post-
Angioplasty (Post-A) trial, (a) & (b) Vastus lateralis (VL) (c) & (d) Medial gastrocnemius and (e) & (f) 
Lateral gastrocnemius 
 
Figure 7.12 shows changes in muscle activity in the diseased leg before and after 
angioplasty when normalised using the MVC and Mean Dynamic methods. VL. MG 
and LG, normalised using the MVC method, showed a greater muscle activity before 
angioplasty. Whereas when normalised using the Mean Dynamic method, their 
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activity levels were only greater after angioplasty, except for MG which remained 
similar over the trials. 
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Figure 7.13: Lower limb muscles of the Healthy and Diseased leg in the Post - Angioplasty trial 
(Post - A) normalised to MVC Method (left column) and Mean Dynamic Method (right column) (a) 
& (b) Medial gastrocnemius and (c) & (d) Lateral gastrocnemius 
 
 
The differences between muscle activity in the healthy and diseased leg after 
angioplasty is shown in Figure 7.13. VL activity in the healthy leg is not shown due 
to technical problems with the EMG leads. The MG activity was similar between the 
healthy and diseased leg after angioplasty, when normalised using the MVC 
method. Whereas using the Mean Dynamic method of normalisation, MG activity in 
the diseased leg was greater than the healthy leg after angioplasty. LG normalised 
using the MVC method, showed LG activity in the diseased leg to be greater than 
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the healthy leg after angioplasty. However, LG activity was similar in both legs when 
normalised using the Mean Dynamic method. 
 
7.4 DISCUSSION 
 
Angioplasty is an invasive procedure that is used commonly in the management of 
PVD where there is a predominant single lesion causing obstruction of blood flow. 
This procedure was successful in both of the patients described. After angioplasty 
there was decreased blood flow velocity at the site of the lesion (indicating 
improved, less turbulent flow), decreased pain during walking and increased 
functional capacity in both patients. Improved functional capacity was always 
thought to be related to improved blood flow to the ischemic leg. To my knowledge, 
this is the first study to measure muscle activity before and then within days after 
angioplasty. This was performed to determine the role of muscle activity in exercise 
intolerance in patients with PVD. 
 
Surface EMG is considered an appropriate non-invasive method to investigate the 
underlying mechanism of exercise intolerance in patients with PVD. This study has 
also evaluated the two recommended methods of EMG normalisation described in 
the clinical population (MVC method and Mean Dynamic method) to analyse muscle 
activity in these patients before and after angioplasty. 
 
7.4.1 Methods of normalisation 
 
One of the main findings of this study was that muscle activity of the lower leg 
changed after restoration of blood flow through angioplasty. Altered muscle activity 
patterns are seen using both methods of normalisation. The MVC method of 
normalisation is the standard method of normalisation. The MVC method is still 
recommended for the measurement of EMG in the clinical population (172). In the 
present study, muscle activity normalised using the MVC method, decreased in the 
diseased leg after angioplasty for most lower leg muscles, in both patients (Figures 
7.5 e and 7.12). However, when EMG activity was normalised using the Mean 
Dynamic method, muscle activity in the diseased leg, increased after angioplasty in 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
                                                                                                         CHAPTER 7 
 - 167 - University of Cape Town 
both patients. Furthermore, the results of this study show that the MVC method of 
normalisation is less sensitive than the Mean Dynamic method in tracking changes 
in muscle activity with increasing exercise intensity. 
 
It is reasonable to expect muscle force output and EMG amplitude to have a linear 
relationship, as both variables are dependant on the number of motor units recruited 
(60). For this reason, EMG amplitude has been shown to increase with increasing 
power output/workload (18; 51; 52; 119). A possible reason for the muscle activity of the 
diseased leg being greater before angioplasty (normalised to the MVC method) 
could be explained by the application of the normalisation equation. 
 
Muscle activity during the MVC contraction (before angioplasty) produced lower 
force output with a resultant lower EMG amplitude compared to the trial after 
angioplasty (Tables 7.3, 7.4, 7.6 and 7.7). This resulted in a lower value of the 
denominator of the normalisation equation, which in turn equates to a higher % of 
MVC value (refer to equation in Chapter 1 Section 1.3.1). After angioplasty, force 
output increased, resulting in a possible increase in EMG amplitude, and thus a 
higher denominator value and lower % MVC. For example, in Figure 7.12 e, patient 
AB demonstrated muscle activity of the LG before angioplasty to be approximately 
600 % MVC. This high percentage could be explained by abnormally low EMG 
activity, leading to an apparent activation of 600 % of MVC. This implies that muscle 
activity was greater during walking on a treadmill at 3.2 km.h-1 than during a 
maximal contraction (before angioplasty). However, this changes after angioplasty, 
as muscle activity of LG decreases to approximately 50 % of MVC. This 
demonstrates that it is possible to misinterpret the EMG data when normalising 
using the MVC method especially in a clinical population. In addition, the 
repeatability of force output during MVCs is a requirement for the method’s 
reproducibility. Highly reliable force output measurements are a basic requirement 
for reliable EMG measurements (105).  
 
The discrepancy between the two methods of normalisation is further highlighted 
when muscle activity is compared in the healthy and the diseased leg before and 
after angioplasty. Using the MVC method for normalisation of EMG resulted in the 
muscle activity in the healthy leg of AA to be greater than in his diseased leg, before 
angioplasty. However, for AB, muscle activity in the healthy leg was considerably 
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lower than his diseased leg, before angioplasty. In contrast, in both patients, muscle 
activity was greater in their healthy legs (for most muscles) when normalised using 
the Mean Dynamic method before angioplasty. Thus the use of the MVC method 
displayed conflicting results between patients, whereas using the Mean Dynamic 
method showed more consistency in the results as both patients displayed the same 
outcome (increase in muscle activity after angioplasty). 
 
The MVC method of normalisation involves a maximal static contraction. The nature 
of this contraction does not represent the same physiological mechanisms, including 
lengthening and shortening muscle actions and speed of muscle contraction, which 
are evident in walking. Furthermore, maximal contractions in the patient population 
could cause pain and inhibition of muscle activity (21). Thus, conscious or 
subconscious inhibition could occur through patients anxiety related to their 
diseased state.  
 
Bolgla & Uhl (21) highlighted that previous studies investigating EMG amplitude using 
the MVC method used healthy populations and inferred the similar findings to 
symptomatic subject populations. Bolgla & Uhl (21) have therefore also recognised 
the difficulty in using the MVC method of normalisation and proposed the alternative 
Mean Dynamic method of normalisation since it was able to identify differences in 
EMG amplitude between exercises but with less risk of injury or discomfort.   
  
Thus utilisation of the Mean Dynamic method in the clinical population is favoured 
for the following reasons. Firstly, the Mean Dynamic method is repeatable with 
preferable inter and intra-subject variability (24; 168; 169; 198). Secondly, this method of 
normalisation uses the same muscle action which is used during walking. This could 
possibly reduce the contribution of extrinsic factors associated with errors in 
measuring EMG during dynamic activity as outlined in Chapter 1. Thus, by using this 
method, changes in muscle activity are influenced less by these extrinsic factors and 
influenced more by biological variation. Importantly, during the application of this 
method work output of the patients is controlled, as they walked at the same speed 
and gradient both before and after angioplasty. It must be acknowledged that the 
muscle activity during the normalisation (walking at 3.2 km.h-1) could also have 
altered after angioplasty, affecting the denominator in the normalisation equation. 
Yet, muscle activity using this method of normalisation, tracks changes in force 
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output and exercise tolerance. Thus, the results of this study favour the use of the 
Mean Dynamic method of normalisation in this patient population. 
 
Further discussion is therefore based on the data generated by using the Mean 
Dynamic method of normalisation for EMG analysis. 
 
7.4.2 Muscle activity before and after angioplasty 
 
Muscle activity in the diseased leg increased in both patients after only three days 
recovery from the angioplasty procedure. By comparing the healthy leg to the 
disease leg in the Pre-A trial, AA and AB showed different muscle activity patterns. 
AA was diagnosed with unilateral popliteal artery occlusion of the lower leg. VL was 
assumed to be the least affected by the limited blood flow as it obtains collateral 
blood flow from the femoral profunda artery. VM, MG and LG do not receive 
collateral flow.  
 
Indeed, VL activity appeared to be slightly greater in the diseased leg than the 
healthy leg before angioplasty. This could be due to a compensation of VL activity 
for the muscles that were directly affected by the stenosis in the diseased leg. VM, 
MG and LG activity decreased in the diseased leg compared to the healthy leg, after 
angioplasty. After angioplasty, VL activity remained greater in the diseased leg than 
in the healthy leg. But, VM, MG and LG muscle activity improved in the diseased leg 
after angioplasty. 
 
AB was diagnosed with a unilateral femoral artery occlusion of greater than 80 %. 
The muscle activity in all the muscles measured increased after angioplasty, in the 
diseased leg. However, before angioplasty, all the measured muscles in the 
diseased leg were found to be less active than the healthy leg. Furthermore, after 
angioplasty, all the measured muscles EMG amplitudes increased more than the 
EMG amplitudes in the healthy leg. It is possible that the inhibition of skeletal muscle 
activity in his diseased leg might occur due to the inhibition of central drive to the 
skeletal muscle (146). It is possible that these changes could reflect the readjustment 
of the central drive to the lower limbs musculature, resulting in a possible regulatory 
mechanism to protect the body from being harmed, especially in this diseased state. 
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To my knowledge, these findings have not been described in any literature thus far. 
It is interesting to note that a study conducted by Kayser et al. (96) investigated the 
effects of hypoxia on muscle activity. The study found that lower limb iEMG did not 
increase as much during cycling in hypoxic conditions as it did during normoxic 
conditions (in which a higher maximum power output was achieved). However, 
when oxygen was supplied, iEMG activity and power output increased. The same 
analogy could thus be applied to this patient population. It is possible that the 
restriction in blood flow to the active muscles results in lower oxygen saturation with 
a decrease in muscle activity. Once the restriction is removed, oxygen saturation 
increases and muscle activity increases accordingly. Therefore, in the study by 
Kayser et al. (96) as in the present study, lack of oxygen to the active muscle might 
cause central reduction in neural recruitment to protect the tissues from hypoxia. 
 
The only published studies investigating EMG in patients with PVD, have studied 
changes in median frequency (MDF) and nerve conduction velocity of peroneal and 
tibial nerves in patients with PVD (8; 125; 151; 155). McDermott et al. (125) measured 
peroneal nerve conduction velocity in patients with PVD and control subjects. 
Patients with PVD had slower nerve conduction velocity and a lower muscle power 
output compared to controls. This study suggested a decrease in muscle fiber 
stimulation from the central nervous system. A further study conducted by Pedrinelli 
et al. (155) examined conduction velocity and MDF of Tibialis anterior muscle during 
tetanic electrical stimulations in patients with PVD and controls. Conduction velocity 
ranges did not differ significantly between patients and healthy controls. However, 
MDF of both the ischemic and non-ischemic legs were found to be significantly 
lower than the controls, as the healthy limb also showed a decrease in MDF. This 
finding suggests that chronic ischemia was not the cause of lower MDF in patients 
with PVD. It is of interest to note that this study used a 3 week walking program 
intervention, which resulted in improved exercise tolerance in patients with PVD. 
These findings suggest that central drive increases following a supervised walking 
program and that factors other than ischemia and physical inactivity underlie the 
abnormal EMG signal in patients with PVD.  
 
It is possible that a change in fiber type could also account for the changes in MDF  
(109; 125; 126; 155).  In addition, fiber type composition rather than oxygen availability 
could limit the endurance capacity of skeletal muscle in patients with PVD (166). Thus 
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the altered neural drive and fiber type composition in patients with PVD could both 
be contributing factors to the lower functional capacity experienced by these 
patients.  
 
7.4.3 Changes in other physiological variables 
 
Blood flow velocity in the affected arteries decreased in both patients substantially 
after angioplasty. AA’s blood velocity decreased from 206 to 97 cm.s-1 (normal blood 
velocity range of the popliteal artery is 69 ± 14 cm.s-1) and AB’s blood velocity 
decreased from 382 to 159 cm.s-1 (normal blood velocity range of the femoral artery 
is 114 ± 25 cm.s-1) (176). Although these values were not within the normal range, the 
decrease in blood velocity is indicative of the improved blood flow after angioplasty 
in both patients. 
 
Peak and average force outputs from the quadriceps and calf muscles improved in 
both patients after angioplasty (Tables 7.3, 7.4, 7.6 and 7.7). In addition, both 
patients showed improvements in the physiological variables measured during 
graded maximal exercise. Heart rate and oxygen consumption decreased after 
angioplasty (Figures 7.2 and 7.8.). Research suggests that peak oxygen 
consumption in patients with PVD is approximately 18 ml.kg-1.min-1 (83). Both patients 
showed similar peak values, where AA’s peak oxygen consumption was 16.2 ml.kg-
1.min-1 and AB’s was 19.7 ml.kg-1.min-1 before angioplasty. Therefore their peak 
oxygen consumptions can be regarded as normal for their age group. 
 
It is of interest to note that exercise intolerance in patients with PVD is assumed to 
be due to blood flow to the lower limbs and/or accumulation of lactate in the skeletal 
muscles and blood as a result of ischemia (101; 118; 177). However, patients with PVD 
terminate exercise at lower peak blood lactate concentrations than do patients with 
other chronic diseases (152). A study conducted in this laboratory by Parr (152) found 
that PVD patients who performed a GTET, showed peak blood lactate 
concentrations of 3.3 ± 1.4 mmol.l-1, whereas patients with chronic heart failure have 
peak lactate concentrations of 4.6 ± 0.5 mmol.l-1 (41) and patients with chronic 
obstructive pulmonary disease have peak lactate concentrations of 5.1 ± 2.7 mmol.l-
1 (32). Healthy controls performing similar exercise to exhaustion had peak lactate 
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concentrations of 9.7 ± 2.7 mmol.l-1. Furthermore, only post-exercise blood lactate 
concentrations ≥ 8 mmol.l-1 are supposedly a marker of oxygen dependant 
glycolysis (15; 87). The patient, described in this study, had a peak lactate 
concentration of 2 mmol.l-1 after 3 minutes of performing the GTET. Peak lactate 
concentration decreased to 1.8 mmol.l-1 in the Post-A trial (Figure 7.9). It is therefore 
unlikely that the blood lactate concentration of this patient is related to low blood 
oxygen dependant glycolysis and pain, as the blood lactate concentrations were 
very low. However, it must be noted that lactate concentrations could have been 
high in the skeletal muscles, and unable to diffuse out due to low blood flow. 
 
Ratings of perceived exertion seemed to have increased prior to pain becoming 
evident. It is possible that different physiological factors affect the perception of 
effort and pain. The pain and RPE scores of both patients were lower after 
angioplasty (Figures 7.3 and 7.10). Since the rate of increase in RPE predicts time 
to exhaustion (55), this indicates the central processes generating the RPE “knew” 
that angioplasty had produced cardiovascular and metabolic changes which would 
allow exercise to continue for longer. Note this effect was present within 6 minutes 
of start of exercise in the Pre – A trial, and only presented at minute 12 after 
angioplasty (Fig 7.10 b). 
 
There are certain limitations to his study, whilst the aim was to recruit up to 15 
patients with PVD who had single lesion amenable by angioplasty only two patients 
were recruited for this study. More subjects would have allowed an appropriate 
investigation of methods of normalisation for this patient population. The many 
challenges experienced in recruiting these patients involved the fact that 1) most 
patients diagnosed at the hospital suffered from severe diabetes or had to undergo 
emergency angioplasty; 2) due to peripheral neuropathy, diabetic candidates were 
not ideal for a study investigating EMG and muscle activity; 3) most of the patients 
diagnosed with Peripheral Vascular Disease (PVD) have multiple areas of 
atherosclerotic plaque development and not just one lesion amenable to angioplasty 
as required by this study. Thus the stenosis is not isolated to one area. This 
inclusion criterion was necessary for this study, which examined the effects of rapid 
reversal of a single occlusion. Future studies should include investigation of time 
course changes following angioplasty and consider the measurement of muscle 
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fiber conduction velocity. Furthermore, evaluation of muscle biopsy for lactate 
analysis and fiber typing should be considered. 
 
In conclusion, this case series found clinical changes in EMG and functional 
capacity in two patients with PVD, following angioplasty. Both patients described in 
this series demonstrated improvement in functional capacity and changes in muscle 
activity during incremental exercise until exhaustion.  These findings suggest that a 
reduction in muscle activity is seen as a physiological attempt to protect the body 
from serious harm in this diseased state. In addition, both patients showed 
improvements in other physiological variables, including a decrease in heart rate, 
perception of effort, pain and peak blood lactate concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 7  
Department of Human Biology - 174 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
                                                                                                         CHAPTER 8 
 - 175 - University of Cape Town 
CHAPTER 8  
 
SUMMARY AND CONCLUSIONS: 
PRACTICAL GUIDELINES FOR NORMALISATION OF EMG IN THE 
LABORATORY 
 
8.1 OVERVIEW 
 
The objective of the thesis was to critically analyse the various methods of 
normalising EMG during dynamic exercise with the goal of minimising the 
contribution of extrinsic factors by using the most appropriate method of 
normalisation.  Furthermore, the thesis aimed to illustrate that decisions regarding 
the most appropriate method of normalisation should be based on the study design, 
research question (absolute muscle activity or changes in muscle pattern) and the 
muscles being investigated. 
 
8.1.1 Chapter 2 
 
Few studies have used alternative methods of normalisation for EMG during cycling. 
Therefore the aim of this study was to critically examine alternative methods of EMG 
normalisation during cycling, where each method’s ability to show repeatability, 
reliability and sensitivity was examined. Two maximal static methods (MVC and AP 
MVC methods) and two dynamic methods (Sprint and 70 % PPO) were analysed 
and compared.  
In summary, the data showed that for the normalisation of EMG during cycling: 
 
(i) The most appropriate method was the submaximal dynamic method of 
70 % PPO, showing the highest repeatability, lowest intra-subject 
variation and highest sensitivity to changes in exercise intensity. 
 
(ii) The Sprint method of normalisation provided a better representation of 
muscle activity than the MVC method when investigating the amount of 
muscle activated during cycling. The Sprint method showed greater 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 8  
Department of Human Biology - 176 - 
repeatability, lower intra-subject variability and better sensitivity than the 
MVC method. 
 
(iii) The MVC method showed ‘fair’ repeatability for most muscles examined. 
However, this method was unable to adequately detect changes in EMG 
amplitude with corresponding increases in power output.  
 
In conclusion, these data suggest that normalising EMG to dynamic methods (70 % 
PPO and the Sprint methods) are more suitable for examining muscle activity during 
cycling over different testing days and for once-off measurements.  
 
8.1.2 Chapter 3 
 
The aim of this study was to critically examine alternative methods of EMG 
normalisation during running. The ability of each method of normalisation in 
demonstrating repeatability, reliability and sensitivity was examined. The maximal 
static method (MVC method) and two dynamic methods (Sprint and 70 % PRS) 
were investigated. In summary, the data showed that for the normalisation of EMG 
during running: 
 
(i) The most appropriate method of normalisation was the maximal dynamic 
Sprint method, as this method showed the highest repeatability, low intra-
subject variation and high sensitivity to changes in exercise intensity. 
 
(ii) The submaximal dynamic method had ‘poor’ repeatability for most muscles; 
however this method also had the lowest intra-subject CV and greatest 
ability to detect changes with increasing running speed.  
 
In conclusion, the data suggests that normalising EMG during running to dynamic 
methods is more suitable than normalising to the static MVC method. The Sprint 
method of normalisation is recommended for researchers who are investigating 
maximal muscle activity over different days and for once-off measurements. 
Moreover, the 70 % PRS method is also recommended for measurement over days 
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since it has the lowest intra-subject variability and the greatest ability to track 
changes in muscle activity with increase in exercise intensity.  
 
8.1.3 Chapter 5 
 
By applying the findings from Chapter 2, this chapter attempted to answer a 
physiological question regarding the muscle activity at exhaustion during cycling. 
The aim of this chapter was to use an appropriate method of normalisation to 
measure maximal muscle activity at exhaustion and to investigate if muscle activity 
is indeed submaximal during maximal exercise to exhaustion. The main findings of 
this study were; 
(i) The Sprint method was the most appropriate method of normalisation to 
answer the research question, because this method had a greater 
reliability, greater repeatability (predominantly for VM, RF and MG) and 
greater sensitivity (predominantly for VM, VL, RF and BF) than the MVC 
method. This method also uses the same dynamic movement which 
occurs in the activity being investigated and is thus a better 
representation of muscle activity during cycling. 
 
(ii) Muscle activity was submaximal at exhaustion ranging between 36 % - 
65 % of muscle activity during a maximal cycle sprint. This indicates that 
muscle activity does not reach ‘maximal’ capacity at exhaustion. 
 
(iii) Muscle activity at exhaustion varied on different days for each subject.  
 
In conclusion, this study showed that muscle activity was submaximal during an 
incremental cycle test to exhaustion (PPO). The finding provides evidence of central 
regulation of exercise and confirms that only a certain percentage of the limb muscle 
mass is active during maximal exercises. These findings are not compatible with the 
peripheral model of fatigue, as the model assumes that the total muscle mass must 
be active at exhaustion. 
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8.1.4 Chapter 6 
 
This study was analogous to Chapter 5, in applying the most appropriate method of 
normalisation to measure maximal muscle activity at exhaustion during running 
(from Chapter Three) and to investigate if muscle activity is indeed submaximal 
during maximal running exercise to exhaustion. The main findings of this study 
were: 
 
(i) The Sprint method of normalisation was the most appropriate method of 
normalisation to answer the research question. The method had greater 
repeatability (predominantly for VL, RF and LG), reliability and sensitivity; 
than the MVC method. 
 
(ii) Muscle activity was submaximal at exhaustion ranging between 42 % - 
66 % of a 20 m sprint, indicating muscle activity does not reach ‘maximal’ 
capacity at exhaustion. 
 
(iii) The agonist and antagonist muscles were the most activated, RF (55 % - 
64 %) and BF (58 % - 59 %) respectively, possibly to assist with 
increasing the joint stiffness, to prevent unnecessary yielding of the 
ankle, knee and hip joints. 
 
(iv) At exhaustion, quadriceps muscle activities were the most repeatable 
over 3 days, whereas the gastrocnemius muscles showed ‘poor’ 
repeatability at exhaustion. 
 
In conclusion muscle activity during running is indeed submaximal at exhaustion and 
supports the findings of Chapter Five. These findings also support the model of 
central regulation of exercise and confirm that only a certain percentage of muscle is 
active during maximal exercises. 
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8.1.5 Chapter 7 
 
The aims of the chapter were to firstly apply an appropriate method of normalisation 
for measurement and evaluation of muscle activity in patients with PVD (before and 
after angioplasty). The chapter used two recommended methods of normalisation 
from the literature (MVC method and Mean Dynamic method), since the low subject 
number impeded the measurement of repeatability, reliability and sensitivity. 
Secondly, the study aimed to investigate the effect of angioplasty on skeletal muscle 
activity and physiological variables in patients with PVD. The main findings of the 
chapter were; 
 
i) EMG data analysis using the MVC method of normalisation resulted in 
conflicting results when the data was normalised using the Mean 
Dynamic method. The MVC method demonstrated that muscle activity in 
the diseased leg decreased after angioplasty, whereas the Mean 
Dynamic method showed the muscle activity in the diseased leg 
increased after angioplasty.  
 
ii) The Mean Dynamic method was chosen as the more appropriate 
method, as the MVC method could have produced abnormally low EMG 
activity during the MVC (due to possible muscle inhibition). In addition, 
the MVC method of normalisation is considered less sensitive than the 
Mean Dynamic method in tracking changes in muscle activity with 
increasing exercise intensity. 
 
iii) By using the Mean Dynamic method, the study found muscle activity to 
be reduced in the state of peripheral vascular disease and muscle 
activity in the diseased leg was able to increase to muscle activity 
percentages greater than the asymptomatic (healthy) leg, after 
angioplasty. 
 
iv) Peak blood lactate concentration (which has been assumed to be the 
reason for claudication pain) was less than that of healthy controls and in 
patients with other chronic diseases. 
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(v) Both patients showed improvements in the other physiological variables 
measured. 
 
In conclusion, the MVC method of normalisation should not be used in the clinical 
population. The subjects are unable to perform a valid MVC possibly due to pain 
and/or muscle inhibition. Therefore a submaximal method is the most appropriate 
method to normalise EMG in the clinical population as it is able to identify 
differences in EMG amplitude between trials and with increasing workload but with 
less risk of injury or discomfort.  Furthermore this study demonstrated that exercise 
intolerance in these patients is affected by muscle activity. These findings advocate 
the central regulation of exercise, where the reduction in muscle activity is viewed as 
a physiological attempt to protect the body from serious harm so as to maintain 
homeostasis, in the diseased state. 
 
It is important to note that the thesis was unable to provide these guidelines for the 
clinical population (patients with PVD). The study was unable to investigate the 
repeatability, reliability and sensitivity of the MVC and Mean dynamic methods of 
normalisation used in the clinical case studies, due to the low subject number. 
Therefore no valid recommendations are made for the appropriate method of 
normalisation to be used in clinical studies; however, the thesis has questioned the 
credibility of the MVC method, since it is not as sensitive in detecting changes in 
workload. 
 
8.2 INTERPRETATION AND GUIDELINES 
 
The overall theme of the thesis is that researchers should use a method of 
normalisation that is appropriate for their study design, research question and 
skeletal muscles being investigated. This increases the chance of detecting true 
biological variation rather than incurring experimental error which will subsequently 
reduce the chance of detecting biological variation. 
 
The thesis has also highlighted the importance of using the ideal method of 
normalisation for the analysis of EMG during cycling and running (Chapter 2 and 3 
respectively). The data from the various studies in this thesis provides possible 
guidelines to researchers who are planning studies involving EMG measurements. 
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The following organograms (Figure 8.1 for cycling and 8.2 for running) offer 
evidence-based guidance on the selection of the most appropriate method of 
normalisation for different research designs. 
 
 
Cycling
Testing 
Protocol
Once-off Repeated days
Outcome
measure Maximal activity 
Change in muscle
activity with increasing 
workload
Intervention/Change in muscle
activity
Norm 
method Sprint method
70 % PPO
method
Repeatable Reliable SensitiveRepeatable SensitiveReliable
MG
LG
BF
VM
VL
MG
VL
VM
BF,LG
VM
BF
VL,
RF,
MG,
LG
LG
VL
MG,VM
BF
RF
MG
LG
VL
RF
BF
VM
BF
VM
VL,BF
LG
RF
 
Figure 8.1: Schematic guideline for normalising EMG during cycling that is suitable for the 
study design, research question and skeletal muscles being investigated. The muscles are 
displayed from highest to lowest ranking order. The muscles corresponding to the Sprint method is 
highlighted in grey. 
 
Figure 8.1 presents a schematic guideline for normalising EMG during cycling 
studies. If a researcher is investigating muscle activity on a once-off cycling trial, and 
intends to measure maximal muscle activity or changes in muscle activity, the Sprint 
method of normalisation is recommended. This method has demonstrated ‘fair’ to 
‘good’ repeatability for most of the muscles measured, where the MG and LG have 
shown to have the highest repeatability. The MG and VL are the recommended 
muscles to use for low intra-subjection variation. The VM and BF are the most 
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sensitive muscles in tracking changes in workload, followed by the remaining four 
muscles (VL, RF, MG and LG). Important to note is that RF is not recommended as 
a muscle to measure when investigating maximal muscle activity, since RF has 
‘poor’ repeatability and intra-subject reliability. However, RF activity does track 
changes in workload to the same extent as does VL, MG and LG.  
 
Furthermore if a researcher is investigating muscle activity over repeated days, and 
intends on measuring maximal muscle activity, the Sprint method of normalisation is 
also recommended. The Sprint method demonstrates the same guidelines as 
mentioned above. However, if a researcher intends on measuring a change in 
muscle activity (through an intervention), the 70 % PPO method is recommended. 
All the measured muscles had ‘good’ repeatability, where LG and VL demonstrated 
the highest ICC values. The lowest intra-subject variability was demonstrated with 
BF and VM muscles. The gastrocnemius muscles were the most sensitive in 
tracking changes in workload. 
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Testing 
Protocol
Outcome
measure
Norm 
method
VM
MG
BF
VL
RF
LG
Change in muscle
activity with increasing 
workload
70 % PPO
method
Sensitive
VM
RF
VL
LG
BF
MG
MG
VM
LG
BF
VL
RF
BF
VL
LG
MG
RF
VM
BF
RF
MG
VL
LG
VM
Running
Once-off Repeated days
Maximal activity Intervention/Change in muscleactivity
Sprint methodMVC method Sprint method
BF
RF
LG
MG
VM
VL,RF
BF
VM
VL
MG
LG
BF
RF
Repeatable ReliableRepeatable SensitiveReliable
MG
VM,LG
VL,BF
RF
 
Figure 8.2: Schematic guideline for normalising EMG during running that is suitable for the 
study design, research question and skeletal muscles being investigated. The muscles are 
displayed from highest to lowest ranking order. The muscles corresponding to the Sprint method is 
highlighted in grey. 
 
Figure 8.2 presents a schematic guideline for normalising EMG during running 
studies. If a researcher is investigating muscle activity in a once-off running trial, and 
intends to measure maximal muscle activity or changes in muscle activity, the Sprint 
and MVC methods of normalisation are recommended. These methods have 
demonstrated ‘fair‘ to ‘good’ repeatability for most of the muscles measured, where 
the VM had the highest repeatability for both methods. The MG and VM are the 
recommended muscles to use for low intra-subject variation. The BF is the most 
sensitive muscle in tracking changes in workload.  
 
Furthermore if a researcher is investigating running muscle activity over repeated 
days, and intends on measuring maximal muscle activity or changes in muscle 
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activity, the Sprint method of normalisation is recommended. The Sprint method 
demonstrates the same guidelines as mentioned above. In addition, the 70 % PRS 
method is also recommended. Although this method has ‘poor’ repeatability for most 
muscles (except BF and RF which had ‘fair’ repeatability), this method has the 
lowest intra-subject variability, particularly in the gastrocnemius muscles. The 70 % 
PRS method of normalisation had the most sensitivity to changes in workload. VM 
and VL muscles showed the greatest ability to track EMG changes to increasing 
workloads.  
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APPENDIX 
 
Informed Consent for Running Trials 
Department Of Human Biology, Faculty Of Health Sciences 
University Of Cape Town 
UCT/MRC Research Unit of Exercise Science and Sports Medicine 
 
Measurement of EMG activity during maximal running 
 
Informed consent 
 
The MRC / UCT Research Unit for Exercise Science and Sports Medicine will be 
conducting a study to measure EMG activity of the active leg muscles during 
running till exhaustion. This means that we want to find out how your various muscle 
groups are recruited during maximal tests until exhaustion occurs.   
 
In order to do this, we will require you to perform three maximal tests until 
exhaustion. You will be required to come into the Sports Science Institute of South 
Africa on 4 occasions.  
 
On the first visit  
 
PRELIMINARY TESTING 
 
 You will be required to fill out a Quality of Health Questionnaire, this 
questionnaire will ask you questions about your physical function etc  ; 
 We will measure your weight, height and percentage of body fat, determined by 
measuring 7 skinfolds, including triceps, biceps, suprailiac, subscapular, calf, 
thigh and abdomen.  This is a non-invasive test for the estimation of body fat. 
 You will be familiarised with the treadmill and then you have to perform a 
progressive treadmill test to determine your peak treadmill running speed 
(PTRS). The gradient will be set at zero and the treadmill speed will start at a 
speed of 10 km.h-1. Every 30 seconds, treadmill speed will be increased by 0.5 
km.h-1 until you are unable to maintain the pace of the treadmill. The PTRS is 
defined as the fastest running speed you can maintain for 30 seconds. 
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 You will practise performing maximal voluntary contractions of your quadricep, 
hamstring and calf muscles of your right leg. We will measure you maximal 
voluntary contraction using the Biodex Dynamometer 3 (Biodex Medical 
Systems, New York) – where you will be required to push against a non-moving 
arm attachment using muscles in your leg. Your hips, thighs and upper body will 
be firmly strapped to the seat of the dynamometer. Your arm position for this  
test is standardised, where you have to cross your arms over your chest. This 
test will be conducted with your knee resting at a 60° angle from full leg 
extension (straightened leg) for the thigh and hamstring muscles. Whereas for 
the calf muscles, the leg will be elevated forming a 30° angle at the knee 
between the upper and lower leg and the foot firmly strapped against a foot-
plate. You have to push against the foot-plate using your calf muscles. A 
standardise warm up before the maximal voluntary contraction includes four 
contractions of the knee and calf extensors at 50 %, 60 %, 70 % followed by 80 
% of your subjective maximum. The test included three maximum voluntary 
contractions (MVC) of 5 seconds each separated by 60 second intervals. You 
will be verbally motivated so as to encourage you to achieve your maximum 
potential. The purpose of the MVC allows measurement of muscle recruitment 
patterns during the running test to be expressed as a percentage of this method.  
 
 You will be familiarised with he pacing lights in the gym. You have to keep up 
with speed of the lights which are placed on the inner circumference of the track 
at an interval of 7 m and can be set to blink sequentially at a given running 
velocity. The pacing lights will be set to mimic the Peak Treadmill Running 
Speed test where the speed will start at 10 km.h-1. Every 30 seconds, the pacing 
light speed will be increased by 0.5 km.h-1 until exhaustion. The peak speed 
maintained 30 seconds prior to test termination will be taken as the PRS.  
 
EXPERIMENTAL TESTING 
After preliminary testing, the actual study, consisting of 3 trials separated by 5-7 
days (in which you have to maintain your training and no hard training within 24hrs 
of testing).  The protocol for all trials are the exact same 
 
When you arrive at the lab for the trials the following will be measured prior to the 
start of the exercise test 
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 EMG electrodes will be placed on your 6 muscles- Two electrodes which 
measures your muscle activity will be placed onto the skin surface of each of the 
following lower limb muscles during all the tests; Vastus lateralis (VL), Vastus 
medialis (VM), Rectus femoris (RF), Biceps femoris (BF) and Medial and Lateral 
gastrocnemius (MG and LG  respectively). Prior to placing the electrodes on the 
skin, the skin over the muscle will be shaved and cleaned with alcohol. Two 
electrodes will be was placed on the belly of each muscle with an inter-electrode 
distance of 10 mm and carefully taped. 
 
 We will measure you maximal voluntary contraction using the Biodex 
Dynamometer 3 (Biodex Medical Systems, New York) – where you will be 
required to push against a non-moving arm attachment using muscles in your 
leg. Your hips, thighs and upper body will be firmly strapped to the seat of the 
dynamometer. Your arm position for this test is standardised, where you have to 
cross your arms over your chest. This test will be conducted with your knee 
resting at a 60° angle from full leg extension (straightened leg) for the thigh and 
hamstring muscles. Whereas for the calf muscles, the leg will be elevated 
forming a 30° angle at the knee between the upper and lower leg and the foot 
firmly strapped against a foot-plate. You have to push against the foot-plate 
using your calf muscles. A standardise warm up before the maximal voluntary 
contraction includes four contractions of the knee and calf extensors at 50 %, 60 
%, 70 % followed by 80 % of your subjective maximum. The test included three 
maximum voluntary contractions (MVC) of 5 seconds each separated by 60 
second intervals. You will be verbally motivated so as to encourage you to 
achieve your maximum potential. The purpose of the MVC allows measurement 
of muscle recruitment patterns during the GTET test to be expressed as a 
percentage of this method.  
 
 Perform a 2 X 20 m maximal sprint on the gym track 
 
 Perform the peak running speed (PRS) test on the gym track, where the speed 
of the pacing light will start at 10 km.h-1. Every 30 seconds, the pacing light 
speed will be increased by 0.5 km.h-1 until exhaustion. The peak speed 
maintained 30 seconds prior to test termination will be taken as the PRS.  
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 Following a 20 minute resting period the runners will then perform a submaximal 
run on the track at 70% of PRS for 5 minutes.  
 
 Heart rate (Polar ® Heart Rate Monitors, Polar Electro OY) will be measured 
throughout the trial 
 
Because each trial is a maximum all-out effort, you will be requested to refrain from 
doing any high intensity exercise the day before testing.  You should also make sure 
that you eat and drink as you normally do before the trials.  Also, you should attempt 
to keep your own personal training routine constant for the time it takes to complete 
the 3 trials.   
 
Possible risks of participation 
 
There are no risks involved in the measurement of heart rate and EMG.   
 
The exercises itself carries no major risks other and is no more risky than 
performing recreational exercise at a high intensity.  Additionally, each trial will be 
supervised and aspects such as your heart rate will constantly be recorded and 
monitored by means of sophisticated equipment. 
 
Statement of understanding and consent: 
 
I confirm that the exact procedure and techniques, and possible complications of the 
above tests have been thoroughly explained to me. I am free to withdraw from the 
study at any time, should I choose to do so. I understand that I may ask questions at 
any time during the testing procedure. I know that the personal information required 
by the researchers and derived from the testing procedure will remain strictly 
confidential and will only be revealed as a number in statistical analysis.   
I have carefully read this form and understand the nature, purpose and procedures 
of this study. I agree to participate in this research project of the MRC / UCT 
Research Unit for Exercise Science and Sports Medicine 
 
Name of volunteer: …………………………………………………………... 
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Signature of volunteer: ……………………………………………………… 
 
Name of investigator: ……………………………………………………….. 
 
Signature of investigator: ………………………………………………….. 
 
Date: ……………………………………………………………………………. 
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Department Of Human Biology, Faculty of Health Sciences 
University of Cape Town, South Africa 
UCT/MRC Research Unit for Exercise Science and Sports Medicine 
 
 
INFORMED CONSENT 
 
“Skeletal muscle in patients with peripheral vascular disease before and after 
angioplasty”  
 
Dear Subject 
 
The UCT/MRC Research Unit for Exercise Science and Sports Medicine is 
conducting a study to investigate the effect angioplasty on skeletal muscle 
recruitment during a graded treadmill exercise test until exhaustion (maximal test).  
This simply means that we want to examine how your muscle activity changes 
before and after blood flow is restored to your lower limb. 
 
In order to examine “how your skeletal muscle and body responds” to the restoration 
of blood flow, we will take the following measurements before, during and after your 
tests: 
 
PRELIMINARY TESTING 
 Medical history recorded by the medical practitioner who is a co-investigator of 
this study, based at the Sports Science Institute of South Africa 
 Anthropometrical measurements including body weight, height and skinfolds 
(triceps, biceps, suprailiac, subscapular, calf, thigh and abdomen); 
 Familiarisation to treadmill running 
 Familiarisation to rating on the Borg category ratio scale (Rating of Perceived 
Exertion Scale) 
 Familiarisation to rating on the Perception of Pain Scale 
 Measurement of the ankle brachial blood pressure index meaning we will 
measure your blood flow at the ankle and calculate ankle brachial blood 
pressure index 
 Measure heart rate using electrocardiogram (ECG) 
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 Measure blood flow non-invasively in affected limb using the Colour Duplex 
Doppler at Kingsbury Hospital 
 
Experimental Testing 
 
 Trial 1: Graded treadmill exercise test till exhaustion (GTET) 
Please note the test will be supervised by a qualified medical doctor from our 
department.  
 
Prior to exercise test the following will be performed: 
- Measure ankle blood pressure to calculate ankle brachial index 
- Shave your leg to attach the EMG electrodes to your skin so as to measure 
muscle activity during the maximal voluntary contraction and the exercise 
test 
- Resting venous blood sample (two millilitres) will be drawn from the forearm 
vein 
 
During the GTET the following measurements will also be performed: 
- Muscle activity of the 6 muscles mentioned above (using the EMG system) 
- Heart rate will be recorded continuously using the electrocardiogram monitor; 
- Effort perception (RPE) and perception of pain every 2 minutes; 
- Blood pressure every 2 minutes 
- Heart rate measures every 2 minutes 
- Measure the amount of oxygen you breath in and the carbon dioxide you 
breath out 
- Pain free walking distance 
- Maximal walking distance 
 
After the GTET the following measurements will also be performed: 
- Measure ankle brachial blood pressure 
- Measure ankle brachial index  
- venous blood sample (two millilitres) will be drawn from the forearm vein at 
3, 4 and 5 minutes post exercise test 
 Trial 2: Graded treadmill exercise test till exhaustion (GTET)  
 To be conducted 3 days after angioplasty 
Please note the test will be supervised by a qualified medical doctor  
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- The test will follow 3 days after angioplasty 
 
Prior to exercise test the following measurements will be performed: 
-Blood flow using the Color Duplex Doppler at Kingsbury Hospital 
- Measure ankle blood pressure to calculate ankle brachial index 
- Shave your leg to attach the EMG electrodes to your skin so as to measure 
muscle activity during the maximal voluntary contraction and the exercise 
test 
- Resting venous blood sample (two millilitres) will be drawn from the forearm 
vein 
 
During the GTET the following measurements will also be performed: 
- Muscle activity of the 6 muscles mentioned above (using the EMG system) 
- Heart rate will be recorded continuously using the electrocardiogram monitor; 
- Effort perception (RPE) and perception of pain every 2 minutes; 
- Blood pressure every 2 minutes 
- Heart rate measures every 2 minutes 
- Measure the amount of oxygen you breath in and the carbon dioxide you 
breath out 
- Pain free walking distance 
- Maximal walking distance 
 
After the GTET the following measurements will also be performed: 
- Measure ankle brachial blood pressure 
- Measure ankle brachial index  
- venous blood sample (two millilitres) will be drawn from the forearm vein at 
3, 4 and 5 minutes post exercise test 
 
Possible risks participating in this trial 
The complications associated with exercise testing are relatively low (ACSM, 2000), 
however you need to be aware that you are at an increased risk when performing 
exercise. There are possible risks associated with exercise testing; you may 
experience arrhythmia (irregular, fast or slow heart rhythm), possible plaque rupture, 
acute thrombosis, drop in blood pressure, ischaemia (decreased oxygen to the 
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heart), pain and/or cramps in lower limbs, claudication, fatigue, shortness of breath 
and in very rare instances heart attack, stroke or death. Every effort will be made to 
minimize these risks by evaluation of preliminary information relating to your health 
and fitness and specifically throughout observations during your testing and by 
ensuring trained medical supervision throughout the trial. In addition to minimising 
the above mentioned risks, emergency equipment and trained personnel will be 
available to deal with unusual situations should they arise. 
 
Blood will be sampled by means of placing a cannula in the forearm vein and will 
flush with sterile saline solution after each blood sampling time-point.  Sterile 
techniques will be used, and the cannula will be inserted by a medical doctor. Risks 
associated with the drawing of blood include discomfort, infection (wound sepsis), 
muscle bruising (haematoma formation) and numbness (peripheral subcutaneous 
nerve injury). The risks will be minimized by cleaning the area around the vein with a 
disinfectant alcohol swap before the blood will be drawn. Immediately afterwards a 
protective plaster will be applied. 
 
There are no risks involved in the measurement of heart rate and EMG, except as 
otherwise stated in association with exercise. 
 
 
I,____________________________________clearly understand the nature of the 
study and the possible risks associated with the trial.  I also understand the extend 
of each procedure as described in the information sheet and listed above; 
 
I confirm that the exact procedure and techniques, and possible complications of the 
research trial have been thoroughly explained to me. I am aware that participation in 
this research study is absolutely voluntary and that I am free to withdraw from the 
study at any time without stating a reason and without prejudice.  I am also aware 
that the doctor or researcher can withdraw me from the study. I am aware that there 
will be trained medical supervision throughout the trial. In addition to minimising the 
above mentioned risks, emergency equipment and trained personnel will be 
available to deal with unusual situations should they arise.  
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 I know that any personal information required by the researchers and derived from 
the testing procedure will remain strictly confidential and will only be revealed as a 
number in statistical analysis. 
 
I have carefully read this form together with the information sheet and understand 
the nature, purpose and procedures of this study. I agree to participate in this 
research project of the UCT/MRC Research Unit for Exercise Science and Sports 
Medicine. 
 
Name of volunteer: …………………………………………………………... 
 
Signature of volunteer: ……………………………………………………… 
 
Name of investigator: ……………………………………………………….. 
 
Signature of investigator: ………………………………………………….. 
 
Date: ……………………………………………………………………………. 
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Modified Physical Activity Readiness Questionnaire (PAR-Q) 
Name Date 
DOB Age Home Phone Work Phone 
    
Regular exercise associated with many health benefits, yet any change of activity 
may increase the risk of injury. Completion of this questionnaire is a first step when 
planning to increase the amount of physical activity in your life. Please read each 
question carefully and answer every question honestly: 
Yes No 
1) Has a physician ever said you have a heart condition and you 
should only do physical activity recommended by a physician? 
Yes No 2) When you do physical activity, do you feel pain in your chest? 
Yes No 
3) When you were not doing physical activity, have you had chest 
pain in the past month? 
Yes No 
4) Do you ever lose consciousness or do you lose your balance 
because of dizziness? 
Yes No 
5) Do you have a joint or bone problem that may be made worse by 
a change in your physical activity? 
Yes No 
6) Is a physician currently prescribing medications for your blood 
pressure or heart condition? 
Yes No 7) Are you pregnant? 
Yes No 8) Do you have insulin dependent diabetes? 
Yes No 9) Are you 69 years of age or older? 
Yes No 
10) Do you know of any other reason you should not exercise or 
increase your physical activity? 
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If you answered yes to any of the above questions, talk with your doctor BEFORE 
you become more physically active. Tell your doctor your intent to exercise and to 
which questions you answer yes. 
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Anthropometrical and Information Work Sheet for cyclist 
 
Name:     ___________________________Date:________________ 
 
DOB:      ___________ 
 
Weight:  ___________Height:  ________________ 
 
EMG & Battery: Day 1_______          Day 2:________        Day 3:__________ 
 
Skinfold Measurements: 
Anatomical Areas 1 2 Avg 
Triceps 
Biceps 
Subscap 
Supra iliac 
Abdomen 
Thigh 
Calf 
Mid-Thigh circumference 
Upper________, Middle________, 
Lower________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PPO 1 (__/___/_): File Name___________                           Watts:_______ 
 
PPO 2 (__/___/_): File Name___________                           Watts:_______ 
 
PPO 3(__/___/_): File Name___________                           Watts:_______ 
Chair Settings: 
Chair length: Dyno length: 
Chair height: Dyno height: 
Leg attachment length:Bike Settings: seat height- 
Ankle length:chair height-Handle bar- 
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Anthropometrical and Information Work Sheet for Runners 
 
Name:     ___________________________Date:________________ 
 
DOB:      ___________ 
 
Weight:  ___________Height:  ________________ 
 
Skinfold Measurements: 
Anatomical Areas 1 2 Avg 
Triceps 
Biceps 
Subscap 
Supra iliac 
Abdomen 
Thigh 
Calf 
Mid-Thigh circumference 
Upper________, Middle________, 
Lower________ 
Length of quad ________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak treadmill running speed: ____________, Time: ______________ 
 
Biodex Chair Settings: 
Chair length: Dyno length: 
Chair height: Dyno height: 
Leg attachment length: 
Ankle length:Leg rest-across: 
- down: 
 
 
 Sprint Trial 1 (s) Trial 2 (s) Trial 3 (s) 
10 m       
20 m       
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Anthropometrical and Information Work Sheet for patients with PVD 
 
Name:     ___________________________Date:________________ 
 
DOB:      ___________ 
 
Weight:  ___________Height:  ________________ 
 
Trial 1:Trial 2 
ABI preABI pre 
 
ABI post ABI post 
 
Skinfold Measurements: 
Anatomical Areas 1 2 Avg 
Triceps 
Biceps 
Subscap 
Supra iliac 
Abdomen 
Thigh 
Calf 
Mid-Thigh circumference 
Upper________, Middle________, 
Lower________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chair Settings: 
Seat length 
Chair  length:Dyno length: 
Chair height: Dyno height: 
Leg attachment length: 
Down 
Across 
Ankle length: 
Leg Support: 
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PAIN SCALE 
 
 
 
 
 
 
 
 
0 
 
No pain 
 
 
1 
 
 
Very Very Slight 
 
2 
 
 
Very Slight 
 
 
3 
 
 
Slight 
 
4 
 
 
Mild 
 
5 
 
 
Moderate 
 
6 
 
Moderate to Severe 
 
 
7 
 
 
Severe 
 
8 
 
 
Very Severe 
 
9 
 
 
Very Very Severe 
 
10 
 
 
Maximum 
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BORG SCALE OF PERCEIVED EXERTION 
6 
7 Very, Very Light 
8 
9 Very Light 
10 
11 Fairly Light 
12 
13 Somewhat Hard 
14 
15 Hard 
16 
17 Very Hard 
18 
19 Very, Very Hard 
20 
